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Abstract 
The binding of a range of biologically prevalent anions to several novel lanthanide(III) 
complexes has been studied by emission spectroscopy, 1 H-NMR and mass spectrom-
etry. In each case, the resultant solution adduct and the mode of anion binding 
was characterised through analysis of spectral response. Following the first chapter, 
in which relevant background work and literature reports are discussed, the novel 
lanthanide(III) complexes described herein are separated into three chapters. 
Chapter 2 describes a range of complexes bearing a pendant azaxanthone or aza-
thioxanthone derived chromophore. Binding of anions was examined largely through 
sensitised emission, additionally the cellular localisation and toxicity profiles of each 
complex was studied. Of particular interest was the discovery of a family of com-
plexes that localised within the mitochondria of the cell lines examined, and exhib-
ited pC02 dependent luminescence, notwithstanding protein quenching. 
Chapter 3 describes the synthesis and evaluation of two stereoisomer^ dimeric 
complexes, in which the conformation of each was controlled by the differing relative 
stereochemistry of their linking unit. A range of luminescence and NMR studies was 
performed to establish the relative affinities of these complexes for selected anionic 
species, and to compare their binding properties to that of the related monomeric 
complex. 
Chapter 4 describes the immobilization of two related complexes onto various 
solid-phase supports. The ability of the immobilized complexes to selectively bind 
to, retain then release phospho-anions on addition of a competitive aqueous anionic 
buffer is examined. The utility and advantages of using such materials as tools for 
the enrichment of phospho-peptides is discussed in relation to previously published 
procedures and materials. 
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Chapter 1 
Introduction and literature review 
1.1 Introduction 
The role of anions in Nature is wide ranging and significant, exemplified by the reg-
ulation of many biological processes at the intracellular level. These often involve 
anionic species that play roles as signaling molecules and distributors of chemical 
energy. To fully understand the role of anions in events at the intracellular level, 
the development of selective synthetic probes is required. These probes may act 
as receptors for the specific anion of interest and then subsequently report upon 
the binding event. To this end, recent research has focused on the development of 
receptors that can reversibly bind to anions in aqueous media. 
During the design of aqueous phase anion receptors there are several major points 
to consider. The first of these is the free energy of hydration of the anion (Table 1.1). 
Due to the high free energy of hydration, in particular for oxyanions, a large elec-
trostatic contribution to binding is required so that the receptor can compensate 
for the unfavourable desolvation term. Indeed, it is often anion desolvation that 
is the key factor in determining the free energy of binding to the receptor.1 , 2 In 
addition, the local hydrophobicity of the receptor binding site must be considered. 
The energetic cost of desolvation of the receptor binding site upon anion binding 
will also be a key factor in determining the overall free energy change accompanying 
the anion binding process. The overall free energy of binding will usually be greater 
when there is less local hydration around the receptor binding site. 
4 
Anion Radius (A) A G ^ k J m o r 1 ) 
r 2.20 -275 
C N - 1.91 -295 
Br- 1.96 -315 
H C O 3 - 1.56 -335 
c r 1.81 -340 
F " 1.33 -465 
H 2 P0 4 - 2.00 -465 
S O 4 2 - 2.30 -1080 
C0 3 2 - 1.78 -1315 
P O 4 3 - 2.38 -2765 
Table 1.1 - Thermochemical radii and experimental standard molar Gibbs free en-
ergy of hydration for various anions,3 highlighting the high free energies of hydration 
observed for oxyanions. 
Certain anions exist within defined pH limits, whilst others vary in charge within 
a narrow pH window, thereby changing their electrostatic interactions. The pH of 
an analyte needs to be monitored and controlled to establish the relative proportions 
of anionic species in solution. Therefore, a suitable receptor needs to be effective 
within a defined pH region. Finally, anions occur in a range of shapes and geome-
tries. For example, halides are spherical, CN~ linear, HC03~ trigonal planar and 
P O 4 3 - tetrahedral, meaning careful receptor design is required to provide shape 
complementarity with respect to the target anion. 
1.2 The development of synthetic anion receptors 
Many functionalities forming the basis of early synthetic anion receptors can be 
seen in analogous systems present in nature. For example, the protonated forms of 
spermidine and spermine, naturally occurring polyamines, are reported to bind to 
phosphates in aqueous solution. 4 , 5 The active centres of phosphatases make use of 
the guanidinium functionality, 6 reflected in the widespread use of the guanidinium 
functionality in synthetic phosphate receptors. Receptors based upon metal cations 
find analogous examples in many enzyme active sites. For example, phospholipase 
C and alkaline phosphatase contain Zn(II) ions that provide the electrostatic basis 
for phosphate binding in these systems. This section will briefly highlight the use of 
various functionalities commonly employed in synthetic anion receptors. 
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The earliest synthetic anion receptors incorporated highly charged binding sites 
to provide a basis for strong electrostatic interactions, in order to compensate for 
unfavourable solvation in aqueous media. Early work described 'molecular inclusion' 
complexes with anions bound inside a molecular cavity by a tetrahedral array of 
+ N-H- • -X" hydrogen bonds and electrostatic interactions.1 Incorporated into a 
receptor, the ammonium functionality offers high charge density, hence efficient ion 
pairing. Also, ammonium groups can impart structural rigidity into a macrocyclic 
structure that can help complement the shape of a target anion. Halide anions 
were amongst the first anionic species to be recognised in aqueous media. For 
example, chloride ions were shown to be bound by the tetra-protonated form of the 
spheroidal cryptand, 1. This cryptand was more than a thousand-fold more selective 
for chloride than bromide.7 
H 
o J o r; 3 H r N N N-H H-N N N V N N 
H H 2 
H 
1 
Later work extended the scope of recognition. For example, 2 bound to linear tr i-
atomic anions selectively over non-linear anions.8 In both cases anion selectivity was 
controlled by cavity shape and size. The major limitation of such polyammonium 
receptors is the limited pH range in which they are operational. Despite this, there 
are many examples of such polyammonium receptors being developed for use in the 
field of aqueous phase anion recognition.9 
Early anion binding studies with macrocyclic guanidinium salts utilised the 
guanidinium pKa of 13.5 to ensure that anion binding properties of such systems 
were relatively pH independent.10 In addition, the positive charge of the functional-
ity, combined with its hydrogen bonding capabilities, make it an effective receptor 
6 
for carboxylate and phosphate recognition. 1 1 , 1 2 One of the main disadvantages of 
the guanidinium functionality in aqueous media is that it suffers from high levels of 
competitive solvation. Because of this, anion binding studies are often carried out in 
less polar aqueous alcohol solutions to increase binding specificity. Additionally, the 
guanidinium functionality may be incorporated next to a hydrophobic structure in 
an effort to reduce guanidinium solvation, although this reduces receptor solubility 
in aqueous conditions. In either case, the resulting receptors will perform optimally 
in non-aqueous conditions, rendering them less suitable for use in a biological envi-
ronment. One such example is the ditopic guanidinium receptor, 3, which was shown 
to bind to dicarboxylates in methanol. 1 3 This receptor exhibited a preference for 
malonate (log K = 4.2) over longer and shorter dicarboxylates. However, significant 
guest binding (log K = 2.4-3.4) was observed for all other dicarboxylates indicating 
the flexibility of the receptor with respect to guest anion structure. 
Bu Bu 
Si (C 6 H 5 ) , (CeHsaSf 
O 
NH HN 
C O . V NH 
HN 
3 
In addition to the polyamine and guanidinium functionalities present in early 
synthetic anion receptors, many other functionalities have since been utilised. Most 
commonly these functional groups are ureas, thioureas, amides, thioamides, pyrroles, 
indoles and hydroxyl groups, often present as part of a macrocycle.12 Not all of these 
functionalities have been utilised in aqueous media. 
One other class of synthetic anion receptors are those based upon a central metal 
cation. An appropriately positioned metal cation in a synthetic anion receptor can 
provide a strong basis for electrostatic attraction; often the metal cation is encapsu-
lated inside a macrocyclic ligand. A strong contribution from electrostatic attraction 
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is beneficial for aqueous phase anion receptors and metals of different charge density 
can be used to modulate the electrostatic affinity. Examples commonly include those 
containing Zn(II) or Ln(III) cations; several examples are covered in detail later. 
1.3 Methods of signal transduction 
There are several methods by which a binding event at a synthetic receptor may be 
reported. However, i t is important to realise at the outset that some signal trans-
duction methods are intrinsically restrictive and will impact upon the final utility of 
the probe. With regards to the design of synthetic receptors that can report upon 
anion binding events at a cellular level, it is clear that very few signal transduc-
tion methods fulfil the requirements needed to report on events with high spatial 
resolution. For such biological systems the use of luminescent probes is dominant. 
Luminescent probes offer the advantages of high sensitivity, with detection limits 
down to a single molecule,14 and spatial resolution down to the submicron level. 1 5 
Optical probes are able to relay information about anion binding events through 
changes to the local environment of the reporting unit. In general, anion binding is 
followed using UV/visible absorption and emission spectroscopy, by the monitoring 
of an intensity change or wavelength shift. Monitoring of emission lifetime and po-
larisation is also possible. There are many examples of fluorescent organic molecules 
that may be utilised to create luminescent organic probes. However, the excited 
state chemistry of Ln(III) ions is well suited to such applications and research into 
Ln(III) probes is now widespread. 
Other methods of signal transduction methods have been utilised. Of these, 
magnetic resonance is one of the most informative. Monitoring of the chemical shift 
or relaxation rate properties of a system can result in a large amount of structural 
information. In particular, the introduction of a paramagnetic metal ion into a probe 
can yield detailed results. Paramagnetic Ln(III) probes will be discussed later in 
this chapter. Magnetic resonance is restricted by the fact that its spatial resolution 
is insufficient to monitor events at a cellular level. Also, it is relatively insensitive 
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and requires expensive instrumentation. 
Electrochemical methods have also been reported where changes in current or 
emf, proportional to the anion concentration, are detected. Examples include the 
development of potentiometric ion-selective electrodes, created by the incorporation 
of neutral, anion selective ionophore molecules into a polymer membrane. 1 6 , 1 7 Bind-
ing of target anions is monitored by changes in the measured potential across the 
membrane. In general anion recognition by an ionophore is based upon hydrogen 
bonding or Lewis acidic interactions. The use of electrochemical methods is re-
stricted by the invasiveness of the techniques, the need for careful calibration, slow 
response times and often short working lifetimes of the polymer membranes. 
1.4 Approaches to selective anion recognition 
Much of the published research on anion recognition has been based on receptors 
operating in non-aqueous environments. This is of little surprise when considering 
the energetic cost of anion desolvation in aqueous media. However, research into 
systems operating in an aqueous environment is becoming more common. Much of 
this report will discuss our approach to anion recognition utilising Ln(III) complexes 
in an aqueous environment. This section will review recent reports of synthetic anion 
receptors that function in aqueous media and have been or possess the potential to 
be utilised as analytical probes. Each is based on strategies that do not involve 
Ln(III) complexation to achieve selective anion binding. Receptors of anions most 
relevant to the results published in this report will be emphasised, these include 
phosphorus(V) oxyanions, bicarbonate and citrate. 
1.4.1 Receptors and probes for phosphorylated anions 
Phosphates are ubiquitous in biological systems. For example, it is well understood 
that O-phosphorylated proteins play an important role in intracellular communica-
tion and also in the functioning of the nervous and immune systems. Phosphory-
lation of these proteins is carried out by protein kinases - these enzymes are phos-
photransferases and rely upon the nucleoside triphosphate, A T P 4 - , as the source 
9 
of the phosphoryl group. 1 8" 2 2 ATP 4 ~ itself is established as an intracellular energy 
source and is now understood to be involved in extracellular signalling, as are other 
nucleoside pyrophosphates.2 3 , 2 4 Because of the importance of this family of oxy an-
ions much effort has been devoted to the development of selective phospho-anion 
probes.25 
Anthracene bis(zinc(II)-dipicolylamine) complexes were reported to be the first 
selective artificial receptors of a phosphorylated peptide in aqueous solution. 2 6 - 2 8 
These bis-Zn(II) receptors, loosely mimicking the alkaline phosphatase active site, 
were found to selectively recognize a singly-phosphorylated peptide, phosphorylated 
on tyrosine. Binding was monitored by a fluorescence enhancement of [ Z n 2 L 4 ] 4 + or 
[ Z n 2 L 5 ] 4 + at 420 nm. This recognition, at pH 7.2, contrasted with the absence of 
fluorescence enhancement observed in binding studies with the non-phosphorylated 
analogue. Fluorescence enhancement upon anion binding was ascribed to suppres-
sion of photoinduced electron transfer quenching by a benzylic amine of the ligand. 
9 
\ 
N 
Zn 2 \ * N N N N N N N N 
O 
Zn 2* 
N 
f \ 
[Zn 2L 4] 4 + [Zn 2L 5] 4 + 
Binding studies with other singly-phosphorylated peptides revealed that the overall 
peptide charge was crucial to recognition, with negatively charged peptides being 
recognised whilst neutral and positively charged phospho-peptides resulted in either 
very weak or no receptor fluorescence enhancement. Accordingly, the apparent bind-
ing constant increased as the charge on the peptide increased. In addition, [ Z n 2 L 4 ] 4 + 
was shown to discriminate between ( 0 - P - T y r ) 2 - and H P 0 4 2 _ ; only (O-P-Tyr) 2 -
gave rise to receptor fluorescence enhancement. In contrast, both anions caused 
a fluorescent enhancement with [ Z n 2 L 5 ] 4 + . Subsequently [ Z n 2 L 4 ] 4 + and [ Z n 2 L 5 ] 4 + 
were used to monitor the phosphatase-catalyzed dephosphorylation of a peptide, 
10 
utilising the change in receptor fluorescence intensity during the dephosphorylation 
process to follow the reaction. [ Z n 2 L 4 ] 4 + was also used as a selective staining reagent 
in SDS-PAGE, preferentially staining phosphoproteins in a mixture of other proteins 
on the gel. 2 9 A major limitation of these receptors as potential intracellular probes 
is their reported lack of discrimination between different nucleoside pyrophosphates 
and phosphorylated proteins and peptides. In each case binding was signalled by a 
fluorescence change. 
In related work, complexes of two Zn(II)-(Dpa) units connected by various 2,2'-
bipyridine linkers were prepared, as receptors targeting di-phosphorylated peptides 
via intrapeptide cross-linking.30 
X) N N 
N N N N Si Z n 2 N N N 
N 
5^  [Zn2L6] [Zn 2 L 7 ] 4 + : X = CH 4+ 
[Zn 2 L a ] 4 + : X = N 
[ Z n 2 L 6 ] 4 + was tested with model a-helical di-phosphorylated peptides and a singly 
phosphorylated analogue (phosphorylated at serine), and also with residues 1154-
1165 of the activation loop of insulin receptor kinase (IRK) in non-, mono- and 
di-phosphorylated forms (phosphorylated at tyrosine). Aqueous conditions at pH 
8 were used. Results showed that binding affinity was highly dependent on the 
number of phosphorylated residues. The di-phosphorylated peptides were bound 
over ten times more strongly than their mono-phosphorylated analogue in the case 
of the model system. A modest 3-fold selectivity within the series of model di-
phosphorylated peptides was observed despite phosphorylation being at positions 
5 and 16, 9 and 16 or 12 and 16 respectively, suggesting a high degree of peptide 
and receptor flexibility. These studies utilised circular dichroism (CD) to show an 
increase of the diphosphorylated peptides a-helix conformation upon binding with 
[ Z n 2 L 6 ] 4 + , attributed to intrapeptide cross-linking stabilization. Fluorescence emis-
sion decreases at 389 nm were also used to monitor peptide binding to [ Z n 2 L 6 ] 4 + . 
11 
Studies with the IRK peptide yielded similar results. A 20-fold binding selectivity 
between di-phosphorylated and mono-phosphorylated fragments was recorded; bind-
ing to the non-phosphorylated fragment was not observed. The authors later utilised 
this intrapeptide cross-linking strategy with receptors [ Z n 2 L 7 ] 4 + and [ Z n 2 L 8 ] 4 + to 
disrupt the interaction between a di-phosphorylated peptide and a phosphoprotein 
binding domain via competitive receptor-peptide binding. 3 1 Studies were performed 
under aqueous conditions at neutral pH. In each of these reports, no competitive 
binding studies between the receptors and other common endogenous anionic species 
(e.g. H C O 3 - , citrate, lactate) was reported. 
Zn(II)-(dpa) complexation chemistry has been exploited more recently as part of 
a hybrid receptor where one Zn(II)-(dpa) unit was conjugated to a phosphoprotein 
binding domain. 3 2 
N 
[ZnL 9] 2+ 
Protein Pinl binds selectively to the multiphosphorylated C-terminal domain re-
peat sequence of RNA polymerase I I through the phosphoprotein binding (group 
IV WW) domain. Crystallographic analysis of a di-phosphorylated peptide (pS2,5-
CTD, phosphorylated at (0-P-Ser)2~ residues 2 and 5) bound to the phosphoprotein 
binding domain had shown only the pS5 residue interacted strongly with the binding 
domain. [ Z n L 9 ] 2 + was incorporated into three mutant W W domains at side-chains 
which, from crystallographic evidence, were in close proximity to the weakly bound 
(0-P-Ser)2~. Only one hybrid receptor, retaining the native-like conformation of the 
binding domain, was examined further. Following addition of a bis-phosphorylated 
pS6,9-CTD peptide to a solution of the chosen hybrid receptor, the stilbazole fluo-
rescence emission at 440 nm increased by up to 60 %, following excitation at 340 nm. 
This increase in emission is reported to be due to binding causing the stilbazole to 
rigidify, minimising relaxation associated with the torsional rotational freedom of the 
12 
two aromatic groups. The binding constant of the hybrid receptor with the peptide 
was found to be ~ 10-fold larger than that with the native W W domain and ~ 1000-
fold larger than that with [ Z n L 9 ] 2 + alone, suggesting a large degree of cooperativity 
in the binding process. A much lower binding constant was observed in binding 
studies with a bis-phosphorylated segment of IRK (1156-1164) compared to pS6,9-
CTD. In addition, the affinity of the hybrid receptor for nucleoside pyrophosphates 
was comparatively low. This marked selectivity was utilised in a real-time assay 
monitoring kinase-catalyzed phosphorylation by fluorescence enhancement. Phos-
phorylation of a substrate peptide, pS9-CTD, at Ser-6 was monitored by the hybrid 
receptor. No fluorescence intensity increase was observed in the absence of either 
A T P 4 - , pS9-CTD or the kinase enzyme, but a gradual increase occurred when all 
three were present. 
A strategy has been reported affording ribonucleopeptides (RNPs) as receptors 
that selectively bind to (O-P-Tyr ) 2 - or short peptide sequences containing (O-
P-Tyr) 2~. Initially, the authors reported the isolation of RNP receptors specific 
for (O-P-Tyr) 2 - that discriminated ( 0 - P - T y r ) 2 - from Tyr, (O-P-Ser)2" and (O-P-
T h r ) 2 - . 3 3 In vitro selection was used to select RNPs that bound (0-P-Tyr) 2 ~ from 
a pool of (4) 3 0 RNA sequences. Later work extended the RNP concept by isolating 
RNPs capable of distinguishing between two (O-P-Tyr ) 2 - containing tetra-amino-
acid motifs within the same protein (Figure 1.1).34 
O f ^ ~ \ Substrate / ^ ^ M fluor°Phore 
i ^ E Converting to an in vitro Selection Modification at 
ci7~~X RRENn RNA Library ^ P = q ^ p = } the AMerminal 
of Rev peptide 
Rev-RRE complex RRENn RNP Receptor RNP Sensor 
(RNP) RNP Library for GpYSR for GpYSR 
Figure 1.1 - Graphical illustration of the methodology used to isolate fluorescent 
RNP probes selective for a single (O-P-Tyr) 2 - site in a tetra-amino-acid motif. 3 4 
Receptors that bound to the desired (O-P-Tyr ) 2 - containing peptide sequence were 
converted into fluorescent probes via replacement of the peptides used with fluores-
cently labelled peptides. This yielded a fluorescent RNP that selectively responded, 
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via a fluorescence intensity increase, to the binding of the desired substrate phospho-
peptide and not to structurally related phospho-peptides. A 95-fold difference be-
tween the binding affinities of the two (0 -P -Tyr ) 2 - containing tetra-amino-acid mo-
tifs was observed. Despite the promising selectivities observed in these two reports 
the dissociation constants are not low enough for practical use. Dissociation con-
stants, at best, were in the low u.M range. However by using larger phospho-peptide 
or phospho-protein targets affinities may be increased. 
Selective probes for nucleoside polyphosphates have been developed based upon 
the high affinity observed for them by probes such as [ Z n 2 L 5 ] 4 + and related com-
plexes.35 One particular approach was based upon the switching on of the fluo-
rescence of [ Z n 2 L 1 0 ] 4 + upon nucleoside polyphosphate binding. The complex was 
reported to detect A T P 4 - at concentrations of less than 1 0 - 6 M . 3 6 
HO 
N N N 
H, 
OH OH HO OH 
[ Z n 2 L 1 0 ] 4 + [ Z n 2 L 1 , ( O H ) ] 3 + 
In a neutral aqueous solution [ Z n 2 L 1 0 ] 4 + exists in a deconjugated form, due to nu-
cleophilic attack of a water molecule coordinated to the two Zn(II) ions, resulting in 
the formation of [ Z n 2 L n ( O H ) ] 3 + . Upon addition of A T P 4 " to the solution, a 30-fold 
fluorescence increase at 523 nm (A e x=488 nm) was observed as binding saturation 
was reached. This behaviour was attributed to recovery of the conjugated form of 
the xanthene ring. Binding studies of [ Z n 2 L u ( O H ) ] 3 + with nucleoside monophos-
phates, phosphodiesters and oxyanions such as bicarbonate resulted in no recovery 
of fluorescence. The response of the complex to ATP 4 ~ was stable between pH 6 and 
8. As a result of the observed selectivity, an acetylated analogue of [ Z n 2 L n ( O H ) ] 3 + 
was used to visualise local particulate stores of A T P 4 - in Jurkat cells following 
intracellular complex hydrolysis by local esterases. 
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1.4.2 Receptors and probes for citrate and bicarbonate 
Outside the family of phosphate anions, there is a variety of other oxyanions that 
play key roles in intracellular events. For example, bicarbonate plays important 
roles in intracellular signal transduction (e.g. via bicarbonate regulation of cAMP 
synthesis),37 in the regulation of intracellular pH and volume, in photosynthesis and 
the Krebs cycle. 3 8 The citrate anion is of interest as an in vivo marker for several dis-
eases. For example, the marked difference in citrate accumulation and secretion by 
healthy and cancerous human prostate secretory epithelial cells is well established.39 
Citrate is also a key component in the Krebs cycle and has roles in fatty acid 
synthesis, photorespiration, the glyoxylate cycle and nitrogen metabolism. Despite 
the importance of these two anions, and in contrast to the field of selective phos-
phate recognition, there are very few reports detailing the development of selective 
receptors for bicarbonate and citrate. This section outlines the limited number of 
selective receptors and probes that have been studied in competitive aqueous media. 
One recent communication reported a fluorescent HC03~ probe constructed from 
a pyrene residue linked, via a triamine linker, to 7-cyclodextrin (12). 4 0 
Between pH 7 and 9, an association dimer of 12 is formed that can act as a re-
ceptor for H C 0 3 ~ . Upon addition of HC03~, a distinctive change in the form and 
intensity of the fluorescence spectrum of pyrene is induced that is not observed with 
other common anions. This selective response suggests that only HCO3 - binds to 
the probe. This behaviour was tentatively attributed to the formation of a pseudo 
azacrown ring by the triamine linker, under the experimental conditions, that can 
selectively bind to HCO3 - . The change of the fluorescence spectra upon HC0 3 ~ 
addition was assigned to a change in conformation, from parallel to twisted, of the 
two pyrene rings in the cavity of the association dimer. This twist reduces the 
overlap of the aromatic functionalities and therefore reduces overlap of ir orbitals, 
H H 
N N N 
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causing the excimer fluorescence to shift to shorter wavelength. The probe could 
reportedly signal changes in the concentration of aqueous solutions of HCC>3~ at a 
concentration of 1 mM and above. 
Another approach to HCO3 recognition was reported by Fabbrizzi, based on a 
displacement assay.41 
N NH HN 
C u 2 + C u N N 
N 
H H 
NH HN 
X T OH 
[Cu 2 L 1 3 ] 4 + 14 
The dicopper(II) complex, [ C u 2 L 1 3 ] 4 + , was earlier shown to possess some selectivity 
for H C 0 3 - , N3~ and N C O - in aqueous solution at pH 8. However, [ C u 2 L 1 3 ] 4 + was 
limited by its low response to anion binding with indistinct changes to the absorption 
spectra. Research into the use of [ C u 2 L 1 3 ] 4 + was subsequently extended by the use 
of coumarin 343 (14) to signal anion binding. At pH 7, coumarin 343 and [ C u 2 L 1 3 ] 4 + 
formed a 1:1 complex in which strong coumarin fluorescence at 487 nm was com-
pletely quenched (A e x c=424 nm). Upon competitive titration of the complex with 
H C O 3 - , N 3 - or N C O - , the titrated anion displaced coumarin 343 and its fluores-
cence was completely restored. Titrations with other anions (e.g. S O 4 2 - , HPO4 2 ") 
yielded only minor fluorescence enhancements. The coumarin 343 - [Cu2L 1 3 ] 4 + com-
plex was subsequently used in the determination of H C 0 3 - concentration in mineral 
water samples. The main disadvantage of such multi-component probes is that, for 
them to work, each component has to be spatially localised. This means that applica-
tions of these multi-component systems are limited to controlled assay environments. 
In addition, a recent report was published of a 'sensor' that chromogenically 
signalled the presence of H C O 3 - in neutral aqueous solution, Figure 1.2.42 
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Figure 1.2 - Proposed mechanism of operation of the pyrylium-containing polymer 
film 
The sensor was based on a pyrylium-containing polymer film that exhibited a col-
orimetric response to the presence of HC03~ in aqueous solution. Sensitivity was 
determined to be as low as 1 ppm from the published titration curves. The pos-
tulated mechanism of the sensor suggested that it is not based upon direct anion 
recognition, but is related to an acid-base reaction between H C O 3 - and H 2 0 . This 
releases O H - that attacks, in turn, the pyrylium sensor resulting in a colour change. 
This suggests a huge pH dependence of the response of the sensor that may lower 
its range of applicability. 
Zn(II) complexes that can act as H C O 3 - receptors have been used as models 
for the active site of carbonic anhydrase enzymes, 4 3 - 4 5 the aim being to more fully 
understand the role of the Zn(II) ion present in these proteins. Carbonic anhy-
drase enzymes catalyse the reversible hydration of C 0 2 and dehydration of HC03~, 
Figure 1.3. 
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Figure 1.3 - Carbonic anhydrase catalysis of CO2 hydration. 43 
One complex in particular, [ Z n L 1 5 ] 2 + , has proved extremely useful as the ligand 
provides the Zn(II) ion with a similar ligand field to that surrounding the Zn(II) ion 
in carbonic anhydrase. 
Studies have been carried out comparing anion recognition of Zn(II) active site model 
complexes and the carbonic anhydrase active site. Differences in ligand affinity and 
pK a values have been used to elucidate information about the enzyme mode of ac-
tion. For example, it is important to understand the role of amino acid residues 
surrounding the carbonic anhydrase active site in the catalytic cycle. For [ Z n L 1 5 ] 2 + 
catalysed hydration of CO2 to occur the complex has to be able to activate H 2 0 
at physiological pH. I t was found that one water molecule bound to [ Z n L 1 5 ] 2 + . 4 4 
The p K a value of the bound H 2 0 was determined to be 7.3 (25°C) and the sta-
bility constant of the hydroxide complex was log K = 6.4. Zn 2 + -OH was a good 
nucleophile in the catalysis of ester hydrolysis and acetaldehyde hydration. For the 
enzyme, the p K a value of Z n 2 + bound H 2 0 is reported as 6.8. 4 3 This suggests that 
the carbonic anhydrase Zn 2 + -OH complex is more stabilised than the model com-
plex, possibly by hydrogen bonding to surrounding amino acid side chains. H C O 3 -
n H H 
N 
"J 
Z n 2 + 
N 
H 
[ Z n L 1 5 ] 2 + 
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recognition by [ Z n L 1 5 ] 2 + was demonstrated during its catalysis of C 0 2 hydration 
and H C 0 3 - dehydration reactions.45 The affinity constant of Zn-HCC-3~ in car-
bonic anhydrase and [ Z n L 1 5 ] 2 + was reported to be log K = 1.6 (pH 8.5) and log K 
— 2.8 (pH 8.4, 25°C) respectively.43 These catalytic studies showed that the com-
plex could mimic the action of carbonic anhydrase, and that it exhibited moderate 
catalytic activity. Large differences between the reactivity observed for the complex 
and for carbonic anhydrase unsurprisingly suggest that further factors play a role in 
favouring the carbonic anhydrase system. These may include effective preassocia-
tion of substrates C 0 2 and HC0 3 ~ with the hydrophobic and hydrophilic pockets of 
the enzyme respectively. Binding studies of [ Z n L 1 5 ] 2 + with various anionic species 
known to inhibit carbonic anhydrase catalysed HC0 3 ~ were carried out. Anions ex-
amined included N 3 _ , NCS - and deprotonated sulfonamides. I t was concluded that 
inhibition was due to competitive coordination to Zn(II), however it gave experi-
mental confirmation that other functionalities within the carbonic anhydrase active 
site were not involved in inhibition. 4 3 In conclusion, this work highlighted that even 
simple synthetic anion receptors can play an important role in deducing mechanistic 
the behaviour of complex natural analogues such as enzymes. 
Amongst the earliest synthetic citrate receptors were those reported by Anslyn, 
who described a guanidinium based receptor that exhibited selectivity for citrate 
over other di-carboxylates such as succinate and glutarate. 4 6 Citrate was found to 
bind with the greatest affinity to 16 followed by 18 then 17. Binding was monitored 
by ^ - N M R . This suggests that preorganisation (contrast 16 and 17) and hydrogen 
bonding (contrast 16 and 18) are important in terms of complementary receptor 
design. 16, in general, exhibited a binding affinity for citrate one order of magnitude 
greater than that of other carboxylates (103 M _ 1 compared to 102 M _ 1 in D 2 0 at pD 
7.8). A T P 4 - was also demonstrated to bind to 16 with a lower affinity than citrate, 
a result that further emphasises the need for receptor-substrate complementarity. 
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Despite the degree of citrate selectivity exhibited by 16, it was also observed that 
high phosphate and sulfonate buffer concentrations impaired binding to the receptor. 
This may limit future applications of such receptors in biological media. This was 
exemplified in following work which combined 16 with a pH sensitive fluorophore 
such as carboxyfluorescein (19). In this case, changes in the absorption and fluo-
rescence spectra of a complex of 16 and carboxyfluorescein were used to monitor 
citrate binding optically through fluorophore displacement. 4 7 , 4 8 Due to fluorophore 
pH sensitivity a buffer was needed to maintain a constant pH. This required the 
use of methanokl^O mixtures to minimize competitive buffer-receptor interactions, 
highlighting a disadvantage of using such pH sensitive fluorophores. 
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Recent work has described the further use of indicator displacement assays to 
monitor citrate binding to related receptors. Reports described a receptor, 20, 
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similar to 16, incorporating a guanidinium functionality. 4 9 ' 5 0 Citrate detection is 
based on displacement of the receptor bound indicator carboxyfluorescein. As car-
boxyfluorescein is liberated from 20 fluorescence at 518 nm and 335 nm is restored. 
Titrations determined the binding affinity of 20 with citrate to be 1.6 x 105 M _ 1 
(pH 6.3, H 2 0 ) . A greater than ten-fold selectivity over the closely related structures 
of malate and tartrate was observed. The high binding constant and selectivity of 
this receptor for citrate derives primarily from the greater electrostatic binding with 
the citrate tri-anion. Additionally, the short wavelength fluorescence of the pyrrole 
unit limits its use in the presence of strongly absorbing biological molecules. 
Separate work based on carboxyfluorescein displacement from the copper(II) cy-
clam complex, [ C u 3 L 2 1 ] 6 + , was also recently reported.5 1 The binding affinity of 
this complex for citrate was determined to be log K = 5.59 (pH 7, H2O, HEPES), 
compared to log K values of 4.5, 4.1 and 3.8 for malate, tartrate and succinate 
respectively. This is one of the highest citrate-receptor binding affinity values re-
ported. However, despite the affinities realised and the selectivities observed, the 
use of dye displacement as an indicator of citrate binding is restrictive, and may be 
impractical in biological media due to competitive electron transfer quenching of the 
dyes used by protein or other reductants. In addition, no binding studies of these 
complexes with other common anions such as phosphates have been carried out to 
establish a full range of binding selectivities amongst biological anions. 
1.5 Anion binding utilising Ln(III) complexes 
The choice of kinetically stable chiral Ln(III) complexes based upon substituted 
cyclen ligands has proved to be a promising line of research in the development of 
synthetic anion receptors. 2 , 5 2 These Ln(III) complexes offer several features that 
are desirable. Ln(III) ions exhibit a high coordination number, usually 8 or 9. This 
allows the Ln(III) to be encapsulated by a macrocycle, such as a cyclen derivative, 
whilst retaining vacant coordination sites (occupied by labile solvent molecules) re-
quired for anion ligation. Anion affinity may be tuned through variation of the 
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Ln(III) ion and/or the macrocycle. For example, anion affinity follows the charge-
density trend Yb^Tm>Tb>Gd>Eu>>Ce. The macrocyclic ligand may be varied 
in numerous ways. For example, anion affinity may also be tuned by changing the 
electrostatic gradient around the Ln(III) ion centre, through variation of the charge 
carried by the ligand substituents. The steric bulk of the ligand may also be ad-
justed via variation of the ligand substituents. 
The excited state chemistry of Ln(III) ions may be utilised to develop emissive 
complexes that can be used to monitor anion binding. For example, the incorpora-
tion of a suitable sensitiser into the ligand structure offers the possibility to develop 
highly sensitive probes (e.g. selected emission bands in the luminescence spectra of 
Eu(III) complexes can be used to analyse the coordination environment around the 
Eu(III) ion). The use of paramagnetic Ln(III) complexes facilitates structural analy-
sis of bound anionic species by NMR, with the relationship between NMR properties 
of Eu(I I I ) /Yb(I I I ) complexes and the axial ligand proving to be a reliable means 
of determining the solution structure of complexes. This section will outline key 
points of these properties, and review recent examples of Ln(III) based synthetic 
anion receptors. 
1.5.1 Ln(III) luminescence 
The excited state chemistry of Ln(III) ions is well understood. Emission spectra 
contain characteristically sharp bands, Figure 1.4, due to their shielded valence 
4/ orbitals, and excited state lifetimes are long lived as ff transitions are Laporte 
forbidden. Owing to the forbidden nature of the ff transitions, the Ln(III) ions have 
low extinction coefficients. Unless the Ln(III) excited state is populated directly 
by an intense laser light source, unsuitable for many biological samples, sensitised 
emission is required, Figure 1.5. 
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Figure 1.4 - Partial energy level diagrams for Eu(III) (left) and Tb(III) (right). 
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Figure 1.5 - Photochemical pathway of sensitized Ln(III) luminescence. 
The properties required of a sensitiser, in order to maximise the efficiency of 
the sensitiser —• Ln(III) energy transfer process, are well known. 5 3 The choice of 
sensitiser is greatly dependent upon the energy of the emissive state of the Ln(III) 
ion. A range of sensitisers that efficiently populate the excited state of Eu(III) and 
Tb(III) ions, encapsulated within functionalized cyclen ligands, has recently been 
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devised and examined in detail. 
Each of the excited states present in Figure 1.5 are susceptible to quenching, 
Figure 1.6. This results in a reduction of the quantum yield and/or radiative lifetime 
of the complex. 
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Figure 1.6 - Illustration of the sensitiser and Ln(I I I ) excited states, showing how 
each may be peturbed through various deactivation processes. 
Of particular importance in the aqueous phase is non-radiative deactivation of the 
L n ( I I I ) excited state by energy matched X H oscillators, such as water molecule 
stretches and vibrations. Early work, comparing fluorescent yields and lifetimes of 
various L n ( I I I ) salts, reported enhancements in their respective values when mea-
surements were carried out in D 2 0 compared to H 2 0 . 5 5 ' 5 6 Later work assessed the 
relative contributions to the deactivation of the L n ( I I I ) excited state, by ligand N H 
and CH oscillators and closely diffusing solvent molecules, of a wide range of E u ( I I I ) , 
T b ( I I I ) and Y b ( I I I ) complexes. 5 7 This allowed relationships to be established be-
tween excited state radiative decay constants, k, in H 2 0 and D 2 0 , and the degree 
of inner sphere hydration of the complexes. The formulation of these relationships 
has since been used to determine the binding mode of various anions w i t h such 
complexes (e.g. monodentate or bidentate ligation), through analysis of complex hy-
dration levels before and after anion addi t ion . 5 8 
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Finally, the emission spectra of Eu( I I I ) complexes are perhaps the most informa-
tive of all the L n ( I I I ) ions, due to the sensitivity of various transitions to the local 
Eu ( I I I ) coordination environment . 5 9 ' 6 0 For example, the number of distinct Eu( I I I ) 
environments ( 5 D 0 —> 7 F 0 ) , ligand field strength and symmetry (5D\—>7F0) and co-
ordination environment around the metal ( 5 D 2 —> 7 F 0 ) can be deduced f rom analysis 
of the stated transitions. For this reason the E u ( I I I ) ion is the most widely utilised 
L n ( I I I ) ion in synthetic anion receptors reported so far. Correlations between struc-
tural and electronic spectral information for L n ( I I I ) complexes of derivatised cyclen 
ligands are discussed below. 
1.5.2 Ln(III) NMR properties 
A l l the L n ( I I I ) ions, apart f rom L a 3 + (f°) and L u 3 + ( f 1 4 ) , possess unpaired electrons. 
Any N M R active nuclei wi th in close proximity to the L n ( I I I ) ion wi l l experience 
the fluctuating magnetic field induced by its unpaired electrons. This leads to the 
broadening of the nuclei resonant signal due to the enhancement of the longitudinal 
and transverse relaxation rates ( T i and T 2 respectively). Due to the asymmetric 
distr ibution of electrons of the L n ( I I I ) ions, a shift of the nucleus resonant frequency 
may occur, the exception being G d ( I I I ) . The paramagnetic properties of these ions 
have found valuable uses either as N M R shift reagents or as probes for protein cal-
cium binding s i tes . 6 1 , 6 2 
For the nuclei of a ligand coordinated to a L n ( I I I ) ion, there are three contribu-
tions to the lanthanide induced shift (LIS, A ) , the diamagnetic (Ad), contact ( A c ) 
and pseudocontact ( A p ) shi f ts . 6 3 
A = A d + A c + A p (eqn. 1) 
The contribution of the diamagnetic shift, originating f rom conformational and in-
ductive effects, is usually small enough to be neglected except for nuclei directly 
coordinated to the L n ( I I I ) ion. Contact shifts arise f rom a 'through-bond' trans-
mission of L n ( I I I ) ion unpaired electron density to the bound nucleus. The contact 
shift contribution is normally huge for a bound nucleus but decreases rapidly as the 
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number of bonds between the L n ( I I I ) ion and the nucleus increases, hence facili-
ta t ing the identification of any L n ( I I I ) bound nuclei. The pseudocontact (dipolar) 
shift results f rom a through space interaction between the magnetic moments of the 
unpaired electrons of the L n ( I I I ) and the nucleus in question. The pseudo-contact 
contribution usually dominates as unpaired electron spin density resides mainly on 
the L n ( I I I ) ion. The magnitude of the dipolar shift is dependent on the geometric 
position of the resonating nucleus wi th respect to the L n ( I I I ) ion, allowing useful 
structural information to be obtained f rom analysis of the LIS. 
Each of the L n ( I I I ) ions possess differing electronic configurations, electronic 
magnetic moments and electronic relaxation times, so therefore behave differently 
under N M R conditions. The choice of which L n ( I I I ) ion to use as a shift reagent 
is a balance between the shift ing abili ty of the ion and the extent of associated line 
broadening. In the development of synthetic anion receptors, E u ( I I I ) and Y b ( I I I ) 
ions have proved particularly useful as they offer informative spectra due to a good 
balance between these two factors. In fact, i t has been shown that w i th well de-
fined L n ( I I I ) complexes, the magnitude of selected paramagnetically shifted ligand 
proton resonances provides a clear indication of the local coordination environment 
of the L n ( I I I ) ion (i.e. allowing correlations between the shift of the selected ligand 
resonance and the nature of ligating anion to be m a d e ) . 6 4 - 6 6 The following section 
w i l l discuss such correlations in relation to coordinatively unsaturated Eu( I I I ) and 
Y b ( I I I ) complexes of substituted cyclen ligands. 
1.5.3 Ligand structure 
In order for the solution state characterisation of any synthetic receptor and resultant 
adduct to be relatively simple i t is desirable that the receptor and adduct exist as 
one major isomer in solution. The solution isomerism of L n ( I I I ) complexes based 
upon the D O T A ( L 2 2 ) ligand and further chiral derivatives is well understood and 
has been recently reviewed. 6 3 
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Conformational isomerism exhibited by L n ( I I I ) complexes of substituted cyclen 
ligands may be related to two independent exchange processes. These are rotation 
of the pendant arms clockwise ( A ) or anticlockwise (A) , and the two conformations 
that may be adopted by the ring where the N C C N torsion angle is either positive 
(SS5S) or negative (AAAA). In theory, this results in 4 possible isomers (Figure 1.7). 
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Figure 1.7 - Schematic of the four possible stereoisomers of [ L n L 2 2 ] - (and related 
tetraamide complexes) and route of interconversion.6 7 
W i t h ligands such as D O T M P h A ( L 2 3 ) , each isomer is rendered diastereomeric due 
to the chiral centre 6 to the ring nitrogen. The considerable conformational r igidity 
27 
imparted by this remote chiral centre inhibits arm rotation and results in the ex-
clusive formation of only one of the diastereomers in solution. The helicity of the 
amide arms and the macrocyclic ring conformation is determined by the configu-
ration at the chiral centre, resulting in square anti-prismatic geometries (A(AAAA) 
and A(5558) for S and R configurations respect ively) . 6 8 ' 6 9 
The relative simplification of spectral analysis of L n ( I I I ) complexes, such as those 
of D O T M P h A , due to the presence of a single isomer, facilitated work into the effect 
of the axial ligand of such complexes on their magnetic and electronic proper t ies . 6 5 , 7 0 
This work has shown that for Eu ( I I I ) and Y b ( I I I ) complexes, the second order crystal 
field coefficient, sensitive to the polarisability of the axial ligand, determines the 
dipolar N M R shift; a conclusion also verified for complexes lacking a Cn axis. 6 4 For 
these complexes, selected ligand resonances for which the shift is purely dipolar, e.g. 
the most shifted axial macrocyclic proton H-4 (Figure 1.8), can be used as a reliable 
probe for local magnetic anisotropy and hence complex solution structure. 
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Figure 1.8 - A view along the cyclen ethylene C-C bond showing the relative orien-
tations of the protons including orientation of the paramagnetically shifted axial H 4 
proton 6 5 
In accordance w i t h theoretical ideas, 7 1 this work also concluded that for Eu( I I I ) 
complexes the ratio of the integrated emission intensities for the A J = 2 / A J — 1 spec-
tral bands correlates w i t h axial ligand polarisability. The relative intensity of the 
magnetic-dipole allowed A J = 1 transition is insensitive to changes in coordination 
environment whilst the intensity of the electric-dipole allowed A J=2 transition con-
siderably changes w i t h axial ligand variation. 
The role of the axial ligand field has recently been defined: 'the more polarisable 
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the axial donor the smaller the dipolar N M R shift - and the greater the affinity of 
that axial donor for the lanthanide i o n ' . 6 5 
1.6 Ln(III) based anion probes 
1.6.1 Ln(III) probes for phosphorylated anions 
Early work w i t h E u ( I I I ) complexes of L 2 4 , and related ligands, established that 
inorganic phosphate bound to these systems wi th an aff ini ty constant of log K = 
4.15 (295 K , pH 7.4, collidine buf fe r ) . 5 8 
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These encouraging early results led to binding studies of a variety of phospho-anions 
wi th similar L n ( I I I ) complexes . 6 6 , 7 2 , 7 3 The binding of O-phosphorylated amino acids 
to the complexes [ L n L 2 4 ] 3 + (Ln = T m ( I I I ) , Y b ( I I I ) and E u ( I I I ) ) were monitored by 
N M R , and to complexes [ E u L 2 6 ] 3 + , [ E u L 2 7 ] and [ E u L 2 8 ] 3 - by luminescence mea-
surements, at physiological pH. The N M R measurements revealed that amino acid 
chelation competed wi th phosphate ligation for complexes of the more charge dense 
metals, e.g. T m ( I I I ) and Y b ( I I I ) . However, for the corresponding Eu( I I I ) complex 
only phosphate ligation was observed (Figure 1.9). Binding was monitored by the 
mean shift of the 'pseudo-axial' proton of the macrocyclic ligand, as detailed in sec-
tion 1.5.3. In addition, the chelated binding modes of amino acids and dipeptides, 
w i th the Y b ( I I I ) complex, had been previously observed. 7 4 This work correlated 
axial proton N M R shifts w i t h X-ray structures of amino acid adducts to identify 
solution state isomers. 
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Figure 1.9 - When Ln = Yb( I I I ) or Tm( I I I ) , amino acid chelation competes with 
phosphate ligation (typically in a 1:3 ratio); when Ln = Eu(II I ) , only phosphate 
ligation is observed. pH 7.4, 295 K . 6 6 
Identical O-phosphorylated amino acid binding studies w i t h T m ( I I I ) and Y b ( I I I ) 
complexes of the A^-methylated ligand, L 2 5 , revealed that amino acid chelation be-
came the dominant binding mode in a 4:1 ratio. The conclusion reached was that the 
free energy of hydration of these complexes is reduced, hence favouring the closed 
nature of the chelated binding mode. The most interesting observation of these 
N M R studies was an unprecedented selectivity for ( O - P - T y r ) 2 - over ( 0 - P - S e r ) 2 - of 
approximately 30:1, observed in competitive binding studies w i t h complexes of L 2 4 . 
This selectivity was probed further i n luminescence studies w i t h E u ( I I I ) complexes 
of L 2 6 , L 2 7 and L 2 8 . 
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I t was observed that the luminescence spectra for ( O - P - T y r ) 2 adducts differed to 
that of (O-P-Ser ) 2 - adducts; notably in the relative intensities of the AJ—l and 
A J = 2 bands. Values of log K for the binding of (O-P-Ser) 2 " and ( 0 - P - T y r ) 2 ~ to 
[ E u L 2 7 ] were reported as 2.7 and 4.2 respectively (295 K , pH 7.4, 0.1 M MOPS, 
5 m M NaHCOa). This chemoselectivity was also conserved w i t h phosphorylated 
(O-P-Ser ) 2 - and ( O - P - T y r ) 2 - residues of various hexapeptides, and was retained 
in the presence of protein (HSA, 0.35 m M ) and background bicarbonate (5 m M ) . 
The greater chemoselectivity for ( O - P - T y r ) 2 - was at tr ibuted to its lesser degree of 
hydration in aqueous media. 
A 1:1 complex of T b ( I I I ) w i t h esculetin (29) was recently demonstrated to report 
on the presence of O-phosphorylated amino acids and the phosphorylated residue 
of a peptide, but not on the presence of non-phosphorylated analogues. 2 5 
HO X X X HO O 
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The complex had a A m a x of 465 nm ( A e x c = 405 nm), at tr ibuted to ligand fluores-
cence, whilst no T b ( I I I ) emission was observed. I t was reported that, at pH 7.0, 
ligand fluorescence increased by up to 50% in the presence of O-phosphorylated 
amino acids and phospho-peptide, whilst fluorescence remained unperturbed in the 
presence of non-phosphorylated analogues. Whils t respectable l imits of detection of 
between 5.1-21.8 p.M for the O-phosphorylated amino acids and phospho-peptide 
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were reported, there was no discussion regarding the u t i l i ty of the probe in the pres-
ence of competing anions. 
Recent work has probed the interactions of several E u ( I I I ) and T b ( I I I ) complexes 
wi th various phosphates, w i th the aim of achieving selective binding of specific nu-
cleoside polyphosphates in the presence of competing phosphorylated species and 
nucleot ides . 7 5 - 7 7 
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The complex [ E u L 3 0 ] + was reported to possess selectivity for A T P 4 (log K = 4.3, 
H 2 0 , pH 7.0, TRIS /HCIO4 0.01 M buffer) compared to A D P 3 - and A M P 2 - , however 
a sensitivity towards inorganic phosphate (log K = 4.2, H 2 0 , pH 7.0, T R I S / HC10 4 
0.01 M buffer) was also observed, as was the weak stability of the complex at submi-
cromolar concentrations. The adduct formed on binding to anions was postulated to 
possess a ligand bipyr idyl arm that was more weakly complexed to the metal as a re-
sult of direct phosphate-Ln(III) coordination. This resulted in a hypsochromic shift 
in the absorption spectra and a concomitant decrease in luminescence in tens i ty . 7 5 , 7 6 
Ligand L 3 1 was synthesised in order to form more stable L n ( I I I ) complexes. 7 6 The 
authors anticipated that the increased stability of resultant complexes would re-
sult in their exclusive binding to only the most negatively charged anion of the 
phospho-nucleotides studied, A T P 4 - . However, luminescence ti trations of [ E u L 3 1 ] + 
wi th various anions revealed a loss in selectivity for A T P 4 - as observed for [ E u L 3 0 ] + . 
Instead, strong binding to A D P 3 - , A T P 4 - and H P 0 4 2 ~ was observed (log K = 5.5, 
5.5 and 5.2 respectively, H 2 0 , p H 7.0, TRIS/HC1 0.01 M buffer), but not to A M P 2 " . 
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Similar binding studies wi th a further series of ligands was reported recently ( L 3 2 -
L 3 4 ) . 7 7 [ E u L 3 3 ] + selectively reported the presence of A T P 4 - in aqueous solution, 
but not A M P 2 - , A D P 3 - and H P O 4 2 - . Binding was monitored through emission 
and absorption spectra, results were consistent w i th displacement of the terpyridyl 
arm upon A T P 4 - binding. No quantitative analysis of binding was possible due to 
the weakness of the spectroscopic changes observed. Binding studies wi th [ E u L 3 2 ] + 
suggested that there was no interaction wi th any anion, whilst [ E u L 3 4 ] + showed 
interactions w i t h A D P 3 - , A T P 4 - and H P O 4 2 - . For this complex, quantitative anal-
ysis of binding was again not possible, apart f rom w i t h A T P 4 - , where an upper l imi t 
of the association was estimated to be 1.5 x 10 3 M - 1 . In conclusion, early work wi th 
[ E u L 3 0 ] + revealed promising selectivity for an important class of phospho-anions. 
However, i t appears this selectivity did not carry through in the synthesis of the 
more stable complex, [ E u L 3 1 ] + . Later work w i t h [ E u L 3 3 ] + again identified possible 
selectivities, though reported interactions and responses were weak. Such interac-
tions need strengthening then evaluating in a competitive environment before such 
complexes can be used as probes in biological media. 
A different approach to achieve selective reporting on pyrophosphate in the pres-
ence of competitive anions such as A T P 4 - and A D P 3 - was recently demonstrated. 7 8 
The series of E u ( I I I ) probes reported in this work based their reporting of anion 
binding on competitive displacement of their (3-diketone ligands acting as Eu( I I I ) 
sensitisers. Anion selectivity was tuned by the relative affinities of the ligands and 
anions for the metal ion. 
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Figure 1.10 - L 3 5 and a schematic representation highlighting the pathway of reduc-
tion in Eu(III) emission intensity through displacement of the |3-diketone ligands. 7 8 
[ E u ( L 3 5 ) 2 ] 3 + was used to monitor the hydrolysis of pyrophosphate by pyrophos-
phatase. The quenched luminescence of [ E u ( L 3 5 ) 2 ] 3 + was restored as pyrophosphate 
was hydrolyzed. This highlighted a practical use of such a probe, but also demon-
strated that such displacement systems w i l l only work w i t h anions of higher aff ini ty 
than the ligand. This typically restricts these probes to detection of anions of highest 
negative charge and therefore highest affinity. 
1.6.2 Ln(III) probes for citrate and bicarbonate 
To date, only one L n ( I I I ) probe which is chemoselective for citrate has been re-
ported. [ E u L 3 6 ] 3 + , reported by Parker in 2005. I t is based on a heptadentate cyclen 
ligand, w i th a coordinated azathioxanthone sensitising moie ty 7 9 increasing the steric 
demand at the metal centre. 
Ratiometric analysis of citrate concentrations i n the presence of a mixed background 
of endogenous anions was achieved through analysis of the changes to the rat io of 
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the A J = 2 / A J = 0 bands of the Eu( I I I ) emission. The affini ty of [ E u L 3 6 ] 3 + for citrate 
at pH 7.4 was determined to be 3.7 x 10 3 M - 1 in the presence of competing anions. 
The emission intensity of [ E u L 3 6 ] 3 + also remained constant between the pH range of 
7 and 8.2, and the A J = 2 / A J = 0 ratio remained constant over a wider range. The 
affini ty and chemoselectivity of [ E u L 3 6 ] 3 + for citrate is probably related to both a 
strong Coulombic interaction between the two species and the postulated chelated 
binding mode of citrate involving the a-hydroxy group and adjacent carboxylate. 
The binding of malate and tartrate were reported to yield similar l imi t ing emission 
spectra to that of citrate, but only at much higher concentrations. Therefore, such 
affinity and chemoselectivity as offered by [ E u L 3 6 ] 3 + demonstrates that selective an-
ion recognition in biological media can be achieved, and makes the possibility of 
anion sensing in cellulo much more feasible. 
HC03~ concentrations have been selectively monitored using ratiometric meth-
ods, in work similar to that described above. 8 0 
A series of cationic, neutral and anionic Eu( I I I ) complexes was analysed, [ E u L 3 7 ] 3 + , 
[ E u L 3 8 ] and [ E u L 2 8 ] 3 - are representative examples of the series studied. Overall 
complex charge was modulated through permutation of the cyclen pendant arms. 
Binding of the bicarbonate anion to the complexes could be monitored through 
changes to the ratios of the A J = 2 / A J = l or A J = 2 / A 7 = 4 E u ( I I I ) emission bands. 
The work demonstrated that H C 0 3 - concentrations could be selectively monitored 
in aqueous solutions (pH 7.4), in the presence of a background of competing an-
ions. The greatest aff ini ty for HC03~ was observed, unsurprisingly, wi th cationic 
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complexes followed by neutral then anionic complexes. Af f in i t y constants of com-
plexes in competitive media were measured and the highest observed value was wi th 
[ E u L 3 7 ] 3 + , whilst other aff ini ty constants decreased as complex negative charge in-
creased, Table 1.2. 
C o m p l e x L o g K 
[ E u L 3 7 ] 3 + 2.27 
[ E u L 3 8 ] 1.28 
[ E u L 2 8 ] 3 - 0.99 
Table 1.2 - Apparent affinity constants for complexation of HCO3 (295 K, 0.1 M 
MOPS, pH 7.4; 100 mM NaCl, 2.3 mM sodium lactate, 0.9 m M N a 2 H P 0 4 , 0.13 mM 
potassium citrate). 8 0 
Additionally, several of the complexes studied were also examined in cellular media 
and in cellular uptake experiments. A clear response of the complexes in cellular 
lysate to added HC03~ (3 - 20 m M ) was observed. The complexes were taken up 
into the cellular environment of N I H 3T3 cells and exhibited defined localisation. 
The complexes were reportedly non-toxic to the cells over a 3 h incubation period. 
I t can be envisaged that such complexes could be used to report upon H C O 3 -
concentrations in targeted organelles by read-out of the relative intensities of Eu ( I I I ) 
emission bands. I n addition, binding was selective at H C O 3 - concentrations found 
in the cellular environment, placing the response of the complexes at an optimal 
level. 
1.6.3 Other Ln(III) anion probes 
Other recent examples of L n ( I I I ) based anion probes include those reported by 
Gunnlaugsson. One approach is based on competitive ligation to [ E u L 3 9 ] 3 + . 8 1 
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In this case, at pH 7.5, the aromatic (3-diketonate (40) ligates to [ E u L 3 9 ] 3 + and 
can act as a sensitiser for E u ( I I I ) emission. Other (3-diketonate ligands, such as 4 1 , 
were found not to act as a sensitiser of [ E u L 3 9 ] 3 4 " emission. I t was shown that upon 
addition of certain anions (e.g. lactate, H C 0 3 ~ , acetate, fluoride) to a solution of 
the in i t ia l adduct displacement of the (3-diketonate sensitiser occurred and Eu( I I I ) 
emission was 'switched off ' . This early communication did not report any observed 
anion selectivities or aff ini ty constants. Like the displacement systems described 
earlier, the decreasing luminescence of the complex upon increasing anion concen-
trations is not ideal for a probe. Issues such as signal to noise ratio at higher anion 
concentrations wi l l reduce its sensitivity. In addition, in a biological environment 
such probes could relay no information on the time dependence of local anion con-
centrations due to emission being switched off upon anion binding. 
Other work by Gunnlaugsson developed trimetallic lanthanide luminescent com-
plexes as anion probes bearing an internal reference channel. 8 2 The complex pos-
sessed one cyclen unit and two l-aza-18-crown-6-ether units, allowing up to three 
metal ions to be complexed. One system was synthesised containing two T b ( I I I ) 
cations and one E u ( I I I ) cation, [ E u T b 2 L 4 2 ] 9 + . 
Binding of malonate to the complex was studied through changes to metal based 
emission. Upon anion binding, the observed enhancement of E u ( I I I ) emission was 
much greater than the concomitant decrease in T b ( I I I ) emission, allowing T b ( I I I ) 
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emission to be used as an internal reference channel. I t was postulated that the 
anion bound at the cyclen encapsulated E u ( I I I ) centre, w i t h formation of a 1:1 
complex:anion adduct formed at low anion concentrations, whilst a 1:2 adduct was 
observed at high anion concentrations. Such multi-metallic luminescent systems may 
seem uneccesarily complicated in the quest for ratiometric analysis, when i t could 
be achieved through analysis of E u ( I I I ) emission alone, as observed wi th previously 
mentioned complexes. 
1.7 Summary 
I t is interesting to note the opinion of other scientists working in the field of aqueous 
phase L n ( I I I ) based anion probes. Most strikingly, a recent article stated ' . . . . i t is 
doubtful that europium probes can be used to quantify the concentration of ATP 
(or any of the other analytes listed above) in complex biological samples. Rather, 
their applications are l imited to situations in which the specificity of the probe is 
not crucial and the amount of interferences can be minimized . ' . 8 3 The 'other ana-
lytes' referred to includes citrate, amino acids and HCO3 - , amongst others. This 
statement was made in a report detailing the use of a E u ( I I I ) tetracycline complex, 
as a non-selective fluorescent probe in controlled assay environments, in determining 
the act ivi ty of kinase enzymes. 
Whilst achieving selective anion binding in aqueous media is diff icult , and the in-
tricacies of this task should not be understated, the pessimism of Schaferling and 
Wolfbeis is probably undue at this early stage in the development of L n ( I I I ) based 
anion recognition. There are important examples of selectivity having been achieved, 
or at least steady progress towards this goal. Because of these early foundations, 
the selective recognition and monitoring of certain essential anionic species, in the 
cellular environment and in real time, is very close to being achieved. 
The work presented in the following chapters explores the u t i l i t y of several L n ( I I I ) 
complexes as selective probes for anionic species. This work has focussed on the de-
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velopment of novel sensitised L n ( I I I ) complexes, the development of dimeric L n ( I I I ) 
complexes and the immobilisation of L n ( I I I ) complexes on solid supports. Exami-
nations of the probes in vitro and in cellulo have been carried out. These results 
wi l l be reported and discussed. 
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Chapter 2 
Anion binding studies with 
luminescent Ln(III) complexes 
2.1 An initial luminescence binding study 
As outlined in section 1.6.1, early anion binding studies with complexes of [ L n L 2 4 ] 3 + 
and related ligands observed a binding selectivity for the inorganic phosphate an-
ion, even when in the presence of a background of competing anions and protein. 
Further studies, examining the relative affinities of [ L n L 2 4 ] 3 + complexes for a se-
ries of phospo-anions, reported an unprecedented selectivity for ( O - P - T y r ) 2 - over 
( 0 - P - T h r ) 2 ~ and ( 0 - P - S e r ) 2 - . This was conserved when the residues were present 
in small peptides. In addition, a competitive chelated binding mode (Figure 1.9) 
observed during binding studies with the more charge dense lanthanides (Yb(III) , 
Tm(III ) ) was not observed when [ E u L 2 4 ] 3 + was examined. 
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The behaviour of ( E u L 2 4 ] 3 + encouraged further selectivity experiments with this 
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complex. Recent work examined the binding of [ E u L 2 4 ] 3 + to a peptide, the insulin 
receptor fragment 1154-1165, containing three tyrosine residues. 7 3 Binding analysis 
of [ E u L 2 4 ] 3 + was carried out with three peptides of differing states of phosphorylation 
(43b-d) and the 'parent' non-phosphorylated peptide (43a). It was hypothesised 
that due to the chemoselectivity of [ E u L 2 4 ] 3 + for ( ( 9 - P - T y r ) 2 - residues, the regios-
electivity of complex binding on 43d would be determined by local electrostatic 
contributions from the peptide. 
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H 2 N NH 
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43a R t = R 2 = R 3 = H 
43b R, = R 3 = H; R 2 = O P 0 3 2 -
43c Ri = R 2 = H; R 3 = O P 0 3 2 " 
43d R 1 = R 2 = R 3 = O P 0 3 2 -
This work established that following addition of [ E u L 2 4 ] 3 + to each phosphopeptide 
a phosphate-bound ternary adduct was formed. Upon complex-peptide binding, 
amino acid nuclei in close proximity to the phosphate binding site undergo dipo-
lar coupling to the unpaired electrons of the E u ( I I I ) ion resulting in a paramag-
netic shift. Due to the modest magnetic anisotropy of E u ( I I I ) the distance over 
which paramagnetic shifts are observed is small (<10A). Comparison of the 1 H -
NMR T O C S Y spectra of the various peptides before and after addition of [ E u L 2 4 ] 3 + 
enabled the assignment of amino acid resonances that were previously undetermined 
based upon the analysis of the peptide NMR alone. A modest binding preference of 
[ E u L 2 4 ] 3 + for ( 0 - P - T y r ) 2 - at residue 9 of the triphosphorylated peptide (43d) was 
observed. The binding preference can be explained by local coulombic attraction 
and repulsion within the peptide, with respect to the phosphorylated residues. 
To complement the NMR studies described above, emission spectra of [ E u L 2 7 ] 
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were recorded in the presence of peptides 43a and 43c, Figure 2.1. The Eu(III ) 
emission spectrum of [ E u L 2 7 ] with the non-phosphorylated peptide 43a was identical 
to that of the complex on its own, but very different to that observed in the presence 
of ( O - P - T y r ) 2 - . 
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Figure 2 . 1 - Europium emission spectra for [EuL 2 7 ] (50uM) (lower, black), [EuL 2 7 ] k. 
43a (50uM/100uM) (lower, grey) and [EuL 2 7 ] k (0 -P-Tyr) 2 ~ (50^M/100uM) (top). 
pH = 7.4, 0.1 M MOPS buffer, A e x c = 408 nm. 
The emission spectrum of [ E u L 2 7 ] in the presence of phosphopeptide 43c was similar 
to that of [ E u L 2 7 ] in the presence of ( 0 - P - T y r ) 2 ~ , Figure 2.2. The similarity of the 
splitting pattern of the three bands of the magnetic-dipole allowed AJ=1 manifold 
at ~590 nm, as well as the analogous form and relative intensity of the hypersensitive 
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A J = 2 and A J = 4 transitions at ~616 and ~695 nm respectively provide a clear in-
dication of the similarity of the environment around the Eu(I I I ) ions in each adduct. 
This is consistent with selective binding of the complex to the phospho-anion site of 
43c and consequently confirms the weak binding of [ E u L 2 7 ] to 43a. 
s> 15 
645 
Wavelength (nm) 
720 
Figure 2.2 - Europium emission spectra for [EuL 2 7 ] (50uM) (lower), [EuL 2 7 ] & 43c 
(50nM/100^M) (centre) and [EuL 2 7 ] & (O-P-Tyr) 2 " (50uM/100uM) (top). pH = 
7.4, 0.1 M MOPS buffer, A e x c = 408 nm. 
This work provides further confirmation that [ E u L 2 4 ] 3 + binds to the phosphory-
lated peptides (43b-43d) via the phosphate functionality only. It can therefore 
be established that the paramagnetically shifted resonances observed in the pep-
tide : H - N M R T O C S Y originate only from nuclei in close proximity to phosphate 
binding sites. As described above, the comparison of the peptide ^ - N M R T O C S Y 
spectra before and after addition of the complex enabled the correlation of shifted 
resonances with specific amino acid residues of the peptide that were undetermined, 
based upon the analysis of the peptide spectra alone. The complex [ E u L 2 4 ] 3 + , has 
therefore been shown to serve as a chemoselective paramagnetic probe that targets 
phospho-tyrosine sites in phosphorylated peptides, allowing such complexes to be 
considered as prototypical chemoselective paramagnetic derivatising agents.8 4 
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2.2 Novel sensitised Ln(III) complexes 
The design and synthesis of novel Ln(III ) complexes originated from the above men-
tioned work and phosphate 6 6 , 7 2 , 7 3 and citrate 7 9 binding studies, as outlined in sec-
tions 1.6.1 and 1.6.2 respectively. The structures of the new ligands were designed 
with previous ligands in mind. A key feature was the retention of certain structural 
features essential in defining anion binding preferences of complexes. The rationale 
behind the design and synthesis of these ligands will be discussed in this section.* 
2.2.1 Design and synthesis of analogues of [ E u L 2 4 ] 3 + 
Following the successful use of [ E u L 2 4 ] 3 + as a phospho-anion probe in NMR studies, 
it was decided to synthesise a structurally related complex incorporating a sensitising 
moiety into the ligand structure ( L 4 4 a ) . This allows sensitised emission of the Eu(III ) 
ion to be used to monitor anion binding events. It was essential that the synthesised 
complex [ E u L 4 4 a ] 3 + should possess a high degree of structural homology to that of 
[ E u L 2 4 ] 3 + , in order to retain the favourable binding preferences and affinities with 
target anions. 
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The structure of the proposed complex retains the N4O3 coordination environment 
around the Ln(I I I ) ion, as in [ E u L 2 4 ] 3 + . Only the peripheral segment of one amide 
arm was modified to incorporate the azaxanthone sensitiser. The fourth ring TV-atom 
was left unsubstituted. In previous work it had been observed that TV-methylated 
* All complexes synthesised in this chapter were isolated and analysed as their chloride salts, 
except [ G d L 4 4 b ] 3 + which was isolated and analysed as its acetate salt. [ E u L 5 2 ] 3 + was analysed as 
its triflate salt. 
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complexes tend to favour chelated structures over phosphate-bound adducts. 6 6 The 
azaxanthone sensitiser was chosen following earlier work that established the suit-
ability of these chromophores for sensitising E u ( I I I ) and T b ( I I I ) emission. 5 4 In 
addition, the carboxymethyl substituent of the azaxanthone provides a functional-
ity through which further conjugation of synthesised complexes could be accommo-
dated. 
The synthesis of L 4 4 a involved amide bond formation between a protected cyclen 
ligand bearing a carboxylic acid arm (46), and an azaxanthone derivative with a 
pendant primary amine (47), Figure 2.3. 
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Figure 2.3 - Outline of the synthetic route used for the synthesis of L 4 4 a and L 44b 
The acid 46 was synthesised as shown in Figure 2.4. Selective Af-protection of cyclen 
at the 1,7-positions was achieved following established literature procedures using 
benzyl chloroformate.8 5 The introduction of the two chiral pendant amide arms was 
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achieved by AT-alkylation of the remaining two cyclen secondary amines, followed 
by standard deprotection conditions to remove the Cbz-groups. Mono-protection 
of one of the free ring nitrogens was carried out using B O C 2 0 . However, synthesis 
of the tetra-substituted side product could not be easily avoided and column chro-
matography was required to separate the desired product. The tetra-substituted 
side product (di-BOC) could be transformed back to the starting 1,7-disubstituted 
precursor through standard B O C deprotection chemistry and washing steps. Alky-
lation of 45 with ethyl bromoacetate, followed by hydrolysis, yielded the desired 
protected ligand bearing a pendant acid arm. 
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Figure 2.4 - Outline of the synthetic route taken to achieve the synthesis of 46. 
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The acid, 46, proved to be a versatile intermediate in the synthesis of several other 
complexes reported in this thesis. These complexes will be discussed in later chap-
ters. 
The 2-aminomethylazaxanthone derivative (47) was prepared in good yield from 
the bromomethyl precursor via a Gabriel reaction, Figure 2.5. Initial attempts 
to introduce the amine group via reaction of 7-methoxycarbonyl-2-bromomethyl-l-
azaxanthone with sodium azide proved unsuccessful. The synthesis of 7-methoxycar-
bonyl-2-bromomethyl-l-azaxanthone was undertaken following previously reported 
procedures.5 4 This involved deprotonation of methyl-4-hydroxybenzoate with sodium 
methoxide, followed by coupling with 2-chloro-6-methylnicotinic acid in molten met-
hyl-4-hydroxybenzoate. Electrophilic cyclisation of the resulting intermediate in 
PPA yielded 7-methoxycarbonyl-2-methyl-l-azaxanthone. Benzylic bromination wi-
th NBS using an A I B N initiator yielded the desired product. 
C0 2 Me o o o 
PPA, 120°C 5^ 1. NaOMe OMe OH 
2. 155°C O 32% Cu 2 Me N O N \ / 
IX 
OH O OH 
OMe CI N 
36 <X N O 
> K O 
NBS, AIBN.CCI 
OMe OMe X = 0:14°/ i O 
N DMF N NBS, Benzoyl peroxide, 
CCI N Br X = O:90 % O 
X = S: 92 "X X = S:16% 
V / o o 
1. NH 2NH 2, DCM/MeOH OMe 
2. Cone. HCI N aq 
X = 0:69% NH3CI 
X = S 9 6 % 47(X = 0 ) 
48 (X = S) 
Figure 2.5 - Outline of the synthetic route used to synthesise 47 and 48. 
Problems associated with this synthetic route related to the competitive hydrolysis 
of the methyl ester during work up of the electrophilic cyclisation step, forming an 
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acid that proved difficult to isolate. However, this problem was alleviated when us-
ing MeOH instead of H 2 0 to quench PPA. A further limitation was the formation 
of the dibrominated side product during the benzylic bromination step. However, 
methodology has been established utilising diethyl phosphite to convert this side 
product back to the mono-brominated and non-brominated precursors. 8 6 In any 
case, each of these steps significantly reduced the overall reaction yield. 
Coupling of 46 and 47 was achieved by activation of 46 using carbodiimide chem-
istry, followed by amide formation in good yield upon addition of 47, Figure 2.3. 
Deprotection of the ligand using T F A , followed by complexation yielded the desired 
complex. Ion-exchange chromatography was carried out to convert the complexes to 
their chloride salts, thereby enhancing their water solubility. It should be noted that 
typical methodology used in the research group is to use a slight excess of Ln(III) 
salt over the free ligand during complexation reactions. Excess Ln(III ) salt is then 
removed by adjusting the pH of an aqueous complex solution to 10 to precipitate 
insoluble L n ( O H ) 3 . The solution is then filtered and the pH is adjusted back to neu-
tral. In this work, a slight excess of ligand was used during complexation reactions 
as it was discovered that uncomplexed ligand could be easily removed by washing 
the crude reaction product with CH2CI2. This removed the need for harsh basic 
conditions and ensured N a C l / K C l did not contaminate the final product. 
The azathioxanthone analogue, L 4 4 b , was also synthesised, Figures 2.3 and 2.5. 
Each reaction proceeded in a similar fashion as described previously. During the 
synthesis of 48 the crystal structure of the intermediate 2-phthalimidomethyl-7-
methoxycarbonyl-l-azathioxanthone was obtained, Figure 2.6. 
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Figure 2.6 - Molecular structure of 2-phthalimidomethyl-7-methoxycarbonyl-l-
azathioxanthone, showing the phthalimide unit to be twisted perpendicular with re-
spect to the azathioxanthone. 
The acid analogue of [ E u L 4 4 a ] 3 + , [ E u L 4 9 ] 2 + , was also synthesised, Figure 2.7. 
The free acid group of the complex structure was intended to allow conjugation of 
the complex using standard coupling methods. 
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Figure 2.7 - Outline of the synthetic route used for the synthesis of L . 
The simplest envisaged method by which [ E u L 4 9 ] 2 4 " could be synthesised involved 
mi ld base hydrolysis of [EuL 4 4 *] 3 " 1 ". However, this method proved problematic and 
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decomplexation of the E u ( I I I ) ion was observed. Whilst hydrolysis of complexes 
with octadentate ligands has previously proved to be a successful strategy towards 
the synthesis of Ln(I I I ) conjugates, 8 6' 8 7 the lower coordination environment around 
[ E u L 4 9 ] 2 + gives rise to a less kinetically stable complex that cannot tolerate such 
basic conditions. Other routes towards the synthesis of L 4 9 , via the hydrolysis of the 
parent sensitiser, ultimately did not allow access to the desired ligand. 8 8 Finally, 
synthesis of the desired ligand was achieved through base catalysed hydrolysis of 
B O C protected L 4 4 a , Figure 2.7. The hydrolysis and all subsequent steps were high 
yielding. No undesired side products were detected or isolated. Complexation of 
the resulting ligand, L 4 9 , proceeded as described earlier to yield the desired E u ( I I I ) 
complex. 
The octadentate analogue of L 4 4 a , L 5 0 , was also synthesised as part of wider 
studies examining the mechanism of cellular uptake of Ln(II I ) complexes, Figure 2.8. 
The ligand L 5 0 was one of a series examined in which the resulting complexes dif-
fered in the nature of the pendant arms or the link between the sensitiser and the 
macrocycle. 
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Figure 2.8 - Outline of the synthesis of complex [ E u L 5 0 ] 3 + . 
The synthesis of [ E u L 5 0 ] 3 + involved the intermediate 45, and followed procedures 
outlined previously. The key step involved the introduction of a protected acid fo l -
lowed by its unmasking, Figure 2.8. I n this case, acid activation was achieved using 
T B T U followed by amide formation using the azaxanthone sensitiser 47. Complex-
ation of the subsequent ligand proceeded as described earlier, using a slight excess 
of ligand. A l l complexes and precursors were rigorously characterised by standard 
spectroscopic techniques. I n addition, the pur i ty of the complexes was assessed by 
reverse phase H P L C to ensure that any uncomplexed ligand had been fu l l y removed. 
2.2.2 Design and synthesis of an analogue of [ E u L 3 6 ] 3 + 
In l ight of the citrate selectivity reported for [ E u L 3 6 ] 3 + , 7 9 i t was decided to probe the 
effect of modulating the ligand amide substituents on the anion binding properties of 
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this complex. The proposed ligands ( L 5 1 a / L 5 1 b ) were designed so that the resulting 
complex retained the coordinated chromophore and conserved vacant coordination 
sites, so that labile water molecules could be displaced on anion binding. 
MeO 
H N H Ph 
L N - - , \ . CO,Et 
Ph 
rest r N N O Eu-O o - J N N E t 0 2 C 
UJ ^ H N Ph Ph H H OH H , 0 
[ E u L 3 6 ] 3 + [ E u L 5 1 a ] 3 + ( X = 0) 
[ E u L 5 1 b ] 3 + ( X = S) 
The synthetic route chosen involved the tri-substituted cyclen intermediate, 45, Fig-
ure 2.4. Alkylation of 45 with either 7-methoxycarbonyl-2-bromomethyl-l-azaxanth-
one or 2-bromomethyl-7-methoxycarbonyl-l-azathioxanthone, followed by column 
purification on alumina, yielded the desired protected ligand. Subsequent depro-
tection ( T F A / D C M ) yielded L 5 1 a / L 5 1 b , Figure 2.9. Complexation with E u ( O T f ) 3 
followed by ion-exchange utilised identical methodology as described earlier. Both 
ligands were rigorously characterised by standard spectroscopic techniques. Com-
plexes were also analysed by reverse phase H P L C . 
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Figure 2.9 - Outline of the synthetic route towards ligands L 5 and L 51b 
2.3 Solution studies with coordinatively unsatu-
rated complexes 
2.3.1 Characterisation of complex solution structure 
The series of 7-coordinate complexes was examined in solution to determine the co-
ordination environment about each Ln(I I I ) ion. The E u ( I I I ) complexes [ E u L 4 4 a / b ] 3 + 
and [ E u L 5 1 a / b ] 3 + were characterised by ^ - N M R . As outlined in section 1.5.3, the 
chemical shifts of the axial macrocycle protons can be used to probe complex so-
lution structure. The NMR spectra of [ E u L 4 4 a ] 3 + and [ E u L 4 4 b ] 3 + were virtually 
identical. The spectra, in particular the shifts of the axial macrocyclic protons, are 
very similar to that of [ E u L 2 4 ] 3 + , Figure 2.10. This indicates a high degree of struc-
tural similarity between the complexes and suggests a constant axial donor ligand 
( D 2 0 ) . 
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Figure 2.10 - 1 H - N M R spectra for [ E u L 2 4 ] 3 + (200 MHz) (left) and [ E u L 4 4 a ] 3 + (500 
MHz) (right) (D2O, 295 K, pD 7.8, 1 m M complex). Resonances marked with • are 
assigned to the cyclen N H proton, resonances marked with • are assigned to cyclen 
Hax protons. 
In contrast, the ^ - N M R spectra of [ E u L 5 1 a ] 3 + and [ E u L 5 1 b ] 3 + were suprisingly 
different to each other (Figure 2.11), and were far less well defined than those of 
[ E u L 4 4 a / / b ] 3 + . The broad resonances observed suggest a far greater degree of com-
plex conformational mobil i ty on the N M R timescale. I n addition, the differences 
between the spectra of [ E u L 4 4 a / b ] 3 + and [ E u L 5 1 a / b ] 3 + highlight the effect of varying 
the funct ional i ty l inking the macrocycle and sensitiser on the ligand environment 
about the E u ( I I I ) ion. I t should be noted that the magnitude of the chemical shifts 
in each spectrum suggests a constant axial donor ligand ( D 2 0 ) . 
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Figure 2.11 - X H-NMR spectra for [ E u L 5 1 a ] 3 + (left) and [ E u L 5 1 b ] 3 + (right) (500 
MHz, D2O, 295 K, pD 7.8, 1 m M complex). Resonances marked with • are assigned 
to the cyclen NH proton. 
A further technique by which the solution structure of the complexes may be com-
pared, and related to that of [ E u L 2 4 ] 3 + , is circularly polarised luminescence (CPL) 
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spectroscopy. In C P L spectroscopy the degree of chirality sensed by an electronic 
transition is represented by the emission dissymmetry factor (g e m ) (eqn. 2). 
2 (I L - I R ) 
Sem — (eqn. 2) 
( I I + I R ) 
I I and I R are the intensities of the left or right circularly polarised components of 
the transition, respectively. Accordingly, the sum of the two is the total lumines-
cence intensity of the transition. Conformationally rigid chiral L n ( I I I ) complexes 
may therefore be structurally probed by C P L . The sign and magnitude of g e ni are 
determined by the degree of helical twist about the principal axis of the complex 
and the nature of the ligand field. 8 9 Comparison of the C P L spectra of [ E u L 4 4 a ] 3 + 
and [ E u L 4 4 b ] 3 + with that of [ E u L 2 4 ] 3 + revealed a similarity in form, supporting 
the suggestion of structural homology, Figure 2.12. Additionally, comparison of 
gem values at specific wavelengths also highlights similarities and differences within 
these spectra. For example, g e m values for [ E u L 4 4 b ] 3 + are lower in magnitude than 
those of [ E u L 2 4 ] 3 + , but are of the same sign, Table 2.1. This may suggest increased 
conformational flexibility of the sensitised complex, compared to [ E u L 2 4 ] 3 + , on the 
experimental timescale. This may average the effective local helicity, as reflected by 
the lower gem values. Therefore, from the ^ - N M R and C P L evidence obtained it 
may be concluded that ( 5 5 ' ) - [ E u L 4 4 a / b ] 3 + retains the A-(AAAA) configuration (Fig-
ure 1.7) exhibited by [ ( £ S S ) - E u L 2 4 ] 3 + . 5 8 
610 630 690 670 
Wavelength (nm) 
630 690 670 
Wavelength (nm) 
Figure 2.12 - C P L spectra of [ E u L 2 4 ] 3 + (H 2 0, 1 mM, 295 K, A e x c = 255 nm) (left);8 9 
total luminescence and C P L spectra (x 18) of [ E u L 4 4 b ] 3 + ( D 2 0 , 0.05 mM, 295 K, A e x c 
= 275 nm) (right). 
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C o m p l e x A J = 1 (A) A J = 2 (A) 
[EuL ' 2 4 ] 3 + -0.05 (593) +0.03 (612.) 
[ E u L 4 4 b ] 3 + -0.022 (593) +0.012 (616) 
Table 2.1 - Emission dissymmetry values ( g e m ) at specified wavelengths (D20, 295 
K) ; [ E u L 2 4 ] 3 + in H 2 0 . 8 9 
610 630 650 670 
Wavelength (nm) 
S70 590 610 630 650 670 690 710 
Wavelength (nm) 
Figure 2.13 - Total luminescence and CPL spectra (x 18) of [ E u L 5 1 a ] 3 + (left) and 
[ E u L 5 1 b ] 3 + (right) ( D 2 0 , 0.05 mM, 295 K, A e x c = 235 nm and 275 nm respectively). 
The form and relative intensity of the CPL spectra of [ E u L 5 1 a ] 3 + and [ E u L 5 1 b ] 3 + 
differed, Figure 2.13, and contrasted wi th those observed above, Figure 2.12. This 
difference was reflected by the reversal in sign of the A J = 1 and AJ=2 transitions of 
both complexes, showing that [ E u L 5 1 a ] 3 + and [ E u L 5 1 b ] 3 + are of opposite local helicity 
at Eu ( I I I ) compared to [EuLUa}3+, [ E u L 4 4 b ] 3 + and [ E u L 2 4 ] 3 + . Analysis of the 1 H -
N M R spectra of [ E u L 5 1 a ] 3 + and [ E u L 5 1 b ] 3 + suggest they retain the SAP geometry, 
as complexes w i t h a TSAP geometry have been shown to possess a comparatively 
reduced spectral w i d t h . 5 8 ' 9 0 I t is therefore likely that [ E u L 5 1 a ] 3 + and [ E u L 5 1 b ] 3 + 
possess the diastereomeric configuration as that of [ E u L 4 4 a ] 3 + and [ E u L 4 4 b ] 3 + , i.e. 
A(6666) (Figure 1.7). The difference in the N M R and CPL spectra of [ E u L 5 1 a ] 3 + 
and [ E u L 5 1 b ] 3 + is intriguing; obviously they differ in constitution only at one het-
eroatom of the sensitiser. The proton resonances of the [ E u L 5 1 b ] 3 + ^ - N M R spectra 
appear broader than those of [ E u L 5 1 a ] 3 + . This may be at t r ibuted to a greater degree 
of ligand conformational exchange on the N M R timescale and may be tentatively 
related to a reduced presence of a stabilising hydrogen bond network w i t h this ligand. 
Measurements of the radiative lifetime of each complex in H 2 0 and D 2 0 were 
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taken to allow an estimation of the number of coordinated water molecules, q (Ta-
ble 2 .2) . 5 7 Values of q were estimated to be 2 for complexes wi th an O-containing 
ligand ( [ E u L 4 4 a ] 3 + / [ E u L 5 1 a ] 3 + ) . Those wi th an ^-containing ligand possessed a q 
value closer to uni ty ( [ E u L 4 4 b ] 3 + / [ E u L 5 1 b ] 3 + ) , suggesting these may either be mono-
aqua complexes or mixtures of mono or diaqua species. As suggested above, the 
change f rom O to S in the ligand w i l l presumably reduce the degree of hydration of 
the ligand, as reflected in the q values obtained. 
2.3.2 Anion binding studies 
Studies examining the binding of simple anions to the complexes [ E u L 4 4 a / b ] 3 + and 
[ E u L 5 1 a / b ] 3 + were examined using emission spectroscopy. Ini t ial ly, a series of l imi t ing 
emission spectra were acquired. This involved examination of a solution of complex 
(0.05 m M ) in the presence of 10 eqs. of added anion at p H 7.4. 
A n i o n binding studies w i t h [ E u L 4 4 a ] 3 + and [ E u L 4 4 b ] 3 + 
Emission spectra for [ E u L 4 4 a / b ] 3 + in the presence of H C 0 3 ~ and various phospho-
anions exhibited features previously noted for structurally related complexes . 6 6 , 7 2 , 7 3 
I n particular, l imi t ing emission spectra possessed a A J = 2 / A J = 1 intensity ratio dis-
tinctive for that particular class of anion. Binding of the HCO3"" anion, for example, 
induced a ratio change that was 100 % greater than that of the aqua complex. The 
form of the A J=2 and A J = 4 transitions was distinctive in each of the spectra wi th 
phospho-anions. Phosphate ligation induced a shoulder to appear at 621 nm in the 
A J = 2 emission manifold, Figure 2.14, consistent w i t h earlier observat ions . 6 6 , 7 2 , 7 3 
W i t h [ E u L 4 4 a ] 3 + in the presence of ( O - P - T y r ) 2 - , lanthanide emission appeared 
to be severely quenched relative to the emission of the aqua complex, Figure 2.15. 
Emission was also weak when excitation was attempted at 275 nm, the A m a x of Tyr. 
Quenching of emission w i t h [ E u L 4 4 a ] 3 + was also observed in the presence of Tyr or 
HSA, albeit not as strongly as in the case of (<9-P-Tyr ) 2 - . This presumably reflects 
the weaker binding of Tyr itself to the complex. 
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Figure 2.14 - Emission spectra of [EuL 4 4 *] 3 4 " (blue) and with 10 eqs. H C 0 3 " (red) 
and 10 eqs. H P 0 4 2 _ (green) ( H 2 0 , pH 7.4, 0.05 m M complex, 298 K, A e x c = 335 
nm). These spectra also highlight the fast rate of intersystem crossing in azaxanthone 
based systems as ligand-based fluorescence is not seen. Inset is an enlargement of the 
Eu(III) emission of [ E u L 4 4 * ] 3 * (blue) and wi th 10 eqs. H P 0 4 2 ~ (green). 
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Figure 2.15 - Emission spectra of [ E u L 4 4 a ] 3 + (upper, blue) and with 10 eqs. O-P-
T y r ) 2 - (red) and 0.35 m M HSA (lower, blue) ( H 2 0 , pH 7.4, 0.05 m M complex, 298 
K, e^xc = 335 nm). 
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C o m p l e x / a n i o n fe(H2o)/ms_1 fc(D2o)/ms-1 A f c / m s
- 1 qa>b 
[ E u L 4 4 a ] 3 + / C l - 3.85 1.56 2.29 2.18 
( 0 - P - T y r ) 2 " 2.70 1.69 1.01 0.67 
H C O 3 - 2.44 1.35 1.09 0.77 
HSA 2.63 1.85 0.78 0.35 
[ T b L 4 4 a ] a + / C r 0.85 0.48 0.37 1.5 
( O - P - T y r ) 2 - 0.63 0.55 0.08 0.12 
[ E u L 4 4 b ] a + / C l - 3.03 1.54 1.49 1.24 
( O - P - T y r ) 2 - 2.63 1.64 0.99 0.65 
H C C V 2.38 1.56 0.82 0.47 
HSA 2.70 1.67 1.03 0.72 
Citrate 2.63 1.75 0.88 0.52 
Lactate 2.70 1.59 1.11 0.77 
H P O 4 2 - 2.78 1.54 1.24 0.9 
[ E u L 4 9 ] ' 2 + / C l - 3.33 1.67 1.66 1.5 
( O - P - T y r ) 2 - 2.63 1.72 0.91 0.53 
H C O 3 - 2.44 1.61 0.83 0.41 
HSA 2.63 1.64 0.99 0.62 
H P O 4 2 - 2.56 1.61 0.95 0.6 
(O-P-Ser) 2 " 
(Glc-6-P) 2 " 
2.56 1.72 0.84 0.43 
2.56 1.59 0.97 0.61 
Tyr 2.63 1.67 0.96 0.56 
[ E u L 5 1 a ] 3 + / C l - 3.85 1.67 2.18 2.09 
H C O 3 - 2.56 1.47 1.09 0.79 
[ E u L 6 i b ] 3 + / C r 3.13 1.61 1.52 1.25 
H C 0 3 - 2.94 1.45 1.49 1.26 
HSA 2.17 1.59 0.58 0.12 
H P O 4 2 - 2.17 1.28 0.89 0.52 
Citrate 1.79 1.52 0.27 0 
Lactate 2.13 1.41 0.72 0.34 
Table 2.2 - Effect of added anions on the rate constants (k) ( ± 10 %) for radiative de-
cay of the excited states of [ E u L 4 4 a ] 3 + , [ T b L 4 4 a ] 3 + , [ E u L 4 4 b ] 3 + , [ E u L 4 9 ] 2 + , [ E u L 5 1 a ] 3 + 
and [ E u L 5 1 b ] 3 + (295 K, 0.05 mM complex, 0.5 mM anion except HSA (0.35 mM)) and 
derived hydration numbers, q ( ± 20 %). a t7Eu = 1.2[(*(Hao)-*(DaO))-(0-25+0.07x)] (x 
= number of carbonyl-bound amide NH oscillators) b g T b = 5( /c( H 2 o)- f c (D 2 o)-°-0 6 ) - 5 7 
Several measurements were taken to investigate which excited state was being quenc-
hed, i.e. sensitiser singlet, t r iplet or the Eu( I I I ) excited state. The emission lifetime 
of [ E u L 4 4 a ] 3 + increased upon addition of ( O - P - T y r ) 2 - and HSA, consistent wi th dis-
placement of a E u ( I I I ) coordinated water molecule. This confirms that the quenching 
was not caused by a reduction in Eu( I I I ) excited state lifetime, Table 2.2. These 
results were supported by the observation that [ T b L 4 4 a ] 3 + emission lifetime also in-
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creased upon ( 0 - P - T y r ) 2 binding, whilst emission intensity was severely reduced, 
suggesting that perturbation of the sensitiser was the most likely cause of quenching. 
Given the likelihood of sensitiser-based quenching, the sulfur analogue of the 
E u ( I I I ) complex, [EuL 4 4 1 3 ] 3 " 1 " , was also examined. For [ E u L 4 4 b ] 3 + , the parent aza-
thioxanthone sensitiser possesses a tr iplet energy of 23800 c m - 1 , compared to 24900 
c m - 1 i n [ E u L 4 4 a ] 3 + for the related azaxanthone sensitiser. 5 4 This allows a compar-
ison to see whether the differing tr iplet energies might affect the susceptibilty to 
quenching. Upon addition of ( 0 - P - T y r ) 2 - to [ E u L 4 4 b ] 3 + , emission was quenched, 
Figure 2.16; a similar result was observed w i t h T y r and HSA. Importantly, i t was 
observed that residual ligand fluorescence possessed by [ E u L 4 4 b ] 3 + wasn't quenched 
to any significant degree compared to the quenching of E u ( I I I ) emission. 
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Figure 2.16 - Emission spectra of [ E u L 4 4 b ] 3 + (black) and with 10 eqs. ( 0 - P - T y r ) 2 -
(blue), 10 eqs. (O-P-Ser) 2" (red) and 5 eqs. (O-P-Tyr) 2 - /10 eqs. (O-P-Ser) 2" (green). 
Inset is an enlargement of Eu(III) emission for each adduct and the aqua complex 
( H 2 0 , pH 7.4, 0.05 m M complex, 298 K, A e x c = 372 nm.) 
These results suggest that the quenching process does not perturb the singlet ex-
cited state of the sensitiser. I f this was the route through which quenching occurred, 
the fluorescence of [ E u L 4 4 1 5 ] 3 4 " would also be expected to decrease. As a theoretical 
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value of 24600 cm 1 for Tyr T j to So emission has been c i ted , 9 1 alongside our own 
observation of 29000 c m - 1 ( ± 400cm- 1 ) w i th l B u - T y r (EPA glass, 77 K ) i t would 
appear that sensitiser-Tyr tr iplet-tr iplet energy transfer is unlikely as a source of 
quenching. In particular, i t might be expected that a reduced degree of quenching 
of [ E u L 4 4 b ] 3 + , compared to that of [ E u L 4 4 a ] 3 + , would be observed i f this was the case 
due to the larger energy gap between the sensitiser and T y r tr iplet states. Therefore, 
the most likely mechanism of quenching is by a charge transfer process involving the 
chromophore excited state. Binding of ( 0 - P - T y r ) 2 - to the L n ( I I I ) centre brings an 
electron rich T y r site close to the sensitiser. 
The original binding preference of [ L n L 2 4 ] 3 + for ( O - P - T y r ) 2 " over (O-P-Ser) 2 "/ 
( 0 - P - T h r ) 2 - was also observed in competitive emission spectra w i t h both [ E u L 4 4 a ] 3 + 
and [ E u L 4 4 b ] 3 + . This preference was signalled by a marked reduction in emission in-
tensity following addition of 5 eqs. ( O - P - T y r ) 2 " to a solution of [ E u L 4 4 a ] 3 + / [ E u L 4 4 b ] 3 + 
containing 10 eqs. ( 0 - P - S e r ) 2 - , Figure 2.16. Further competition experiments re-
vealed a selectivity for ( 0 - P - T y r ) 2 - over H C O 3 - . This selectivity was characterised 
by the appearance of the distinctive shoulder at 624 nm in the A J=2 manifold, and 
a severe reduction in emission intensity, upon addition of equimolar quantities of 
( O - P - T y r ) 2 " to a solution of [ E u L 4 4 a ] 3 + / [ E u L 4 4 b ] 3 + and H C 0 3 " . I n addition, the 
quenched emission of [ E u L 4 4 a ] 3 + / [ E u L 4 4 b ] 3 + in the presence of HSA (0.35 mM) was 
partially restored upon the addition of N a H C 0 3 ~ (30 m M ) , Figure 2.17. Conversely, 
the E u ( I I I ) emission intensity of the complex carbonate adduct was reduced upon 
addition of HSA. 
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Figure 2.17 - Emission spectra of [EuL 4 4 *] 3 4 " (blue), with HSA (0.35 mM) (purple) 
and with HSA (0.35 mM) and NaHC0 3 (30 mM) (red) ( H 2 0 , pH 7.4. 0.05 mM 
complex, 298 K, AeXC = 335 nm.) 
The ratio of the intensity of the A J = 2 / A J = 1 E u ( I I I ) emission bands in these l im-
i t ing emission spectra varied, depending upon the species present w i t h i n solution. 
For example, the ratio w i t h the aqua complex (pH 7.4) was ~ 2 ; which was con-
served upon the addition of HSA. W i t h the carbonate-only bound adduct this ratio 
was ~ 4 (Figure 2.14); while upon addition of HSA to this adduct, the ratio de-
creased slightly to ~3.2. These l imi t ing spectra demonstrate that the complex is 
signalling the binding of H C 0 3 ~ in the presence of extracellular concentrations of 
HSA. I t is clear that bicarbonate binding is competitive, as reflected by the 'aver-
aged' A J = 2 / A J = 1 ratio containing the contributions of both the carbonate and 
HSA bound species. 
Changes in 1 H - N M R spectra were also used to confirm anion binding and dis-
tinguish differing ternary anion complexes. For example, the addit ion of an excess 
of NaHCOs to [ E u L 4 4 b ] 3 + in D 2 0 resulted in dramatic changes in the observed 
spectrum, Figure 2.18. Some resonances shifted by up to 15 ppm; consistent w i t h 
the replacement of the hard 'axial ' D 2 0 donor molecule w i t h the more polarisable 
oxygen atom of the chelated carbonate anion. 6 6 
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Figure 2.18 - 1 H - N M R spectra for [EuL 4 4 6 ] 3 " 1 " in the absence (left) and presence 
(right) of 30 m M N a H C 0 3 ( D 2 0 , 500 MHz, 295 K, pD 7.5, 1 m M complex). Reso-
nances marked with • are assigned to the cyclen NH proton, resonances marked with 
• are assigned to cyclen Hax protons. 
Finally, binding of selected anions was monitored by CPL spectroscopy, Fig-
ure 2.19. Bound ( 0 - P - T h r ) 2 ~ resulted in a spectrum whose fo rm at the 5D0-7Fi 
transition resembled that of CPL spectra reported previously of [ E u L 2 4 ] 3 + w i t h 
H P 0 4 2 - and (Glc-6-P) 2 ", but was distinctly different to that w i t h ( O - P - T y r ) 2 " . 6 6 
The spectrum w i t h added sodium lactate closely resembled that of the aqua complex. 
N a H C 0 3 addition modulated the form of CPL emission in the 5 D 0 - 7 F ! transition 
whilst spectra recorded in the presence of HSA resembled the aqua complex, but 
w i th reduced intensity. 
1.5 
J J 
-1 I -1 I -1 I -1 I 
585 590 595 600 585 590 595 600 585 590 595 600 585 590 595 600 
1 Wavelength (nm) 2 Wavelength (nm) 3 Wavelength (nm) 4 Wavelength (nm) 
Figure 2.19 - CPL spectra (x 18) for: (1) [ E u L 4 4 b ] 3 + ; (2) plus 10 eqs. H C 0 3 ~ ; 
(3) plus 10 eqs. lactate; (4) plus 10 eqs. (0-P-Thr) 2 ~. Total luminescence also shown 
(0.05 m M complex, 295 K, A e x c - 275 nm). 
I t was observed that i n l imi t ing emission spectra the acid analogue of [ E u L 4 4 a ] 3 
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[ E u L 4 9 ] 2 + , exhibited identical anion binding properties to the parent system. How-
ever, an interesting feature of this complex was the apparent p H dependent self-
association. The X H - N M R spectrum of this complex (pD 7.8) was different to that 
of [ E u L 4 4 a ] 3 + . I t was noted that a broader set of resonances shadowed the sharp 
resonances at tr ibuted to the complex, Figure 2.20. 
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Figure 2.20 - 'H-NMR spectra for [ E u L 4 9 ] 2 + in the absence (left) and presence 
(right) of 30 mM NaHC0 3 ( D 2 0 , 500 MHz, 295 K, pD 7.8, 1 mM complex). 
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Figure 2.21 - Emission spectra of [ E u L 4 9 ] 2 + at pH 6.25 (blue) and pH 3.65 (red) 
( H 2 0 , 0.05 m M complex, 298 K , A e x c = 332 nm). Also observable is ligand fluorescence, 
contrasting with the spectra of [ E u L 4 4 a ] 3 + where none was present. 
In addition, the q value estimated for [ E u L 4 9 ] 2 + was 1.5. This is lower than the value 
of 2.2 estimated for [ E u L 4 4 a ] 3 + . To test the hypothesis that the complex was weakly 
self-associating through chelation of the sensitiser carboxylate group, H C O 3 - was 
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introduced to the N M R solution. The resulting 1 H - N M R spectrum, Figure 2.20, 
resembled that of [ E u L 4 4 b ] 3 + , i n the presence of 30 m M N a H C 0 3 , Figure 2.18. This 
suggests that competitive chelation of carbonate is displacing the sensitiser acid. 
The emission spectrum of [ E u L 4 9 ] 2 + was recorded at p H 3.65 and p H 6.25, Fig-
ure 2.21. Emission intensity was reduced in the acidic conditions, consistent w i t h 
hydration of the E u ( I I I ) ion following protonation of the sensitiser carboxylate. 
Evidence for self-association was also found in HRMS ( E S + ) analyses. Mass spectra 
gave peaks whose mass and isotopic profile corresponded to [2M - 2 H ] 4 + and [2M -
4 H ] 2 + adducts. 
A n i o n binding studies w i t h [ E u L 5 1 b ] 3 + 
Limi t ing spectra for [ E u L 5 1 b ] 3 + i n the presence of anions revealed a similar binding 
preference w i t h the (0-P-amino ac ids ) 2 - ; ( 0 - P - T y r ) 2 ~ was the preferred anion in 
the presence of equimolar concentrations of ( 0 - P - S e r ) 2 - / ( 0 - P - T h r ) 2 ~ , Figure 2.22. 
Binding of ( 0 - P - T y r ) 2 ~ to this complex, however, resulted in emission that was 
quenched, but not to such an extent as observed w i t h [ E u L 4 4 a / b ] 3 + . 
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Figure 2.22 - Emission spectra of [ E u L 5 1 b ] 3 + (blue) and with 10 eqs. (O-P-Tyr) 2 " 
(brown), 10 eqs. (0-P-Ser) 2~ (red) and 10 eqs. (O-P-Tyr) 2 - /10 eqs. (O-P-Ser) 2" 
(green) ( H 2 0 , pH 7.4, 0.05 m M complex, 298 K, Aexc = 372 nm). 
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Figure 2.23 - Emission spectra of [ E u L 5 1 b ] 3 + (blue) and with 10 eqs. H P 0 4 2 - (red) 
and 10 eqs. H C 0 3 " (green) ( H 2 0 , pH 7.4, 0.05 mM complex, 298 K, A e x c = 372 nm). 
The form of the spectra in the presence of phosphates was not as distinctive for this 
complex, compared to [ E u L 4 4 a / b ] 3 + . For example, addition of H P 0 4 2 ~ did not result 
i n further broadening of the A J=2 emission manifold, Figure 2.23. On addition of 
H C 0 3 ~ the ratio of the A J = 2 / A J = 1 emission bands remained close to that exhib-
i ted by the aqua complex, although to ta l emission intensity d id increase. 
No anion binding information for [ E u L 5 1 a / b ] 3 + could be gleaned f rom ^ - N M R 
experiments, due to the kinetic instabili ty of the complexes in solution. I n the 
presence of N a H C 0 3 or N a H 2 P 0 4 at concentrations of >10 m M , precipitation was 
observed. This is consistent w i t h slow decomplexation of E u ( I I I ) f rom the ligand. 
Unfortunately this instabili ty restricted the scope of anion binding analyses. 
CPL spectra of [ E u L 5 1 b ] 3 + in the presence of selected anions were also recorded, 
Figure 2.24. The 5 D 0 - 7 F X t ransit ion was observed to change i n form upon addition 
of N a H C 0 3 and sodium lactate. In particular, upon addition of the anion a more 
intense C P L transition was observed. The g e m value increased f rom -0.027 at 590 nm 
for the aqua complex to -0.077 w i t h sodium lactate and -0.080 w i t h N a H C 0 3 . This 
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may reflect the change in axial donor polarisability upon anion chelation, but may 
also suggest enhanced rigidification of the ligand, associated wi th anion ligation. 
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Figure 2.24 - CPL spectra (x 18) for: (1) [ E u L 5 1 b ] 3 + ; (2) plus 10 eqs. lactate; (3) 
plus 10 eqs. H C O 3 - . Total luminescence also shown (black) (0.05 mM complex, 295 
K, A e x c = 275 nm). 
F u r t h e r comparat ive anion binding studies w i th [ E u L 4 4 b ] 3 + and [ E u L 5 1 b ] 3 + 
In light of the selectivities observed wi th [ E u L 4 4 a / b ] 3 + and [ E u L 5 1 b ] 3 + , selected anions 
were studied in more de ta i l . 9 2 The association of [ E u L 4 4 b ] 3 + and [ E u L 5 1 b ] 3 + wi th 
H C O 3 - , H P O 4 2 - , lactate and citrate was investigated by a series of luminescence 
titrations. 
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E u ( I I I ) emission spectra were recorded in the presence of varying anion concen-
trations at constant pH. I n addition, the binding of specific anions, at a constant 
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concentration, was monitored as a funct ion of pH. The anion binding properties 
of a structurally related complex reported in previous s tudies , 9 3 , 9 4 [ E u L 5 2 ] 3 + (q = 
0.92), was also investigated, these results are included here for comparison purposes. 
Changes in emission spectral form enabled anion binding to be monitored, exam-
ining the change in the intensity ratio of a pair of emission bands (e.g. 616/614 nm, 
700/687 nm or 594/592 nm). A plot of this ratio against anion concentration was 
fitted to a 1:1 binding model, allowing aff ini ty constants to be calculated, Table 2.3. 
Complex Citrate 
(pH 7.4) 
Lactate 
(pH 6) 
H C 0 3 -
(pH 7.4) 
HPO4 2-
(pH 7.4) 
[ E u L 4 4 b ' 3+ 6.02(03) 2.73(02) 3.50(03) 3.95(03) 
[ E u L 5 1 b ' 3+ 5.24(03) 2.98(02) 2.08(02) 2.60(03) 
[ E u L 5 2 ] 3 + 4.33(02) 2.67(02) 3.01(02) 3.14(02) 
T&ble 2.3 Affinity constants of [ E u L 4 4 b ] 3 + , [ E u L 5 1 b ] 3 + and [ E u L 5 2 ] 3 + with anions 
(298 K, 0.1 M NaCl). The pH regime used was based upon preliminary experiments 
examining the pH dependence of the emission profile at a fixed anion concentration, 
(30 m M HCO3-, 2.3 m M lactate, 0.9 m M HP0 4 2 ~ and 0.1 mM citrate with 10 |xM 
complex) seeking a relatively 'flat ' part of the spectral response/pH profile. 
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Figure 2.25 - Variation of the Eu(III) emission spectra for [ E u L 4 4 b ] 3 + , following 
addition of sodium citrate ( H 2 0 , pH = 7.4 (±0.05), 0.025 m M complex, 298 K, / = 
0.1 M NaCl, Aexc = 375 nm). Inset is a plot of the intensity ratio (616/614 nm) with 
[citrate], allowing calculation of the apparent binding constant. 
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Binding of citrate and lactate to [ E u L 4 4 b ] 3 + induced distinctive changes i n emission 
spectral form. For example, lactate binding resulted in a increase i n relative emis-
sion intensity at 624 nm whilst the spectral response to citrate binding included a 
70 % increase i n the A J = 2 / A J = 1 ratio and the appearence of an isoemissive point 
at 698 nm, Figure 2.25. 
Binding of lactate and H P 0 4 2 ~ to [ E u L 5 1 b ] 3 + resulted in minor changes in E u ( I I I ) 
spectral form, as seen earlier for HC03~ binding. On addition of citrate, a dramatic 
change to the E u ( I I I ) spectral form was seen, Figure 2.26. For example, a 100 % 
increase i n the A J = 2 / A J = 1 ratio was observed, alongside changes to the fo rm and 
relative intensity of the A J = 0 and A ,7=1 transitions. 
t 6000 
25 
5400 
7 20 4800 
/ 4200 
log K = 5.24 (±0.03) 
3600 
10 
E 3000 
2400 
0.14 0.00 0.04 0.08 0.08 0.02 
[citrate] / mM 
1800 
1200 
600 
570 580 590 800 610 620 630 840 650 680 670 680 690 700 710 720 
Wavelength (nm) 
Figure 2.26 - Variation of the Eu(III) emission spectra for [ E u L 5 1 b ] 3 + following 
addition of sodium citrate ( H 2 0 , pH = 7.4 (±0.05), 0.02 m M complex, 298 K, I = 
0.1 M NaCl, Aexc = 375 nm. Inset is a plot of the intensity ratio (616/684.5 nm) with 
[citrate], allowing calculation of the apparent binding constant. 
I n stark contrast, the E u ( I I I ) emission response of [ E u L 5 2 ] 3 + w i t h the anions inves-
tigated was minimal . Changes were just sufficient to allow calculation of apparent 
affinity constants. I n addition, ^ - N M R spectra of [ E u L 5 2 ] 3 + (5 m M , pD 7.8, 295 K , 
200 MHz) alone were compared to those obtained i n the presence of added N a H C 0 3 
69 
(30 m M ) . Add i t ion of H C O 3 resulted in the sharpening of the observed complex 
resonances but no major differences in the 1 H - N M R spectra were observed. 
Of the structurally related complexes [ E u L 4 4 b ] 3 + and [ E u L 5 2 ] 3 + , aff ini ty constants 
were higher w i t h [ E u L 4 4 b ] 3 + . This can be at tr ibuted to the extra enthalpic and en-
tropic benefit of displacing two water molecules in citrate, lactate and bicarbonate 
binding. W i t h [ E u L 4 4 b ] 3 + in the presence of anions at their common 'extracellular' 
concentrations, H C O 3 - competes wi th citrate for E u ( I I I ) coordination. A t i t ra t ion 
of [ E u L 4 4 b ] 3 + w i t h sodium citrate, in a NaHC03 background (30 m M ) , revealed a 
decrease in the aff ini ty constant f rom log K = 6.02 to log K = 3.33 (±0 .02) . This 
allows an estimate of the ratio of the [ E u L 4 4 b ] 3 + citrate adduct to the [ E u L 4 4 b ] 3 + 
carbonate adduct. This is calculated to be 7:1. 
The lower aff ini ty of [ E u L 5 1 b ] 3 + for H C 0 3 ~ and phosphate follows the trend ob-
served in similar complex structures, such as [ E u L 3 6 ] 3 + . 7 9 , 9 5 I n addition, separate 
protein t i t r a t ion experiments, using HSA, wi th each of the three complexes were 
carried out to determine relative protein aff ini ty constants. Assuming 1:1 bind-
ing, an apparent HSA affinity constant of log K = 3.71 (±0 .03) was calculated for 
[ E u L 5 1 b ] 3 + . The value recorded wi th [ E u L 5 2 ] 3 + was log K = 3.10 (±0 .03) . The affin-
i ty of [ E u L 4 4 b ] 3 + w i t h HSA could not be determined due to the severity of quenching 
of the E u ( I I I ) emission. A independent method, monitoring the variation in the re-
laxivity of [ G d L 4 4 b ] 3 + as a function of added protein, also did not permit a protein 
affinity constant to be estimated. 9 6 
The binding studies presented highlight the significant differences in anion selec-
t iv i ty exhibited by these complexes, notwithstanding the small pertubation in ligand 
structure. A n explanation for this differing behaviour may be reached through con-
sideration of the differing coordination geometries of the major solution species. A l l 
evidence obtained for [ E u L 4 4 b ] 3 + suggests that this complex possesses the coordina-
tion environment exhibited by [ E u L 2 4 ] 3 + , the structure of which has been probed 
through X-ray analyses of crystals of [ Y b L 2 4 ] 3 + and citrate, lactate and carboxylate 
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adducts of [ E u L 2 4 ] 3 " 1 " . 6 4 I n each of these complexes a water molecule has been shown 
to occupy the 'axial ' coordination site (upper diagram, Figure 2.27). Upon binding 
to carbonate, this water molecule is displaced by an oxygen atom of the anion. As 
explained in section 1.5.3, this results in a change of the second order crystal field 
coefficient, which gives rise to changes in ^ - N M R and E u ( I I I ) emission spectra. 
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Figure 2.27 - A representation of the hypothesised coordination geometries of 
[ E u L 4 4 b ] 3 + , [ E u L 5 1 b ] 3 + and [ E u L 5 2 ] 3 + . Coordinating cyclen <V-atoms are seen in 
the lower plane (blue), pendant amide arm carbonyl 0-atoms (red) and 'vacant' co-
ordination sites (green) which may or may not be occupied by water (solvent). For 
[ E u L 5 1 b ] 3 + , the coordinating pyridyl iV-atom is shown in blue, above the plane of the 
cyclen TV-atoms. 
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The minimal response in ^ - N M R and Eu(III) emission spectra following anion bind-
ing to [ E u L 5 2 ] 3 + suggests that a benzylic amide carbonyl oxygen must occupy the 
'axial' capping site in both the aqua complex and in its various anion adducts (lower 
diagram, Figure 2.27). Hence, the axial donor ligand, and therefore the second or-
der crystal field coefficient remain constant. This may occur with a distorted square 
anti-prismatic or bicapped trigonal prismatic coordination environment. Consider-
ing the former model, anion chelation could occur at two sites in the plane of the 
square antiprism. Finally, the 'intermediate' behaviour of [ E u L 5 1 b ] 3 + , where citrate 
binding results in large changes in the emission spectra whilst other anion binding 
does not, can be rationalised by consideration of the fluxional nature of the co-
ordination environment of this complex. It is possible that the position of anion 
coordination is dependent upon the steric demand of the anion itself. Small anions 
may be able to bind in the plane of the square antiprism resulting in a minimal 
spectral response, whilst the larger citrate anion must be able to chelate to axial 
and equatorial positions (centre diagram, Figure 2.27). This would be in keeping 
with the hypothesis of a weakly bound pyridyl Af-atom of the sensitiser. 
2.3.3 Luminescence microscopy and cellular cytotoxicity 
studies 
As stated at the outset, these Eu(III) probes could be used to monitor the spatial 
distribution and concentrations of selected anions, in live cells in real time. It 
is therefore important that such probes are not significantly toxic to the cells in 
which they are to be examined. One relative indicator of complex cytotoxicity is 
the M T T assay.97 This assay utilises the conversion of 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide to a purple 'formazan' product by mitochondrial 
dehydrogenase enzymes of viable cells. The 'formazan' product is insoluble in water 
but can be solubilised with DMSO; it is then quantified spectrophotometrically. 
Typically, 24 h incubations of varying concentrations of complex or ligand with 
at least 10000 cells were analysed to obtain an IC5o value. This is defined as the 
concentration of complex required to reduce the absorbance to 50 % of that in the 
untreated cells. 
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Complex or ligand I C 5 0 / p M 
[ E u L 4 4 a ] 3 + 
L44a 
164(±31) 
99.3(±11.8) 
[ E u L 4 4 b ] 3 + 
L44b 
>270 
>350 
[ E u L 4 9 ] 3 + 109(±16) 
[ E u L 5 0 ] 3 + 
L50 
>240 
173(±17) 
[ E u L 5 1 a ] 3 + 
L51a 
173(±34) 
180(±15) 
[ E u L 5 1 b ] 3 + 
L51b 
5.62(±0.34) 
4.87(±1.26) 
Table 2.4 - Cell toxicity profiles ( IC 5 0 in NIH-3T3 cells) for Eu(III) complexes and 
ligands. 
It is seen that the only significant toxicity was observed with [ E u L 5 1 b ] 3 + . This be-
haviour contrasted with every other Eu(III) complex tested. In addition, the com-
plex cytotoxicity was also reflected in the IC50 value of the corresponding ligand, 
L 5 1 b . The correlation of these values is consistent with the dissociation of the com-
plex in cellulo, over the incubation period. The origins of the toxicity of [ E u L 5 1 b ] 3 + 
were examined through the measurement of IC50 values of 2-methylazaxanthone 
(>240 pM), 2-methylazathioxanthone (72.5(±6.3) pM) and the corresponding sul-
foxide (>240 pM) and sulfone (21.1(±0.2) pM) analogues, Figure 2.28. These re-
sults provide a tentative link between I C 5 0 values and oxidative metabolism of L 5 1 b . 
Similar cytotoxicity profiles were observed in Chinese Hamster Ovarian (CHO) cells. 
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Figure 2.28 - Structures of 2-methylazaxanthone, 2-methylazathioxanthone and its 
derivatives and their corresponding IC50 values in NIH-3T3 cells. 
Cellular uptake of the Eu(III) complexes was examined by fixed cell imaging in 
NIH-3T3 and CHO cells. Incubation of cells grown on glass cover-slips for peri-
ods of 20 m to 24 h was carried out in the presence of complex concentrations of 
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10 | i M to 100 uM. The ligand fluorescence (where possible) and Eu(III) emission 
was monitored by fluorescence microscopy after excitation at the sensitiser A m a x . 
Untreated control cells showed no luminescence at wavelengths monitored whilst 
luminescence was observed in treated cells at a variety of optical sections, showing 
that the complex was internalized within the cell and not just associated with the 
cell membrane. Localisation profiles were observed in ceUs at various points on the 
slide. The localisation behaviour of [EuL 4 4 *] 3 *, [ E u L 4 4 b ] 3 + and [ E u L 4 9 ] 2 + was ex-
amined in each cell line. Fluorescence microscopy revealed that within 5 minutes 
of cell incubation with a 50 uM complex solution, the complex was localised within 
the mitochondria. This observation was supported by co-localisation experiments 
with Mitotracker Green™ (Invitrogen) in which merged images corresponded well, 
Figure 2.29. When longer incubation times were used, the complex was observed to 
migrate from the mitochondria to late endosomes/lysosomes. 
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Figure 2.29 - Epifluorescence microscopy images for [ E u L 4 4 b ] 3 + : 50 uM complex, 
4 h incubation (left set of images); 50 uM complex, 24 h incubation (right set of 
images). Images reveal a mitochondrial localisation profile after 4 h and a profile 
consistent with migration of the complex from the mitochondria to the perinuclear 
endosomes/lysosomes after 24 h. Upper images: Eu(IU) complex; centre images: 
Mitotracker Green™; lower images: merged image (scale bars 20 microns). 
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The interesting localisation profiles of [ E u L 4 4 a / b ] 3 + warranted further preh'minary 
investigation. In particular, the known quenching of these complexes in the presence 
of protein, and the observation that the complexes were still highly luminescent when 
localised within the mitochondrial environment posed interesting questions as to the 
nature of their coordination environment. Given the mitochondrial localisation of 
these complexes, and their affinity for carbonate and citrate, i t was hypothesised 
that the majority of intracellular complex adducts would be those of carbonate or 
citrate. To study this hypothesis, an experiment was carried out that monitored 
the relative luminescence intensity of the mitochondrially localised complex, under 
varying atmospheric CO2 concentrations, Figure 2.30. 
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Figure 2.30 - Confocal microscopy images for [ E u L 4 4 a ] 3 + (50 \iM complex, 2-3.5 h 
incubation, AexC = 360 nm) in HeLa cells at 3 % (left image), 4 % (centre image) and 
5 % (right image) atmospheric CO2 (scale bar 20 microns). The graph shows a plot 
of the relative intensities of complex emission as a function of pCC>2. 
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As can be observed, [ E u L 4 4 a ] 3 + emission intensity decreased as the level of atmo-
spheric C 0 2 , and consequentially mitochondrial H C 0 3 ~ concentration, was reduced. 
Earlier experiments with consistent C 0 2 levels had suggested no significant modu-
lation of Eu(III) emission intensity, over the time course of this experiment. This 
preliminary result is encouraging as i t offers the possibility that future work involv-
ing this complex, or related structures, may be able to relay spatial concentrations 
of HCC>3~ in real time. 
The complexes [ E u L 5 1 a ] 3 + and [ E u L 5 1 b ] 3 + were examined within both NIH-3T3 
and CHO cell lines, and exhibited similar localisation profiles. In each case rapid 
transport of the complex to the perinuclear lysosomes was observed to occur by mon-
itoring Eu(III) emission and examining containing experiments with Lysotracker 
Green™, Figure 2.31. 
Figure 2.31 - Epifluorescence microscopy images for [ E u L 5 1 b ] 3 + . 50 uM complex, 1 
h incubation, co-staining experiments with Lysotracker Green™: upper left image: 
Eu(III) complex (575-625 rim); upper right image: Lysotracker Green™ (FITC filter 
set); lower image: merged image (scale bar 20 microns). After 1 h Eu(III) emission 
and Lysotracker Green™ largely correspond, consistent with a common lysosomal 
localisation profile. 
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The use of appropriate filter sets allowed Eu(III) emission and ligand fluorescence 
to be separately observed, Figure 2.32. I t was noted that they did not spatially 
correspond as ligand fluorescence was observed in the mitochondria after 1 h (50 
pM complex), 4 h (20 pM complex) and 24 h (10 pM complex) incubation periods. 
Such an observation is consistent with complex dissociation within the cell, and is 
also consistent with the cytotoxicity profiles of [ E u L 5 1 b ] 3 + and L 5 1 b reported above. 
The high toxicity of the complex, due to its dissociation, resulted in images of lower 
quality being obtained, compared to the other complexes examined. 
Figure 2.32 - Epifluorescence microscopy images for [ E u L 5 1 b ] 3 + . 50 pM complex, 1 h 
incubation, comparing localisation of ligand fluorescence and Eu(III) emission: upper 
left image: Eu(IH) complex (575-625 nm); upper right image: ligand fluorescence 
(450 ± 50 nm); lower image: merged image (scale bar 20 microns). Images reveal 
ligand fluorescence and Eu(III) emission begin not to spatially correspond after 1 h, 
indicating complex dissociation. 
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2.4 Studies with [EuL 5 0 ] 3 + 
As described in section 2.2.1, the octadentate complex [ E u L 5 0 ] 3 + was synthesised as 
part of studies examining the cellular uptake of a wide series of Ln(III) complexes. 
In light of the differing cellular localisation profiles of [ E u L 4 4 a / b ] 3 + and [ E u L 5 1 a / b ] 3 + 
it was appropriate to probe whether the linkage between the sensitiser and complex 
dictated the localisation profile of the complex. [EuL 5 0 ] 3 4 " possesses a similar ligand 
structure to that of [ E u L 4 4 a / b ] 3 + . The only difference is the extra pendant amide 
arm, which may be expected to reduce the conformational mobility of the ligand 
compared to [ E u L 4 4 a / b ] 3 + . The amide linkage between the sensitiser and complex 
may be expected to be orientated around the metal ion in a similar fashion to that 
present in [ E u L 4 4 a / ' b ] 3 + . Therefore, the complex was considered as a good target for 
such a comparative study. 
The ^ - N M R spectrum of the complex showed the presence of a well denned 
major isomer, Figure 2.33. In addition, a small amount (<10 %) of a second isomer 
was also observed. 
JUU 
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Figure 2.33 - JH-NMR spectra for [ E u L 5 0 ] 3 + (500 MHz, D 2 0 , 295 K, pD 7.8, 1 
mM). Resonances marked with • are assigned to cyclen Hax protons. 
The emission spectrum of the complex was acquired in the absence and presence 
of HSA, Figure 2.34. As expected, Eu(III) emission was quenched in the presence of 
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protein. This result provides further support for the hypothesis of a charge transfer 
quenching process. Evidently, the octadentate complex cannot directly bind to the 
protein through the Eu(III) centre. 
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Figure 2.34 - Eu(III) emission spectra for [ E u L 5 0 ] 3 + alone (black) and in the presence 
of HSA (0.35 mM) (red) (H 2 0, pH = 7.4, 0.05 mM complex, 298 K, A e x c = 335 nm). 
The Eu(III) excited state lifetimes were recorded in H2O and D 2 0 and in the 
presence of HSA, Table 2.5. These revealed the direct Eu(III) coordination of one 
water molecule in aqueous solution. On addition of HSA, the q value of the complex 
decreased. This indicates shielding of the complex from the bulk solvent by HSA, 
thereby reducing quenching of the Eu(III) excited state. 
Complex /an ion fc(D2o)/ms_1 A f c / m s - 1 <za 
[ E u L 5 0 ] 3 + / C l - 1.72 0.44 1.28 0.86 
HSA 1.35 0.58 0.77 0.26 
Table 2.5 - The rate constants (k) (± 10 %) for radiative decay of the excited 
state of [ E u L 5 0 ] 3 + (0.05 mM) (± 10 %) as the aqua complex and in the presence 
of HSA (0.35 mM) (295 K, pH 7.4) and derived hydration numbers, q (± 20 %) . a 
</E u = 1.2[(fc(H2o)-A;(D2o))-(0.25+0.07x)] (x = number of carbonyl-bound amide NH 
oscillators).57 
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2.4.1 Luminescence microscopy and cellular cytotoxicity 
studies 
The IC5o value of >240 uM obtained for [ E u L 5 0 ] 3 + shows that this complex is non-
toxic to cells, Table 2.4. Cellular uptake of [ E u L 5 0 ] 3 + was examined by fixed cell 
imaging as described above. 
Figure 2.35 - Epifiuorescence microscopy images for [ E u L 5 0 ] 3 + . Left set of im-
ages (50 uM complex, 4 h incubation, examining mitochondrial localisation): Upper 
image: Eu(III) complex; centre image: Mitotracker Green™; lower image: merged 
image (scale bar 20 microns). Right set of images (50 (xM complex, 4 h incuba-
tion, examining lysosomal localisation): Upper image: Eu(III) complex; centre image: 
Lysotracker Green™; lower image: merged image (scale bar 20 microns). Images 
reveal a localisation profile split between the mitochondria and lysosomes. 
Fluorescence microscopy revealed that within 15 min, in NIH-3T3 and CHO cell 
lines, [EuL 5 0 ] 3 4 " was localised within the mitochondria and late endosomes/lysosomes. 
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Localisation was confirmed by appropriate co-staining experiments with Mitotracker 
Green™ and Lysotracker Green™ (Invitrogen), Figure 2.35. Similar localisation 
was also observed after incubation times of 4 h and 24 h, the relative distribution 
does not appear to change over time. 
These observations suggest that the intra-cellular localisation of complexes of this 
structure type may not be dictated solely by the nature of the functionality between 
the macrocycle and sensitiser. However, the complexes reported here form only a 
very small data set and any relationships drawn between complex structure and 
their intracellular localisation are extremely tentative. Ongoing work is attempting 
to compare a wider range of structures. 
2.5 Conclusions 
A variety of Eu(III) complexes have been synthesised that bind preferentially to 
selected anions in aqueous media. The complexes report on their local coordination 
environment either through modulation of Eu(III) emission or ^ - N M R spectra. 
The syntheses of the complexes were achieved through a variety of common syn-
thetic intermediates, providing routes by which subtly different ligand structures 
could be prepared expediently. The combined wealth of spectral information that 
was gained in these anion binding studies allowed the effect of these subtle ligand 
changes on the anion binding properties of the respective complexes to be probed. 
I t was found that the anion binding selectivities of the complexes could generally 
be 'predicted' for certain classes of anions, based on previous studies. This work 
further demonstrates that knowledge of the behaviour of these cyclen based com-
plexes is certainly sufficient to allow the creation of receptors that target specific 
anions in aqueous media. One common feature of each complex was their preference 
to bind to ( 0 - P - T y r ) 2 - in the presence of equimolar equivalents of any other anion 
examined. This preference is still tentatively attributed to the high charge density 
and reduced level of hydration of (0 -P -Tyr ) 2 - , compared to related phospho-anions. 
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Cellular localisation profiles of the complexes were also examined. The most well 
denned complexes e.g. [ E u L 4 4 a / b ] 3 + proved to be non-toxic to the cells. Complexes 
of low kinetic stability proved toxic and this was tentatively related to the oxida-
tive metabolism products of the ligand. [ E u L 4 4 a / b ] 3 + possessed a very interesting 
localisation profile, remaining within the mitochondrial environment for extended in-
cubation periods before being shuttled along a lysosomal path. Furthermore, these 
complexes remained luminescent within the mitochondrial environment, despite the 
quenching of the complex by protein as revealed in vitro. It is likely that the complex 
is binding to anionic species within the cell. This was backed up by a preliminary 
study that revealed a dependence of [ E u L 4 4 a ] 3 + emission intensity on atmospheric 
pC02- Adducts with anions will probably be in exchange with protein bound com-
plex, as observed in vitro. Aside from carbonate adducts, it is likely that a significant 
proportion of luminescent species within the mitochondrial environment will be cit-
rate adducts. The resulting emission spectra of [ E u L 4 4 a ] 3 + in the mitochondrial 
environment will therefore be a convoluted average of all the species present. 
Notwithstanding the carbonate/citrate selectivity issues, the reported results 
augur well for the future development of a chemoselective probe that can relay the 
concentration of essential anion concentrations such as H C O 3 - or citrate on the 
Eu(III) emission timescale, within specific cellular organelles. 
2.6 Future work 
The mitochondrial localisation of [ E u L 4 4 a / b ] 3 + and [ E u L 4 9 ] 2 + is unprecedented for 
such responsive Ln(III) complexes. Future work should fully exploit this feature. 
An initial experiment would be to repeat the experiment examining the emission in-
tensity of mitochondrially localised [ E u L 4 4 a ] 3 + as a function of pC0 2 . In this repeat, 
one new aspect would be to examine the reversibility of the changes in complex emis-
sion intensity upon the raising and lowering of PCO2, hence establishing whether or 
not this is a dynamic signalling process. 
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To enable intracellular emission spectra to relay the concentration of bicarbon-
ate, a calibration would need to be established, based upon the ratiometric analysis 
of two wavelengths, for example, of the A J = 1 and A J = 2 manifolds. However, a 
further method could be to examine the utility of using [ E u L 4 4 a ] 3 + and [ T b L 4 4 a ] 3 + 
in tandem as a bicarbonate probe. In theory, the ratio of emission at 545 nm 
( [ T b L 4 4 a ] 3 + ) and 616 nm ( [ E u L 4 4 a ] 3 + ) would change as a function of p H C 0 3 - . As 
each complex shares a common ligand, any competing anionic species and protein 
quenching would affect each complex equally, notwithstanding their differing anion 
affinities, and therefore the recorded ratio would include an intrinsic correction for 
these factors. This therefore means that in a competitive anionic environment, such 
as within the mitochondria, any changes in the ratio of both emission intensities 
could be related back, through a calibration plot, to the concentration of bicar-
bonate. Before tandem probe methodology could be established, the response of 
[ T b L 4 4 a ] 3 + to bicarbonate and protein concentrations would have to be thoroughly 
examined through a series of luminescent binding titrations. This is because the 
different charge density of Tb(III) means that its anion and protein affinity will be 
slightly different to that of Eu(III) , and because Tb(III) emission is not as sensitive 
to its coordination environment as Eu(III) emission. 
Another interesting exercise would be to determine the variation of mitochon-
drial pH as a function of pC0 2 . The probe could be based on [ E u L 4 4 a ] 3 + to try 
and conserve cellular localisation properties. The free cyclen amine group would be 
substituted by a pH sensitive functionality that over the physiological pH range will 
ligate to the Eu(III) ion. The resulting emission profile of the complex would be 
related back to the local pH. A previously reported example is that of a sensitised 
Eu(III) complex incorporating an iV-methylsulfonamide moiety. 9 8 , 9 9 This complex 
enabled the measurement of pH in the range of 6-8. An initial step to determine 
the effect of JV-substitution on the cellular localisation of [ E u L 4 4 a ] 3 + could be to 
synthesise the A'-methylated analogue. In addition, the association of bicarbon-
ate and citrate with the Af-methylated analogue could be examined to determine 
if any further selectivity between these two anions could be established with this 
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complex. I t would be expected that association constants for these two anions with 
yV-methylated [ E u L 4 4 a ] 3 + would be greater than for [ E u L 4 4 a ] 3 + , because of the re-
duced free energy of hydration of the former complex, as postulated for related 
complexes such as [ L n L 2 5 ] 3 + . 6 6 
Another route may be to tune complex selectivity more towards either bicar-
bonate or citrate. Because cellular localisation profiles of complexes can not yet be 
reliably predicted, initial work may address the issue of anion selectivity through the 
synthesis of complexes related to [ E u L 4 4 a / b ] 3 + that are of lower global charge, Fig-
ure 2.36. As an initial step the affinity constants of [ E u L 4 9 ] 2 + for HCO3- or citrate 
could be estimated to determine the effect of the reduction in global positive charge 
on anion affinity. I f this complex proved to possess a lower selectivity for citrate 
compared to carbonate then such complexes may be evaluated also. Such a strategy 
would lead to a Eu(III) complex that exhibits enhanced carbonate affinity/reduced 
citrate affinity, retains the mitochondrial localisation profile and remains non-toxic. 
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Figure 2.36 - Proposed complexes structurally related to [ E u L 4 9 ] 2 + bearing a global 
charge of +1 (left) and 0 (right). 
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Chapter 3 
Anion binding studies with 
dimeric Ln(III) complexes 
3.1 Novel dimeric Ln(III) complexes 
3.1.1 Background 
The chemoselective ligation of [ E u L 2 4 ] 3 + to the phosphate functionalities of phospho-
peptides 43b-43d, and the regioselectivity of the complex for binding to residue 9 
of the triphosphorylated peptide (43d) has been described (section 2.1). 
In light of these observations, the design and synthesis of closely related dimeric 
Ln(III) complexes was proposed. The long-term aim of this work was to assess if 
dimeric complexes could be synthesised that bound to multi-phosphorylated pep-
tide fragments, such as 43d, in a regioselective manner. For example, binding of a 
dimeric Ln(III) complex to 43d could occur at adjacent phospho-tyrosine residues 
N H 2 
X NH HN 
4 OR OR CO? HO HO O H,N H H H H H O O O 
r . co2 
CO, 
OR 3 
43a Ri = R 2 = R 3 = H NH NH H 2 N Y 43b R, = R 3 = H; R 2 = O P 0 3 
+NH 
 T  2  3   
 ,  3  ; 2 = 0 3 2 " 
43c R! = R 2 = H; R 3 = O P 0 3 2 " 
43d Ri = R 2 = R 3 = O P 0 3 2 -
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at positions 9 and 10. Intra-peptide cross-linking could also occur due to complex 
binding at residues 5 and 9 or 5 and 10. Finally, inter-peptide crosslinking could take 
place via binding of the complex to phospho-tyrosine residues of different phospho-
peptides. In addition, the affinity of dimeric complexes for the phospho-peptides 
could be estimated and compared to that of the monomeric complex ( E u L 2 4 ] 3 + , to 
establish if any cooperativity occurred in the binding process. 
Several examples of dinuclear Ln(III) complexes have been reported in the li t-
erature. Some recently reported structurally related examples are shown below. 
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One of the most recent reports the dimeric Tb(III) complex, [ T b 2 L 5 2 ] 6 + . 1 0 0 This 
coordinatively unsaturated complex possesses a p-xylylene bridge between the two 
macrocycles allowing the association of the complex with a range of mono- and 
bis(carboxylates) to be probed. The design of the dimeric complex was based on 
the corresponding monomer, [ T b L 3 9 ] 3 + ( [ E u L 3 9 ] 3 + was discussed in section 1.6.3), 
that had been examined in earlier binding studies with aromatic carboxylates.101 
Through analysis of binding titrations, the preference of binding to a range of bridg-
ing bis(carboxylates) and mono(carboxylates) was established in neutral, aqueous 
conditions. The Eu(III) , Tb(III) and Yb(III) D03A analogues of L 5 2 , [ L n 2 L 5 3 ] , 
had been examined in separate earlier work reporting the potential utility of such 
systems as anion receptors or contrast agents.102 Other studies have also examined 
several dimeric Gd(III) complexes as potential MRI contrast agents, L 5 4 - L 5 6 . 1 0 3 , 1 0 4 
3.1.2 Ligand design 
The proposed ligands, L 5 7 and L 5 8 , are simple extensions of the parent ligand, L 2 4 , 
in which the coordination environment around each Ln(III) ion of the resulting 
complexes is predicted to be conserved, along with the anion binding properties of 
the complex. 
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The dimeric ligands were designed so that they possessed a r igid linker backbone 
in order to reduce the conformational flexibility of the molecule. Two amide bonds 
and two adjacent Ph groups were incorporated into the linker of the two cyclen 
units. Such a design was expected to restrict rotation around the central bond. 
The populations of the ligand conformations were expected to be controlled by the 
relative stereochemistry at the C-atom either side of the central l inking bond. For 
example, the use of a l inking molecule possessing (R,R) or (S,S) stereochemistry may 
be expected to result in the formation of stereoisomeric dimeric ligands w i t h concave 
conformations. The use of a l inking molecule of (R,S) (meso) stereochemistry would 
be expected to result in a complex w i t h a more open structure. These conformations 
may be considered through analysis of Newman projections, looking down the central 
bond of the l inking unit , Figure 3.1. 
ROCHN Ph ROCHN Ph 
J 
/ i 
Ph vNHCO NHCOF 
Ph Ph 
H . X ^ N H C O R R O C H N J L w 
H ^ y ^ N H C O R H ^ ^ y ^ N H C O R 
Ph Ph 
Figure 3.1 - Newman projection of the central linking units of L 5 7 (5,5) (left) and 
of L 5 8 (R,S) (right), highlighting the expected conformations based on consideration 
of steric demand. 
Modulat ion of the central stereocentres allows the effect of complex conformation 
on binding to a multi-phosphorylated phospho-peptide to be examined. A concave 
conformation would therefore be expected to be more likely to bind to two phosphate 
residues of the same peptide, whilst a more open structure might be expected to 
result in interpeptide cross-linking. The overall complex r igidi ty is further enforced 
by the pendant chiral amide arms of the macrocycle which serve to favour one major 
solution phase isomer. This is beneficial in the analysis of receptor-anion binding, 
as multiple isomers can complicate subsequent spectral analysis. 
88 
3.1.3 Ligand and complex synthesis 
Ligands L 5 7 or L 5 8 were synthesised following the strategy used in the synthesis of 
L 4 4 a / b , i.e. modification of the parent ligand L 2 4 at the peripheral segment of one 
amide arm. The acid intermediate, 46, was utilised in the synthesis of L 5 7 and L 5 8 , 
Figure 3.2 . Act ivat ion of 46 followed by addition of the simple diamines (lS,2S)-(-)-
1,2-diphenylethylenediamine or meso- 1,2-diphenylethylenediamine resulted in amide 
formation, yielding the desired protected ligands. I t is interesting to note that 
when (lS,25)-(-)-l,2-diphenylethylenediamine was used as the central linking unit 
the coupling agent, EDC.HC1, proved to be effective at facil i tat ing the formation 
of the desired BOC protected ligand. I t was observed, however, when meso-1,2-
diphenylethylenediamine was used as the linking unit and EDC.HC1 as the coupling 
agent only one amine group of the linker reacted. Despite variation of the reagent 
stoichiometries, reaction temperature and solvent, the mono-amide remained the 
major product. Upon changing the coupling agent to T B T U , the desired prod-
uct was obtained in reasonable yield, suggesting a possible steric barrier hindering 
the approach of the mono-amide intermediate toward the active ester of 46, when 
EDC.HC1 was used. Subsequent BOC removal using T F A / D C M yielded the desired 
ligands as their T F A salts. 
The complexation of L 5 7 or L 5 8 was ini t ia l ly attempted w i t h 2 equivalents of 
L n ( I I I ) salt. However, alongside the desired product, this resulted in predominant 
formation of a mono-Ln(I I I ) species, as determined by ESMS analysis. To drive 
complexation to completion typically 6 equivalents of L n ( I I I ) salt were used, result-
ing in the desired dimeric complexes. The excess of L n ( I I I ) salt was ini t ia l ly removed 
by gel f i l t ra t ion chromatography, but this resulted in the loss of large amounts of 
complex. As a result, the u t i l i ty of dialysis tubing was investigated. I t was observed 
that passing large volumes of H 2 0 over a solution of complex (as its chloride/acetate 
salt) in benzoylated tubing, w i th a 1200 M W cut-off, resulted in the removal of L n C l 3 
f rom the samples, leaving the desired product as determined by ^ - N M R , HPLC, 
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high resolution ESMS analysis and preliminary X-ray analysis 105* 
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Figure 3.2 - The synthetic route used for the synthesis of [ L n 2 L 5 7 ] 6 + and [ L n 2 L 5 8 ] 6 + . 
A l l complexes and precursors were rigorously characterised by standard spectro-
* All dimeric Eu(III) and Tb(III) complexes synthesised in this chapter were isolated and analysed 
as their chloride salts and all dimeric Yb(III) complexes as their acetate salts. [ L n L 2 4 ] 3 + complexes 
were analysed as their triflate salts. 
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scopic techniques. I n addition, complexes were characterised by HPLC in order to 
confirm complexation reactions had proceeded to completion. HRMS (ES + ) analy-
sis revealed the rich isotopic fingerprint of the dimeric complexes, Figure 3.3. Such 
isotope patterns proved invaluable in identifying product MS peaks and provided a 
method by which the progress of complexation reactions could be followed. Complex 
ESMS spectra were recorded in the presence of a large excess of ammonium acetate, 
acting as an ionization aid, resulting in more intense complex peaks compared to 
spectra of complexes in the presence of their chloride or tr i f late counterions only. 
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Figure 3.3 - The observed (upper) and theoretical (lower) isotopic distribution pro-
files for the di-acetate ([M + 2(OAc)~ - 2 H + ] 2 + ) adducts of [ E u 2 L 5 7 ] 6 + (left) and 
[ Y b 2 L 5 8 ] 6 + (right). 
The MS analysis of all dimeric complexes, in the presence of excess ammonum ac-
etate, detected solely adducts w i th two acetate anions per dimeric complex, i.e. one 
acetate per metal ion. Adducts were detected as either doubly or t r ip ly charged 
species and were formed through the loss of either one or two protons in addition to 
the two acetate anions associated w i t h the complex. The observed 2:1 aniomcomplex 
stoichiometry clearly indicates that each metal centre can accommodate only one an-
ion, this is consistent w i t h the previously reported crystal structure of the [ Y b L 2 4 ] 3 + 
acetate adduct . 6 4 The crystal structure showed chelated 1:1 association of acetate 
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at the Y b ( I I I ) ion, chelation had displaced both metal-bound H 2 0 molecules. 
3.1.4 Characterisation of ligand and complex solution struc-
ture 
Analysis of the par t ia l 1 H - N M R spectra of the two ligands L 5 7 and L 5 8 immediately 
reveals their structural non-equivalence, Figure 3.4. 
h A iJIM / U w i J \ _ . i \ i \ u h A A A 
5.5 5.4 5.3 5.2 5.1 5.0 4.9 4.8 4.7 
Figure 3.4 - Partial 1 H - N M R spectra of L 5 7 (left) and L 5 8 (right) as their TFA salts 
(MeCN, 700 MHz, 295 K, 3 m M ligand) Resonances marked with • are assigned to the 
linker CH protons, resonances marked with • are assigned to amide arm CH protons. 
The clarity of these spectra is associated w i t h protonation of the macrocycles by 
residual T F A used in BOC removal. This restricts the conformational mobi l i ty of 
the ligand and results in relatively sharper spectra being obtained. W i t h L 5 7 , the 
two linker C H protons are homotopic, as a result they do not couple w i t h each other 
but do couple w i t h adjacent amide protons, resulting in the observed doublet. In 
the case of L 5 8 , the two linker CH protons are diastereotopic. As a result, these two 
protons couple w i t h each other and also to the adjacent amide protons, resulting 
in two overlapping doublet of doublets. I n a similar manner, two resonances were 
observed for the four amide arm CH protons of L 5 7 , whilst four resonances were ob-
served for the four amide arm C H protons of L 5 8 . Because L 5 8 possesses no central 
symmetry each amide arm C H proton is rendered non-equivalent on the timescale 
of the acquisition. For L 5 7 , possessing C2 symmetry, each proton has an equivalent 
tw in on the adjacent macrocycle, resulting in two distinct amide arm C H proton 
environments. 
For each dimeric E u ( I I I ) and Y b ( I I I ) complex a ^ - N M R spectrum was obtained, 
Figure 3.5. The spectra obtained are broader than those of the parent complexes 
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[ L n L 2 4 ] 3 + , and there are noteable differences between the spectra of [ L n 2 L 5 7 ] 6 + and 
[ L n 2 L 5 8 ] 6 + (where L n = Eu or Yb) . 
MjJ ^ M ^ A i 
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Figure 3.5 - 1 H - N M R spectra of [ E u 2 L 5 7 ] 6 + (upper, left), [ Y b 2 L 5 7 ] 6 + (upper, right), 
[ E u 2 L 5 8 ] 6 + (lower, left) and [ Y b 2 L 5 8 ] 6 + (lower, right) ( D 2 0 , pD 7.8, 500 MHz, 295 K, 
2 m M complex). 
The spectra of complexes w i t h the meso linker, [ E u 2 L 5 8 ] 6 + and [ Y b 2 L 5 8 ] 6 + , are the 
simplest, revealing the protons of the two macrocycles to be non-equivalent and the 
presence of only one conformer on the 500 MHz N M R timescale. In contrast, the 
spectra of the complexes w i t h the SS linker, [ E u 2 L 5 7 ] 6 + and [ Y b 2 L 5 7 ] 6 + , exhibited a 
distr ibution of a similar number of paramagnetically shifted resonances; the relative 
ratio of which indicated the presence of at least one minor and one major conformer 
on the N M R timescale. Attempts to simplify the spectrum of [ E u 2 L 5 7 ] 6 + by record-
ing i t at 50°C proved unsuccessful, resulting in an extremely broad spectrum. 
The CPL spectra of [ E u 2 L 5 7 ] 6 + and [ E u 2 L 5 8 ] 6 + were recorded, alongside their 
total luminescence spectra. In each case, the form of the total luminescence spec-
tra was vi r tual ly identical; suggesting that each complex retained a constant axial 
donor ligand ( D 2 0 ) , and possessed a consistent coordination environment around 
the central E u ( I I I ) ions. The CPL spectra of [ E u 2 L 5 7 ] 6 + and [ E u 2 L 5 8 ] 6 + were dis-
t inct ly different. Whereas the spectrum obtained for [ E u 2 L 5 8 ] 6 + was very similar to 
that of the parent monomer, [ E u L 2 4 ] 3 + , the spectrum obtained for [ E u 2 L 5 7 ] 6 + was 
significantly different in form, Figure 3.6. 
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Figure 3.6 - CPL spectra of [EuL 2 4 ] 3 + ( H 2 0 , 1 mM, 295 K, A e x c = 255 nm) (upper); 8 9 
total luminescence and CPL spectra (x 60) of [ E u 2 L 5 7 ] 6 + ( D 2 0 , 1 mM, 295 K, A e x c 
= 255 nm) (lower left) and total luminescence and CPL spectra (x 18) of [ E u 2 L 5 8 ] 6 + 
( D 2 0 , 1 mM, 295 K, A e x c = 255 nm) (lower right). 
Comparison of g e m values at specific wavelengths of the three spectra highlights the 
difference in fo rm of the two dimeric complex spectra and the similarity between the 
spectra of [ E u 2 L 5 8 ] 6 + and [ E u L 2 4 ] 3 + , Table 3.1. 
C o m p l e x A J = 1 (A) A J = 1 (A) A J = 2 (A) 
[ E u L 2 4 ] 3 + +0.04 (588) -0.05 (593) +0.03 (612) 
[ E u 2 L 5 7 ] 6 + -0.03 (588) -0.04 (591) +0.003 (614) 
[ E u 2 L 5 8 ] 6 + +0.03 (588) -0.04 (593) +0.025 (614) 
Table 3.1 - Emission dissymmetry values ( g e m ) at specified wavelengths ( D 2 0 , 295 
K) ; [ E u L 2 4 ] 3 + in H 2 0 . 8 9 
The differences in the CPL spectra of [ E u 2 L 5 7 ] 6 + and [ E u 2 L 5 8 ] 6 + suggest that there 
may be opposing local helicities at the two Eu( I I I ) centres of [ E u 2 L 5 7 ] 6 + . This results 
in a degree of averaging of the CPL originating f rom each E u ( I I I ) ion, culminating in 
a reduced nett CPL. This is reflected by the g e m values of various transitions being 
either of lower magnitude or opposite sign to those of [ E u L 2 4 ] 3 + and [ E u 2 L 5 8 ] 6 + . In 
94 
contrast, the form of the CPL spectra of [ E u 2 L 5 8 ] 6 + can be explained in terms of 
each E u ( I I I ) centre behaving as an independent complex, each wi th the same helic-
ity at E u ( I I I ) , as found in [ E u L 2 4 ] 3 + . This results in no averaging of the global CPL 
signal, rendering the CPL spectrum (and thus the g e m values) vir tual ly identical to 
that of [ E u L 2 4 ] 3 + . 
The magnitude of the paramagnetic shifts observed in the ^ - N M R spectra of 
all complexes, and the similarity in the CPL spectra of [ E u 2 L 5 8 ] 6 + and [ E u L 2 4 ] 3 + 
suggests that the dimeric complexes retain the SAP prismatic geometry around each 
L n ( I I I ) ion as observed previously for [ E u L 2 4 ] 3 + 5 8 and [ Y b L 2 4 ] 3 + . 6 4 
Finally, the hydration states of the complexes were estimated through analysis 
of the radiative decay rate constants of the excited states of the Eu( I I I ) and T b ( I I I ) 
complexes. 
C o m p l e x / anion A; (H 2o)/ms 1 A; ( D 2 o)/ms 1 A f c / m s - 1 
[ E u 2 L 5 7 ] 6 + / C l - 2.78 1.22 1.56 1.28 
[ T b 2 L 5 7 ] 6 + / C l - 0.72 0.47 0.25 0.94 
( (9 -P -Tyr ) 2 " 0.77 0.65 0.12 0.30 
Lactate 0.58 0.49 0.09 0.14 
[ E u 2 L 5 8 ] 6 + / C l - 2.86 1.22 1.64 1.42 
[ T b 2 L 5 8 ] 6 + / C l - 0.79 0.48 0.31 1.26 
( O - P - T y r ) 2 - 0.68 0.49 0.19 0.67 
Lactate 0.59 0.47 0.12 0.3 
Table 3.2 - Effect of added anions on the rate constants (k) (± 10 %) for radiative 
decay of the excited states of [ E u 2 L 5 7 ] 6 + , [ T b 2 L 5 7 ] 6 + , [ E u 2 L 5 8 ] 6 + and [ T b 2 L 5 8 ] 6 + (295 
K, 0.05 m M complex, 0.5 m M anion) and derived hydration numbers, q (± 20 % ) . a 
qEu = 1.2[(fc(H2o)-fc(D2O))-(0-25+0.07x)] (x = number of carbonyl-bound amide NH 
oscillators) b qTb = 5(fc ( H 2o)-fc(D 2O)-0.06). 5 7 
Whereas the parent complexes [ E u L 2 4 ] 3 + and [ T b L 2 4 ] 3 + were shown to possess two 
directly coordinating H 2 0 molecules (i.e. q — ~ 2 ) in aqueous so lu t ion , 1 0 6 estimates 
suggest the dimeric complexes each possess a lower q value. This indicates that for 
each complex there may either be a mixture of q = 1 and q = 2 systems or solely 
q = 1 systems. This may be related to the micro-environments around the metal 
centres being more hydrophobic and sterically demanding than that for the parent 
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complexes, resulting in the lower non-integer values of q observed. 
3.2 Anion binding studies 
The binding of [ L n 2 L 5 7 ] 6 + and [ L n 2 L 5 8 ] 6 + (Ln = Eu, Tb , Yb) to selected anions was 
probed through analysis of ' H - N M R , 3 1 P - N M R , L n ( I I I ) luminescence spectra and 
mass spectrometry data. I t was decided to determine the binding stoichiometrics of 
the dimeric systems to probe whether each encapsulated L n ( I I I ) ion could reversibly 
bind to anions, and to determine whether or not the conformation of each dimeric 
complex restricted the access of anions to the metal centres. In addition, i t was 
also considered appropriate to determine the individual binding constants for anion 
binding at each L n ( I I I ) centre, or at least estimate a global affinity constant for 
anion binding, by analysis of either N M R or luminescence titrations. 
3.2.1 NMR and CPL anion binding studies 
Binding t i t rat ions of the dimeric E u ( I I I ) complexes [ E u 2 L 5 7 ] 6 + and [ E u 2 L 5 8 ] 6 + w i th 
( O - P - T y r ) 2 - , monitored through acquisition of J H-NMR, and 3 1 P - N M R spectra, 
yielded disappointing results. Analysis of the data was hampered by severe line 
broadening in the spectra, in the presence of < 1 eq. added ( 0 - P - T y r ) 2 - . Moreover, 
precipitation occurred in the presence of > 1.4 eqs. added ( 0 - P - T y r ) 2 - , suggesting 
a degree of insolubility of 1:2 adduct between the complex and ( 0 - P - T y r ) 2 - . De-
spite these limitations, the shifts of the Hax resonances in the l imi t ing spectra (in the 
presence > 2.4 eqs. ( 0 - P - T y r ) 2 ~ ) were consistent w i th a E u ( I I I ) bound ( 0 - P - T y r ) 2 -
species.6 6 In addition, the number and ratio of resonances in the l imi t ing spectra 
suggests the presence of two conformers, as observed in spectra of the aqua complex. 
Unfortunately, due to exchange broadening on the N M R timescale no phosphorus 
signal was observable unt i l over 1 eq. ( 0 - P - T y r ) 2 - had been added. This signal 
corresponded to unbound ( O - P - T y r ) 2 - . Presumably, the signal associated wi th 
bound ( O - P - T y r ) 2 - was too broad to be observed. In addition, in all subsequent 
N M R studies, including those mentioned below, no bound phosphorus signal was 
observed. Previous work in monomeric systems had observed such shifted, broad 
3 1 P - N M R signals at -136 ppm ( w 1 / 2 « 200 Hz, 298 K , H 2 0 , 162 MHz, pH 7 .4 ) . 7 3 ' 8 4 
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Despite the adduct solubility issues discussed above, the l imi t ing ^ - N M R spec-
t ra of [ Y b 2 L 5 7 ] 6 + and [ Y b 2 L 5 8 ] 6 + were recorded in the presence of a range of anions, 
Figure 3.7. The Y b ( I I I ) complexes were examined due to the greater spectral range 
of their ligand resonances, aiding the analysis of shifted resonances. I n addition, 
l imi t ing ^ - N M R spectra of [ E u 2 L 5 7 ] 6 + and [ E u 2 L 5 8 ] 6 + were recorded in the presence 
of D-glucose-6-(dihydrogen phosphate) (Glc-6-P) 2 ~ or cx-D-glucose 1,6-bisphosphate 
potassium salt (Glc-1,6-P) 4~, Figure 3.8. 
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Figure 3.7 - Partial 1 H - N M R spectra (500 MHz, D 2 0 , 295 K, pD 7.8, 2 m M complex, 
10 m M added anion) of [ Y b 2 L 5 7 ] 6 + (left spectra set) and [ Y b 2 L 5 8 ] 6 + (right spectra 
set) of the anion adducts of H C 0 3 - , ( O - P - T y r ) 2 - , L-Tyrosine (Tyr) and chloride (un-
bound), showing the most paramagnetically shifted resonances (Hax protons marked 
b y ) . 
For bo th Y b ( I I I ) dimeric complexes, where possible, the mean shift (average of 8) 
of the most shifted macrocycle proton ( H a x ) was calculated, Table 3.3. As described 
in chapter 1, the chemical shift of this resonance is extremely sensitive to the local 
coordination environment, in particular the nature of the 'pseudo-axial' donor atom. 
The mean chemical shift values allow comparisons to be made w i t h [ Y b L 2 4 ] 3 + , for 
which such values had been reported previously. 6 6 
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A n i o n a [ Y b L 2 4 ] 3 + [ Y b 2 L 5 7 ] 6 + [ Y b 2 L 5 8 ] e + 
c r n.d. 56 65 
CF3SO3- 75 n.d. n.d. 
( O - P - T y r ) 2 - 95(40) 85 80 
Tyr 39 55 64 
Table 3.3 - Mean chemical shifts1 5 (295 K, pD = 7.8, 500 MHz) of the most shifted 
axial ring protons in ternary anion adducts. a The value in parenthesis refers to a 
minor chelated species; with chloride or triflate as the counter-ion, there is no bound 
anion.; 6 4 b Values for [ Y b L 2 4 ] 3 + obtained previously.6 6 
The most s tr iking observation in these binding studies is that the spectrum of 
[ Y b L 2 4 ] 3 + in the presence of Tyr was dramatically different to that of the aqua com-
plex, highlighted by the differences in mean shift of the Hax protons, Table 3.3. The 
differences in shift were explained by the formation of a chelate when in the pres-
ence of Tyr , the amino TV-atom capping the square-antiprism w i t h the carboxylate 
0-atom binding in an equatorial position. Such chelated systems were established 
through X-ray analysis of amino acid ternary adducts of [ Y b L 2 4 ] 3 + . 6 4 However, 
comparison of the spectra of [ Y b 2 L 5 7 ] 6 + and [ Y b 2 L 5 8 ] 6 + as the aqua complexes and 
Tyr adducts suggest that formation of this chelate was inhibited, as the spectra 
remained vi r tual ly unchanged. The only evidence of interaction was the broadening 
of the resonances and the appearence of some minor resonances (<15 %) that may 
possibly be a t t r ibuted to a chelated binding mode. Furthermore, w i th [ Y b L 2 4 ] 3 + in 
the presence of added ( O - P - T y r ) 2 - the chelated species was observed to compete 
wi th phosphate ligation in a ratio of ~1:3. 6 6 W i t h [ Y b 2 L 5 7 ] 6 + and [ Y b 2 L 5 8 ] 6 + , in 
the presence of ( 0 - P - T y r ) 2 - , only phosphate ligation was observed. 
The addition of N a H C 0 3 to aqueous solutions of both [ Y b 2 L 5 7 ] 6 + and [ Y b 2 L 5 8 ] 6 + 
induced a significant spectral contraction, as observed for [ Y b L 2 4 ] 3 + , 6 6 consistent 
wi th the replacement of the axial D 2 0 wi th the O-atom of a chelating carbonate. 
The abili ty of each dimeric Y b ( I I I ) complex to bind to the phosphate functionality 
of ( O - P - T y r ) 2 - selectively, coupled wi th an apparent suppression of the competing 
chelated amino acid binding mode is promising for future peptide studies. Although 
the broad nature of the spectra hinders analysis, i t appears that there are the same 
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number of conformers in each adduct spectra as in the parent aqua spectra. The 
suppression of chelate formation w i t h the dimeric systems is intriguing. I t is possible 
that the chelate of the amino acid (possibly formed in a stepwise manner through 
displacement of labile water through equatorial ligation of a carboxylate oxygen 
then axial ligation of the protonated amine) 6 4 may be trapped at the intermediate 
stage where the protonated amine is stabilised in a hydrogen bonding network in-
corporating the ligand and second-sphere solvent, preventing chelation. I t may be 
that the more sterically demanding metal site restricts formation of the 5-membered 
chelate. In these studies the ( 0 - P - T y r ) 2 ~ adducts exhibited part ial insolubility, the 
carbonate adducts less so, whilst no precipitation was observed wi th the complex 
and Tyr mixture. 
Analysis of the ^ - N M R spectra [ E u 2 L 5 7 ] 6 + and [ E u 2 L 5 8 ] 6 + in the presence of 
(Glc-6-P) 2~ and (Glc-1 ,6-P) 4 - suggested that binding of the phospho-anions oc-
curred. The ternary adducts of (Glc-6-P) 2~ and (Glc-1 ,6-P) 4 _ gave rise to somewhat 
different spectra. 
t „ 
(Glc-1,6-P) (Glc-1,6-P) 
• 
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Figure 3.8 - X H-NMR spectra (500 MHz, D 2 0 , 295 K, pD 7.8, 2 mM complex, 10 
mM added anion) of [ E u 2 L 5 7 ] 6 + (left spectra set) and [ E u 2 L 5 8 ] 6 + (right spectra set) 
of the anion adducts of D-glucose-6-(dihydrogen phosphate) (Glc-6-P) 2 ' , a-D-glucose 
1,6-bisphosphate potassium salt (Glc-1,6-P)4~ and chloride (unbound), showing the 
most paramagnetically shifted resonances. 
The broad spectra obtained w i t h [ E u 2 L 5 7 ] 6 + and (Glc-1 ,6-P) 4 _ may be indicative of 
multiple binding modes (e.g. 1:1 and 2:1 aniomcomplex adducts, depending upon 
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complex conformation) and the presence of conformational exchange. In contrast, 
the spectrum obtained w i t h [ E u 2 L 5 8 ] 6 + and (Glc-1,6-P) 4~ is considerably sharper, 
consistent w i t h a lower number of more conformationally rigid solution species. I t 
should be borne in mind that the complexity of these spectra in part may arise f rom 
the formation of diastereoisomeric saccharide complexes, as previously observed. 6 6 
The CPL spectra of [ E u 2 L 5 7 ] 6 + and [ E u 2 L 5 8 ] 6 + adducts w i t h (Glc-6-P) 2 - and 
(Glc-1,6-P) 4 _ were recorded and compared to spectra of the aqua complexes and 
those previously recorded for the [ E u L 2 4 ] 3 + aqua complex and (Glc-6-P) 2~ adduct, 
Figure 3.9. 
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Figure 3.9 - C P L spectra for: (1) [ E u 2 L 5 7 ] 6 + (x 60); (2) [ E u 2 L 5 7 ] 6 + plus 10 eqs. 
(Glc-6-P) 2- (x 60); (3) [ E u 2 L 5 7 ] 6 + plus 10 eqs. (Glc-1,6-P) 4" (x 60); (4) [ E u 2 L 5 8 ] 6 + 
(x 18); (5) [ E u 2 L 5 8 ] 6 + plus 10 eqs. (Glc-6-P) 2- (x 18); (6) [ E u 2 L 5 8 ] 6 + plus 10 eqs. (Glc-
1,6-P) 4 - (x 18). Total luminescence spectra are also shown (black) (1 mM complex, 
295 K, Aexc = 255 nm). 
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For each dimeric complex, the form and sign of the transitions for their (Glc-6-
P ) 2 _ and (Glc-1 ,6-P) 4 _ adducts were identical and were markedly different to that 
of the aqua complex. The [ E u 2 L 5 8 ] 6 + (Glc-6-P) 2~ and (Glc-1,6-P) 4 - adduct CPL 
spectra mirrored the CPL spectrum of the [ E u L 2 4 ] 3 + (Glc-6-P) 2 _ adduct reported 
previously. 6 6 This indicates a homology in the central helicity around the Eu( I I I ) 
ions of the dimeric complex anion adducts, as exhibited by monomer anion adducts. 
In contrast, the [ E u 2 L 5 7 ] 6 + (G lc -6 -P) 2 - and (Glc-1,6-P) 4 " adduct CPL spectra were 
weak and markedly different to that of the [ E u L 2 4 ] 3 + (G lc -6 -P ) 2 - adduct CPL spec-
tra, reinforcing the hypothesis that this dimeric complex exhibits different helicities 
at each E u ( I I I ) centre. 
In the binding studies described above w i t h the dimeric complexes and (O-P-
T y r ) 2 ~ / H C 0 3 - , small amounts of precipitate were immediately observable. In spite 
of this insolubility, N M R studies of complex binding to the phopeptides (43a-43d) 
were undertaken. Unfortunately upon addition of >0.5 eq. of any phosphopeptide 
to either [ E u 2 L 5 7 ] 6 + or [ E u 2 L 5 8 ] 6 + immediate precipitation occurred; the residual so-
lution yielding no useful spectra. Despite the hydrophillic nature of this particular 
peptide, the insolubility of the resultant adduct at the concentration range required 
for lR and 3 1 P - N M R analysis precluded any further N M R investigations. 
Whils t the N M R and CPL data obtained did not allow definite binding stoi-
chiometrics and anion affinites of the dimeric complexes to be obtained, the spectral 
information highlights the conformational differences between the two dimeric com-
plexes, allowing a comparison to be made w i t h the monomer complexes, [ L n L 2 4 ] 3 + . 
As a result, luminescence studies of the dimeric complexes w i t h selected anions were 
undertaken to probe further the binding of anions w i t h these complexes. 
3.2.2 Luminescence studies of anion binding 
Init ially, luminescence studies were attempted w i t h [ E u 2 L 5 7 ] 6 + and [ E u 2 L 5 8 ] 6 + . I t 
was envisaged that anion binding to the L n ( I I I ) centres, w i t h the concomitant dis-
placement of a water molecule, would lead to an increase in the luminescence inten-
sity of the A J = 2 band, following excitation at 255 nm. However, upon addition 
of ( 0 - P - T y r ) 2 - the changes in luminescent intensity were small.* I t was there-
fore decided to utilise the analogous T b ( I I I ) complexes [ T b 2 L 5 7 ] 6 + and [ T b 2 L 5 8 ] 6 + 
in luminescent t i trations. As tyrosine is known to sensitise T b ( I I I ) emission effi-
c i e n t l y , 1 0 7 , 1 0 8 i t was decided to monitor the binding of ( 0 - P - T y r ) 2 - to the metal by 
excitation of the ( 0 - P - T y r ) 2 ~ chromophore that would sensitise the T b ( I I I ) emis-
sion. Therefore, binding could be monitored by following the intensity increase of 
T b ( I I I ) luminescence at 545 nm. Accordingly, luminescent binding titrations of 
[ T b 2 L 5 7 ] 6 + and [ T b 2 L 5 8 ] 6 + w i th ( 0 - P - T y r ) 2 ' - were carried out. In addition, binding 
titrations w i t h [ T b L 2 4 ] 3 + and ( 0 - P - T y r ) 2 - were recorded for comparison purposes. 
Upon addition of ( 0 - P - T y r ) 2 ~ to the complexes, T b ( I I I ) emission was clearly en-
hanced, Figure 3.10. These enhancements indicate population of the 5 D 4 excited 
state of T b ( I I I ) through coordination of the ( 0 - P - T y r ) 2 - sensitiser, and also reflect 
a contribution to emission enhancement f rom displacement of the quenching OH os-
cillators of the metal bound water molecules. Job plots established a 2:1 binding sto-
ichiometry for the association of (<9-P-Tyr) 2~ wi th [ T b 2 L 5 7 ] 6 + and [ T b 2 L 5 8 ] 6 + , and 
a 1:1 binding stoichiometry wi th [ T b L 2 4 ] 3 + , Figure 3.10. These results further are 
corroborated by the HRMS ( E S + ) spectra of the dimeric complexes (section 3.1.3) 
in which two acetate anions are bound per complex in the gas phase, i.e. one per 
metal ion. I t was possible to fit the t i t ra t ion data to appropriate binding models us-
ing the programme SPECFIT, to obtain binding curves and speciation distribution 
diagrams (Figure 3.10) and estimated affinity constants, Table 3.4. This work was 
carried out in conjunction wi th Dr. C. dos Santos (Tr in i ty College Dublin) . 
* This is likely to be due to competitive sensitisation of Eu(III) by the added (0-P-Tyr) 2 , a 
process in which the excited Si state of (O-P-Tyr) 2 - is quenched by electron transfer to Eu(III) 
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Figure 3.10 - Binding curves and speciation distribution diagrams (295 K, pH 7.4, 
A e x c = 275 nm) for the association of (O-P-Tyr ) 2 - . Upper: [ T b 2 L 5 7 ] 6 + (0.05 mM); 
Centre: [ T b 2 L 5 8 ] 6 + (0.05 mM); Lower: binding curve for [ T b L 2 4 ] 3 + (0.11 mM) associ-
ation with (0-P-Tyr) 2 ~ and Job plot establishing 1:1 stoichiometry for its association 
with (O-P-Tyr ) 2 - (295 K, pH 7.4, A e x c = 275 nm), X = [(O-P-Tyr) 2 -)] / ( [ (O-P-
T y r ) 2 - ] + [ [ T b L 2 4 ] 3 + ] ) . 
The binding curve for [ T b 2 L 5 7 ] 6 + shows that T b ( I I I ) emission intensity reached 
a maximum after the addition of 2 eqs. of ( O - P - T y r ) 2 - . Similar behaviour was 
observed w i t h [ T b 2 L 5 8 ] 6 + . However, in this case the emission intensity reached a 
maximum more gradually. The difference in fo rm of the binding curves is reflected 
in the magnitude of the step-wise binding constants. W i t h [ T b 2 L 5 7 ] 6 + , each step-
wise binding constant (and therefore the global aff ini ty constant) was lower than 
the corresponding value estimated for [ T b 2 L 5 8 ] 6 + . The speciation distr ibution dia-
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[ T b L 2 4 ] 3 + [ T b 2 L 5 7 ] 6 + [ T b 2 L 5 8 ] 6 + 
G:L log 0 
G:L Log K 
4.88 
4.88 (±0.10) 
4.60 
4.60 (±0.03) 
5.67 
5.67 (±0.30) 
G 2 :L log (3 
G 2 :L log K 
8.14 
3.54 (±0.10) 
10.45 
4.78 (±0.29) 
Table 3.4 - Affinity constants estimated for the association of (O-P-Tyr)2 with 
[TbL 2 4 ] 3 +, [ T b 2 L 5 7 ] 6 + and [ T b 2 L 5 8 ] 6 + . G = (O-P-Tyr) 2-, L = complex, values in 
parenthesis are the estimated standard deviations. 
grams show that the formation of a 2:1 G:L adduct with [ T b 2 L 5 8 ] 6 + is rapid after 
the addition of >2 eqs. (O-P-Tyr) 2 - . In contrast, the formation of a 1:1 adduct 
with [ T b 2 L 5 7 ] 6 + is the predominant solution species even after the addition of >4 
eqs. (O-P-Tyr ) 2 - . These differences can be explained by the greater steric bar-
rier towards initial and secondary (O-P-Tyr) 2 - binding at the Tb(III) centres of 
[ T b 2 L 5 7 ] 6 + , compared to the more open structure of [ T b 2 L 5 8 ] 6 + . Further analysis 
of anion binding is provided by analysis of the radiative decay rate constants of 
the Tb(III) excited state. In the presence of an excess of (O-P-Tyr) 2 - the derived 
hydration number for each dimeric complex is reduced compared to that of the aqua 
complex. In each case, the change in q is a non-integer value, and most likely reflects 
a complex of mixed hydration states; a situation that can be accounted for by the 
hydrophobic nature of the resultant adduct. For each dimeric complex the initial 
binding constant is one order of magnitude higher than that of the second binding 
constant. This behaviour is consistent with a decrease in overall complex positive 
charge upon initial (O-P-Tyr) 2 - binding, and the effect of increased steric hindrance. 
The binding curve obtained for (O-P-Tyr) 2 - association with [ T b L 2 4 ] 3 + was sub-
jected to the iterative data fitting process used in previous work, to allow comparison 
with earlier binding studies with [EuL 2 7 ] and (O-P-Tyr ) 2 - . 6 6 These results revealed 
an association constant of log K = 4.88 (±0.10), greater than the value of log K 
= 4.2 (±0.2) obtained with [EuL 2 7 ] . However, this latter association constant was 
recorded in the presence of a 5 mM N a H C 0 3 - background, so the greater magnitude 
of the former is not suprising. 
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A similar analysis of the association of lactate with [ T b 2 L 5 7 ] 6 + , [ T b 2 L 5 8 ] 6 + and 
[ T b L 2 4 ] 3 + was undertaken. 
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Figure 3.11 - Binding curves and speciation distribution diagrams (295 K, pH 7.4, 
A e x c = 255 nm, 3.0 ms delay time) for the association of lactate: Upper; [TbzL 5 7] 6 4" 
(0.049 mM), Centre; [Tb 2 L 5 8 ] 6 + (0.049 mM): Lower; [TbL 2 4 ] 3 + (0.097 mM) (lower 
diagrams). 
The affinity constants defining lactate binding were estimated to be lower than 
those for (0-P-Tyr) 2 ~, Table 3.5. This primarily reflects the lower charge of lactate 
compared to ( 0 - P - T y r ) 2 - . 
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[ T b L 2 4 ] 3 + [ T b 2 L 5 7 ] e + [ T b 2 L
5 8 ] 6 + 
G:L log (3 
G:L Log K 
3.80 
3.80 (±0.01) a 
4.50 
4.50 (±0.10) 
4.58 
4.58 (±0.13) 
G 2 :L log (3 
G 2 :L log K 
- 7.70 
3.20 (±0.27) 
7.60 
3.02 (±0.19) 
Table 3.5 - Affinity constants estimated for the association of lactate with [ T b L 2 4 ] 3 + , 
[ T b 2 L 5 7 ] 6 + and [ T b 2 L 5 8 ] 6 + . G = lactate, L = complex, values in parenthesis are 
the estimated standard deviations. a The iterative data fitting process used in the 
analysis of (0-P-Tyr) 2~ association with [ T b L 2 4 ] 3 + was also used to estimate lactate 
association with this complex. . A log K value of 3.95 (±0.01) was estimated using this 
method. 
The lower affinity constants across the series were reflected in the form of the binding 
curves. The intensity increase in Tb(III) emission, as a function of added lactate, 
was observed to reach a maximum after addition of about 20 eqs. of anion. Very 
similar affinity constants were estimated for both dimeric complexes, through fitting 
of the data to a 2:1 G:L binding model. This contrasts with the behaviour in binding 
to (0-P-Tyr) 2 ~, in which the values for were different for each dimeric complex. The 
simplest explanation for this differing behaviour is that the relatively smaller lactate 
anion has equal access to the equivalent metal centres of [ T b 2 L 5 7 ] 6 + and [ T b 2 L 5 8 ] 6 + , 
with steric factors and differing complex conformations influencing the binding free 
energy very little. As a result, each affinity constant is of a similar magnitude. In 
each case, the second affinity constant is lower, as expected for an asociation to a 
complex of lower overall charge. In contrast, the association of the more sterically 
demanding (0-P-Tyr) 2 ~ anion with [ T b 2 L 5 7 ] 6 + and [ T b 2 L 5 8 ) 6 + is influenced much 
more by steric factors and complex conformation, as noted above. The estimated 
association constant for lactate with [ T b L 2 4 ] 3 + was lower than that estimated for 
the initial association of lactate with the dimeric complexes, this is consistent with 
the greater positive charge of the dimeric complexes. The estimated q values of 
0.14 and 0.3 for the [ T b 2 L 5 7 ] 6 + and [ T b 2 L 5 8 ] 6 + lactate adducts respectively, were 
also lower than those estimated with the ( 0 - P - T y r ) 2 - adducts. Such behaviour is 
consistent with the tendency of the lactate anion to bind to the metal centre in a 
chelated manner, as observed in the X-ray crystal structure of the related monomeric 
[ Y b L 2 4 ] 3 + lactate adduct. 6 4 
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3.3 Conclusions 
The synthesis of dimeric Ln(III) complexes with stereoisomeric structures was achie-
ved through a synthetic route allowing the conformation of the resultant complex to 
be modulated through the variation of stereochemistry of the central linking group. 
The stereoisomeric complexes were synthesised via a common intermediate, that fa-
cilitates the synthesis of analogues in which the bridging group is varied. 
The differing conformers of the stereoisomeric complexes and ligands were able 
to be successfully probed by a variety of spectroscopic techniques. These included 
the application of CPL spectroscopy that highlighted the difference in the local chi-
rality at the Ln(III) centres of the complexes. The binding of anions to the dimeric 
complexes was examined, with clear differences being observed between the two 
stereoisomeric structures in the form of the binding curves and the estimated step-
wise affinity constants for association with (O-P-Tyr) 2 - . Differences between the 
association of the dimeric complexes with the smaller lactate anion proved to be 
insignificant. These differences have been rationalised by consideration of the pre-
ferred complex conformation and relative steric bulk of the anions. Unfortunately, 
some adducts at the 2 mM concentration level proved to be partially insoluble, par-
ticularly with phosphopeptide adducts. This prevented more detailed NMR analysis 
from being carried out, and limited studies to luminescence methods at higher dilu-
tion. 
This work therefore indicates that dimeric coordinatively unsaturated Ln(III) 
complexes are appropriate candidates for the synthesis of selective ditopic recep-
tors. The modulation of the bridging linker determines guest binding affinities and 
selectivity for certain anionic guests. 
3.4 Future work 
The stereoisomeric complexes outlined here may be considered suitable targets for 
the phopho-peptide series 43b-43d, although the insolubility of complex adducts 
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precluded detailed analysis of the interactions of these species. Future work may 
revolve around MS analysis of dimeric complex phospho-peptide adducts. Initial MS 
analyses of 1:1 solutions of [ L n L 2 4 ] 3 + (Ln = Eu(III), Tb(II I ) , Yb(III)) and 43b, at 
U .M concentrations, resulted in the detection of 1:1 adducts. Electron-capture disso-
ciation (ECD) of these adducts sequenced the peptide, locating the site of complex 
ligation at the phospho-tyrosine residue.109 As noted earlier, the solubility of the 
dimeric complex phospho-peptide adducts, at mM concentrations, was extremely 
poor. Preliminary MS studies have detected 1:1 adducts of [ E u 2 L 5 7 ] 6 + or [ E u 2 L 5 8 ] 6 + 
and 43b from 1:1 solutions at |j.M concentrations. Future work includes further MS 
analysis, using ECD to sequence the peptide and locate the site of ligation of the 
dimeric complex. An extension of this preliminary study would be the MS analysis 
and ECD sequencing of adducts of [ L n 2 L 5 7 ] 6 + or [ L n 2 L 5 8 ] 6 + with 43d to determine 
any regioselectivity of binding of the complex to the peptide. 
Innumerable closely related analogues of L 5 7 and L 5 8 may be envisaged that 
would be expected to increase the water solubility of resultant adducts, selected 
examples are shown below. 1 1 0 
If anionic functionalities were to be introduced to the ligand the reduced global 
charge of the resultant complexes would be expected to reduced their affinity for 
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anionic species, therefore a balance would have to be struck between solubility and 
affinity. In addition, modulation of the central linker group may alter the conforma-
tion of the complex. Each complex would therefore have to be examined in detail 
to determine the relative orientation of the Ln(III) ions. 
The synthesis of complexes, such as the few examples suggested, could allow the 
desired binding studies to be undertaken. In the longer term, if ditopic anion recep-
tors could be identified that exhibited significantly enhanced selectivity for specific 
sequences of multiphosphorylated phospho-peptides, then the concept could be ex-
amined of a probe (or phosphatase inhibitor) selective for specific phosphate residues. 
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Chapter 4 
Immobilised Ln(III) complexes 
4.1 Phospho-peptide enrichment techniques 
The biological significance of protein phosphorylation was mentioned in section 1.4.1. 
Phospho-proteins are estimated to constitute between 10-35 % of the proteome but 
influence virtually all cell signalling processes.1 1 1 , 1 1 2 Phosphorylation of proteins is 
a dynamic post-translational modification, controlled through the interplay of pro-
tein kinases and protein phosphatases.1 1 3 , 1 1 4 In addition, it is becoming increasingly 
clear that the abnormal regulation of amino acid phosphorylation plays a role in hu-
man disease. For example, the dysregulation of tyrosine phosphorylation is known 
to play a key role in a wide range of diseases including diabetes and cancer. 1 1 2 , 1 1 5 ' 1 1 6 
The ability to establish the sites of phosphorylation within substrate proteins has 
huge medical potential, and also carries significant academic interest. Recent years 
have seen intensive academic research and increased efforts by the pharmaceutical 
industry toward identifying phosphorylation sites, in order to create inhibitors of 
specific kinases and phosphatases. In the case of tyrosine kinases, several specific 
inhibitory drugs have been developed and have yielded promising results in the in-
hibition of tumour cell proliferat ion. 1 1 5 , 1 1 6 
The analytical method of choice for the identification of phosphate sites on 
phosphorylated proteins is mass spectrometry.111 Modern MS techniques, utilis-
ing MALDI-TOF and/or ESI, enable the sequencing of proteins through analysis of 
protein digests and therefore the identification of phosphorylation sites. However, 
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before analysis of digests is undertaken, the phospho-peptides need to be purified to 
enable them to be detected. This is due to the low stoichiometric ratio of phospho-
proteins, resulting in signals due to phosphorylated fragments being swamped by the 
non-phosphorylated background signal. In addition, phospho-peptides (particularly 
multi-phosphorylated fragments) often exhibit a low response in MS analysis due 
to the negative charge of the phosphate functionality. Both of these factors ensure 
that phospho-protein enrichment is a prerequisite in order to increase the levels of 
phospho-peptides to detectable levels. 
Many methods have been reported that enrich phospho-peptide fragments, Fig-
ure 4.1. 
Radiolabetling with 
" P inorganic phosphate 
Phosphoprotein s a m p l e | + - Immune-capture to 
phosphoantibodles 
Immune-capture to 
phrjsphoantibodles 
Edman 
sequencing 
MS and H P L C - M S 
1 /2D-PAGE 
- H P L C 
Dephosphorylation 
Phosphospecific 
derivalisation 
Protein M S 
Electroblotting 
Autoradiography 
phosphor Imaging Enzymatic / chemical digestion I C A T 
quantitation 
Phosphopeptide 
enrichment 
fractionation 
T L C separation 
i 
Scintillation counting 
I 
Capillary zone 
electrophoresis 
fluorescence 
quantitation 
Identification ot phosphopeptide 
I F T - I C R | | Neutral loss s c a n | | Precursor Ion s c a n j | Mapping | I C P | 
Phosphopeptide fragmentation , 
Figure 4.1 - A schematic111 overview highlighting several approaches to phospho-
protein analysis through radiolabelling and mass spectrometric techniques. 
However, these enrichment methods are largely residue specific and very few proce-
dures are applicable to all phospho-proteins. The vast majority of these methods 
are aimed at the enrichment of peptides containing O-phosphorylated amino acid 
residues. The relative abundance of phospho-amino acids within vertebrate cells has 
been estimated at approximately 92.5:7.45:0.05 for (0-P-Ser) 2-/(<9-P-Thr) 2-/(0-
P - T y r ) 2 - . 1 1 7 However, further phosphorylated amino acids exist at significant levels, 
111 
such as the N-phosphorylated amino acids where phosphorylation of the amino acid 
occurs through phosphoramidate bond formation. Kinases and phosphatases are 
known that act on His, Lys, and A r g , 1 1 8 , 1 1 9 and phospho-histidine has been esti-
mated to be between 10 and 100 times more abundant than ( O - P - T y r ) 2 - . 1 1 8 These 
phosphorylated amino acid residues are not detected using conventional enrichment 
techniques due to the lability of the phosphoramidate bond in the moderately acidic 
conditions often used. These will be described below. However, given the estimated 
abundance of phospho-histidine residues relative to phospho-tyrosine, and the lack of 
enrichment techniques designed for TV-phosphorylated residues, suitable analytical 
techniques may reveal much information on their role within the cellular environ-
ment. 
The enrichment of phospho-peptides by immobilized metal ion affinity chro-
matography (IMAC) is well established and several literature reports have described 
the use of this technology. 1 1 1 , 1 2 0 - 1 2 5 The basis of IMAC is that metal ions loaded 
inside a host matrix will selectively interact with the phosphate functionality of 
phospho-peptides present within a protein digest. The 'beads' may then be washed 
to remove unbound material followed by phospho-peptide elution, normally using a 
competitive buffer at acidic pH. The enriched sample may then be analysed using 
MS. Reports have detailed various types of IMAC media, including amongst many 
others, the use of Fe 3 + and Ga 3 + loaded nitrilotriacetic agarose, 1 2 3 , 1 2 4 Fe 3 + im-
mobilized on magnetic nanoparticles120 and iminodiacetic acid functionalised silica 
particles loaded with Fe 3 + . 1 2 2 The IMAC enrichment method does not discrimi-
nate between different phosphate residues, so that (0-P-Ser) 2 - , (O-P-Thr) 2 - and 
(O-P-Tyr) 2 - containing residues may be identified. The metal, matrix and loading 
levels of an IMAC material may be modulated easily to allow the optimisation for 
specific concentrations and conditions. In addition, extremely low concentrations 
of phospho-peptide have been detected using IMAC coupled with MALDI-TOF 
detection (5 x 1 0 - 1 1 M for 100 pL of a purified standard). 1 2 0 Disadvantages of 
this technique include non-specific retention of non-phosphorylated residues rich in 
acid functionalities (Asp, Glu), although this may be circumvented by quantitative 
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methylation of acid residues. Furthermore, multi-phosphorylated peptide frag-
ments have been shown to be difficult to elute from IMAC media. Thus, variation 
of the metal ion and modulation of phosphate affinity may be required for each 
sample, in order to identify every phosphorylated residue. 1 2 3 ' 1 2 4 Additionally, the 
use of high salt eluants may also be required, which then makes de-salting essential 
prior to MS analysis, and the use of acidic buffers may catalyse the hydrolysis of 
any N-phosphorylated amino acids present. 
One technique which may be classed as 'residue specific' includes the (3-eliminati-
on of the phosphate residue, followed by the introduction of a tag that enables the 
modified peptide to be isolated from untagged species, Figure 4.2. Solid phase and 
affinity based methods have been utilised to enrich tagged peptides. 1 2 6 , 1 2 7 The re-
leased phospho-peptide fragment is then typically analysed by MS. ( 0 - P - T y r ) 2 -
residues do not undergo (3-elimination and so may not be modified using this tech-
nique. 
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Figure 4.2 - A general schematic showing base mediated (3-elimination followed by 
Michael addition of a thiol-tag for (0-P-Ser)2- and (0-P-Thr) 2-. 
Several disadvantages to the (3-elimination process have been identified. These in-
clude the slow (3-elimination of the (O-P-Thr) 2" phosphate (up to 6 h for quantita-
tive elimination) and competitive hydrolysis of the phosphate ester.126 In addition, 
it is reported that (3-elimination and subsequent Michael addition can occur at cys-
teine, glycosylated serine and glycosylated threonine residues, potentially resulting 
in the identification of false phosporylation sites. 1 2 8 One specific advantage of the 
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(3-elimination method is the removal of the phosphate functionality that hinders MS 
analysis. 
Combined IMAC separation followed by on-resin (3-elimination and Michael addi-
tion has been reported. 1 2 8 This approach was designed to allow peptides containing 
( 0 - P - T y r ) 2 - residues to be retained through to the analysis step, and to reduce the 
number of false phosphorylation sites to be identified from glycosylated serine and 
threonine residues. In addition, it was expected that liberation of retained peptides 
from the IMAC bead by (3-elimination would reduce the number of contaminat-
ing non-phosphorylated peptides in the final analysis sample, attributed to binding 
through acidic residues. Promising results were recorded, such as no glycosylation 
sites being detected in the final sample. However, the basic conditions required for 
effective (3-elimination of phosphate residues also resulted in the non-specific elution 
of peptides from the resin, and incomplete (3-elimination resulted in lower than ex-
pected signal intensities. 
The immunoprecipitation of (0-P-Tyr) 2~ containing proteins and peptides has 
been demonstrated through the use of (O-P-Tyr) 2 - specific antibodies. 1 2 9 , 1 3 0 Be-
cause of the specificity of antibodies for particular targets, often more than one 
antibody has to be used in global studies of a whole cell lystate, for results to 
be representative.129 Following isolation, phospho-proteins are often digested and 
subjected to further IMAC enrichment. The immunoprecipitation enrichment of 
proteins containing (O-P-Ser) 2 - and (0 -P -Thr ) 2 - residues, however, has been sel-
dom demonstrated. 1 3 1 , 1 3 2 A chemoenzymatic technique for enrichment of peptides 
containing ( 0 - P - T y r ) 2 - residues has been reported. 1 3 3 Based on tyrosinase oxida-
tion of dephosphorylated ( 0 - P - T y r ) 2 - residues to an orf/w-quinone followed by their 
tagging and purification, this methodology was shown to enrich the desired peptide, 
but involves multiple-steps that make it impractical in its current form. 
It is clear that despite the wide range of enrichment techniques available there are 
no methods that may be regarded as universally applicable across the whole range of 
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phosphorylated residues that may be encountered within a cell lysate, whilst remain-
ing simple, selective and high yielding. In particular, the coupling of an improved 
enrichment technique with mass spectrometric analysis would further improve this 
range of powerful tools for identification of protein phosphorylation sites. 
4.2 Immobilised Lanthanide Affinity Chromatog-
raphy (ILAC) 
4.2.1 Designing novel I L A C media 
The complex [ E u L 2 4 ] 3 + was considered for incorporation into a novel chromato-
graphic media, defined as immobilised lanthanide affinity chromatography (ILAC). 
The binding of [ E u L 2 4 ] 3 + to phospho-peptides has been shown to be selective 
for side-chain ligation at O-P-sites of tyrosine/serine/threonine. Competitive C-
or /V-chelation was shown to be significantly less favoured. 6 6 , 7 2 , 7 3 Furthermore, the 
preference of [ E u L 2 4 ] 3 + and related complexes for binding to (O-P-Tyr) 2 - residues 
over (0-P-Ser) 2 - / (0-P-Thr) 2 - (log K = 4.2 vs. 2.7 respectively for [EuL 2 7 ] ; 298K, 
5 mM NaHC0 3 , pH 7.4) 6 6 may favour discrimination of (O-P-Tyr) 2 -" sites. 
It was envisaged that, given appropriate conjugation to a suitable solid phase 
support, the complex would retain the binding properties and selectivity profile ob-
served in solution studies. This would result in a material that would have a much 
higher specific retention than currently available IMAC materials, thus reducing the 
leakage of non-phosphorylated fragments into the final analysis sample. Addition-
ally, the use of an acidic buffer solution to remove the sample from the solid support 
would not be needed with an ILAC material. The phospho-peptide can be eluted 
selectively through the addition of a competitive anion, e.g. by using aqueous am-
monium carbonate solution (30 - 50 mM) under ambient pH conditions. The eluted 
phospho-peptide solution could then simply be evaporated and the volatile ammo-
nium carbonate removed under reduced pressure to leave the enriched phospho-
peptide, without contamination from residual salt. An additional advantage that 
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may be envisaged is that separate elution of (0-P-Ser) 2 / (0 -P-Thr) 2 from (O-P-
Tyr) 2 ~ could be possible, if a gradient elution was used with the aqueous carbonate 
solution. The higher affinity of [ E u L 2 4 ] 3 + for (O-P-Tyr) 2 " suggests that (0-P-Ser) 2-
and (O-P-Thr) 2 - would be eluted first, under these conditions. 
The design of novel media suitable for ILAC has to take into consideration two 
key points. The first is the choice of solid support to which the Eu(III) complex 
would be conjugated; the second is the method and point of complex conjugation 
to the chosen solid support. A general representation of the envisaged material is 
shown in Figure 4.3. 
Figure 4.3 - Proposed general structure for a resin bound Eu(III) complex for use 
Numerous polymeric resins and nano-particles are commercially available. Mate-
rials are available in a range of dimensions and are derivatised to various extents with 
a choice of functionalities. Given the past experience of the research group with the 
conjugation of Ln(III) complexes, 8 6 , 8 7 it was decided to couple the chosen support 
and complex by amide formation, with the solid support being chosen to carry the 
amine functionality. TentaGel™ S-NH2 (crosslinked polystyrene matrix to which 
is grafted amine functionalized PEG spacers) and Affi-Gel® 102 (amino-terminal 
crosslinked agarose gel) were chosen due to their favourable swelling/solubility char-
acteristics in water. SiMAG-Amino (amine functionalized non-porous silica matrix) 
was also chosen as the magnetic properties of these amine functionalized nanoparti-
cles facilitate isolation of bound phospho-peptides, Figure 4.4. 
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Figure 4.4 - The chemical structure of the spacer groups linking the terminal amine 
groups and the bulk matrix of the selected support. Structures are as described in the 
manufacturers specifications. 
4.2.2 Synthesis of immobilised complexes 
The designed ligand, L 6 1 , incorporated a simple conjugation point at the peripheral 
C-atom of the central amide arm. As structurally related complexes (e.g. [ E u L 4 4 a ] 3 + , 
[ E u L 4 4 b ] 3 + , [ E u L 4 9 ] 3 + , section 2.3.1) had retained a high degree of structural homol-
ogy to the 'parent complex', [ E u L 2 4 ] 3 + , i t was expected that a relatively minor 
modulation of the periphery of the central amide arm would also not change the 
coordination properties of [ E u L 6 2 ] 2 + compared to [ E u L 2 4 ] 3 + . The incorporation of 
the modified amide arm into the cyclen framework proceeded through the acid inter-
mediate, 46 (section 2.2.1), utilising amide formation between the acid functionality 
and the amine, 59 (Figure 4.5). The intermediate, 60, was isolated by column 
chromatography on alumina. 
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Figure 4.5 - Outline of the synthesis of [ E u L 6 1 ] 3 + . 
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Figure 4.6 - Outline of the synthesis of the pendant amide arm intermediate, 59. 
The synthesis of 59 (Figure 4.6) commenced with the iV-protection of commer-
cially available (S)-(-)-l-(4-bromophenyl)ethylamine, followed by its conversion to 
the nitrile. However, subsequent syntheses of 59 proceeded through the one-pot 
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protection and bromination of (5)-(-)-a-methylbenzylamme, via protonated 1,3-
dibromo-5,5-dimethylhydantoin, as described previously.13(1 The latter route was 
considerably less expensive than the former. At each stage, the required product 
could be easily recrystallised, negating the need for column chromatography. 
Following the isolation of the desired complex, [ E u L 6 1 ] 3 + , * the methyl ester of 
the central amide arm was hydrolysed to unmask the acid. However, a small amount 
of precipitate was observed via this synthetic route, possibly due to Eu(III) decom-
plexation, resulting in the precipitation of the free ligand. Therefore, to circumvent 
possible competing decomplexation and to confirm the purity of the final acid com-
plex, [ E u L 6 2 ] 2 + , the methyl ester of the intermediate, 60, was hydrolysed so that no 
post-complexation transformations were required, Figure 4.7. 
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Figure 4.7 - Outline of the synthesis of [ E u L 6 2 ] 2 + . 
The chosen solid supports and [ E u L 6 2 ] 2 + were coupled together using standard 
amide coupling chemistry, Figure 4.8. The carboxyl group in [ E u L 6 2 ] 2 + was activated 
* All complexes described within this chapter were isolated as their chloride salts. 
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in situ, using either pH controlled aqueous reactions or changing to organic based 
amide formation, if required, when in aqueous media yields were poor. 1 3 5 After each 
coupling reaction was completed, the remaining free amine groups of the support 
were capped using the NHS ester of acetic acid. A small amount of uncapped 
material was retained for comparison purposes. In each case, the materials were 
subjected to several washing steps to ensure all unreacted complex has been removed 
from the samples. 
Figure 4.8 - Outline of the coupling of [ E u L 6 2 ] 2 + with various solid supports, followed 
by capping of the free amines. Derivatization yields refer to the maximum loadings 
obtained. The percentage level of Am- Gel® 102 derivatization is not given. This 
is because this material was supplied in its gel form with NH2 levels indicated as a 
concentration, and the exact dilution of the starting material being unknown. 
In a separate experiment, amide formation was used to couple [ E u L 4 9 ] 2 + (sec-
tion 2.2.1) with TentaGel™ S-NH 2, to allow luminescence measurements to be used 
to probe the complex environment around the Eu(III) ion in the resin, Figure 4.9. 
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Figure 4.9 - Outline of the coupling of [EuL 4 9 ] 2 + with TentaGel™ S-NH2. 
4.2.3 Characterisation of [EuL 6 2] 2+ and ILAC media 
Al l complexes and intermediates were rigorously characterised by standard spectro-
scopic techniques. The 1 H-NMR spectra of [ E u L 6 1 ] 3 + and [ E u L 6 2 ] 2 + were acquired, 
Figure 4.10. Each spectrum exhibited very similar paramagnetically shifted reso-
nances. Both were also virtually identical to that of the 'parent' [ E u L 2 4 ] 3 + spectrum, 
Figure 2.10, consistent with their high degree of structural homology. 
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Figure 4.10 - ^ - N M R spectra for [ E u L 6 1 ] 3 + (left) and [ E u L 6 2 ] 2 + (right) (500 MHz, 
D2O, 295 K, pD 7.8, 1 mM complex). Resonances marked with • are assigned to the 
cyclen NH proton, resonances marked with • are assigned to cyclen Hax protons. 
The rate constants for the radiative decay of the excited state of [ E u L 6 1 ] 3 + in 
H 2 0 and D 2 0 were 3.60 and 1.64 ms" 1 respectively, giving a q value of 1.8. This is 
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consistent with the value of q = 2, estimated for [ E u L 2 4 ] 3 + . 1 0 6 
Following the solid phase immobilization of [ E u L 6 2 ] 2 + the level of Eu(III) loading 
was determined through combustion analysis, using ICP-MS measurements. Eu(III) 
loadings varied widely depending upon the support and reaction conditions used. 
Samples of [ E u L 6 2 ] 2 + loaded TentaGel™ S-NH2 and [ E u L 6 2 ] 2 + loaded Affi-Gel® 102 
were submitted for MAS ^ - N M R analysis. Whilst spectra obtained with the latter 
proved to be too broad for any paramagnetically shifted resonances to be observed, 
broadened complex resonances were clearly observable with the sample of the former, 
alongside a sharp peak attributed to capping acetyl groups. This provides further 
evidence for the covalent linkage of [ E u L 6 2 ] 2 + to TentaGel™ S-NH2. 
4.3 Preliminary phospho-anion separation stud-
ies with ILAC media 
4.3.1 Luminescence studies of immobilized [EuL 4 9 ] 2 + 
In preliminary work, several samples of [ E u L 4 9 ] 2 + immobilised on TentaGel™ S-
N H 2 have been examined. It was desirable to observe the binding of anions to the 
immobilized complex through observation of changes to the complex lifetime and 
spectral emission profile. Samples were typically prepared through the mixing of 
2-3 mg of the resin on a glass slide with 10 pi of a sample solution, followed by the 
sealing of the mixture under a glass-cover slip. Samples examined were the Eu(III) 
resin bead alone, the Eu(III) resin mixed with H 2 0 (pH 7.4) and the Eu(III) resin 
mixed with NaHCC"3 solution (30 mM, pH 7.4). The radiative decay curves of each 
sample were recorded (using a long pass filter) following laser excitation at 355 
nm. I t was interesting to note that the sample of the dry Eu(III) resin and the 
Eu(III) resin immersed in H 2 0 possessed similar luminescent decay curves. These 
were best fitted to a biexponential decay profile, indicating the presence of two 
luminescent species in each sample. The complex lifetimes recorded were 0.04 ms 
and 0.25 ms, present in the ratio 1:0.9. The decay curve obtained for the Eu(III) 
resin with bicarbonate fitted well to a monoexponential decay, consistent with one 
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major species that could involve a bound carbonate anion at the Eu(III) centre. 
The observed lifetime was 0.15 ms. These results may be explained by considering 
that the Eu(III) complex is conjugated to a resin consisting of flexible PEG chains 
and free amine groups that would be protonated at pH 7.4. I t is therefore likely 
that there will be various species trapped by these PEG chains such as metal ions, 
water molecules and anions that may bind to the complex or quench its emission, 
resulting in the two luminescent species observed. The lifetimes of the immobilized 
complex and its anionic adducts are lower than those of the untethered complex 
(Table 2.2) suggesting that additional quenching of the Eu(III) ion is occurring, 
possibly through an electron transfer process. 
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Figure 4.11 A graph comparing emission of [ E u L 4 9 ] 2 + immobilised on 
TentaGel™ S-NH2 (black) to that of the underivatised resin alone (red) (resins in 
H 2 0 , 298 K, A e x c = 355 nm). 
In addition to the lifetime measurements recorded, the emission spectrum of the 
immobilised Eu(III) ion in both H 2 0 (Figure 4.11) and bicarbonate solution was 
acquired. I t was hoped that analysis of the A J = 2 /A J = 1 ratio would reveal 
the coordination environment around the central Eu(III) ion. Unfortunately, resid-
ual fluorescence from the polystyrene resin overlapped with metal based emission 
inhibiting ratiometric analysis. Attempts to normalize the emission proved unsuc-
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cessful. 
In conclusion, the modulation of the complex lifetime upon the addition of bi-
carbonate indicates that the immobilised complex was associating with the added 
anions. I t may expected that the analogous complex [ E u L 6 2 ] 2 + should also still as-
sociate with anionic species when immobilised on the resin. The emission spectra 
obtained may be in future simplified through the use of time gated acquisition. 
4.3.2 Trial phospho-anion separation experiments 
The indication that the lifetime of immobilised [ E u L 4 9 ] 2 + was being modulated in the 
presence of anionic species encouraged the examination of [ E u L 6 2 ] 2 + , immobilised on 
TentaGel™ S-NH 2, for selective retention of phospho-anions. The simplest way to 
initially study the resin was to examine its ability to retain (O-P-Tyr) 2 - selectively, 
when present in a mixture with tyrosine. An experimental procedure was designed to 
investigate the retention capabilities of the immobilized complex, Figure 4.12. The 
aim of the experiment was to examine if the ILAC media could selectively retain 
( 0 - P - T y r ) 2 - residues in a mixture also containing tyrosine residues in excess, then 
liberate the complex bound residues using aqueous ammonium carbonate solution. 
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Figure 4.12 A schematic detailing the trial separation of (O-P-Tyr) 2 _ from ty-
rosine. Steps detailed are: (A) addition of a mixed solution of (O-P-Tyr) 2 - and 
Tyr (H2O, pH 7.4) to the resin contained within an eppendorf; (B) vortex mixing 
(3 min) of the sample followed by centrifugation (2 min, 3000 rpm); (C) removal of 
solution containing unbound residues; (D) addition of further H2O to wash .the resin; 
(E) addition of ammonium carbonate solution to the resin (H2O, 30 mM, pH 8.1); 
(F) as step (B); (G) removal of solution containing displaced (O-P-Tyr) 2 - residues; 
(H) addition of further ammonium carbonate solution to the resin to displace (O-P-
T y r ) 2 - residues still bound; (I) following displacement steps the resin may be washed 
for re-use. 
Initial experiments utilised [ E u L 6 2 ] 2 + immobilised on TentaGel™ S-NH2 (261 
mg, 4.4 % derivatization, 0.0052 mmol Eu(III) binding sites, remaining amine groups 
were acetyl capped), pre-soaked in H2O overnight. Typically, experiments have ex-
amined separations of mixed solutions of (O-P-Tyr ) 2 - and tyrosine (1 ml, pH 7.4) 
in the region of ~0.5 mg/ml final amino acid concentrations. The total number of 
amino acid molecules loaded onto the resin was always lower than the total number 
of Eu(III) binding sites available. In each experiment, the procedure outlined in 
Figure 4.12 was followed. The resin was subjected to one further washing step with 
H 2 0 (1 ml, step (D) ) , followed by displacement of bound residues with ammonium 
carbonate solution (1 ml, 30 mM, pH 8.1, step E) with one additional displacement 
step (step ( H ) ) . Each solution was collected by a syringe needle, then lyophilized 
under reduced pressure to remove solvent and the volatile ammonium carbonate. 
Control (O-P-Tyr) 2 -/tyrosine separation experiments, utilising resins that were not 
conjugated to the Eu(III) complex, were also carried out. The two resins used 
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were 'uncapped' TentaGel™ S-NH2 and 100 % './V-acetyl capped' TentaGel™ S-
NH 2 . These control separation experiments followed the procedure described above 
and in Figure 4.12. The relative concentration of (O-P-Tyr ) 2 - and tyrosine in 
each isolated solution was determined, as described in detail within the experi-
mental chapter, through quantification using LCMS analysis. A typical result set 
obtained for separation of (O-P-Tyr) 2 - and tyrosine with [ E u L 6 2 ] 2 + immobilised on 
TentaGel™ S-NH2 is shown in Figure 4.13. 
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Figure 4.13 - A representation of the relative concentrations of (O-P-Tyr) 2 - and 
tyrosine solutions at each stage of the separation experiment. The solutions are named 
as; Mix: The concentration of (O-P-Tyr) 2 - and tyrosine in the 1 ml solution initially 
loaded onto the resin in stage (A) (Figure 4.12); Soln A: The concentration of (O-P-
Tyr) and tyrosine in the solution removed from the resin in stage (C); Soln B: The 
concentration of (O-P-Tyr) 2 - and tyrosine in the solution removed from the resin in 
stage (C) after one further washing step (stage (D)); Soln C: The concentration of 
(O-P-Tyr) 2 - and tyrosine in the solution removed from the resin in stage (G); Soln 
D: The concentration of (O-P-Tyr) 2 - and tyrosine in the solution removed from the 
resin in stage (G) after one further displacement step (stage (H)). The number above 
each pair of bar graphs is the ratio of the tyrosine/(O-P-Tyr) 2 - concentrations. 
I t is seen from the results, after loading the initial amino acid mixture (tyrosine 
in 4.5 fold excess) onto the resin, followed by mixing and removal of the solvent, 
that the tyrosine/(O-P-Tyr) 2 - ratio increased to ~44 in the isolated solution, con-
sistent with the selective retention of (O-P-Tyr) 2 - residues. A second H 2 0 wash of 
the resin removed virtually only tyrosine residues. The molar ratio (tyrosine/(O-P-
T y r ) 2 - ) of this solution was ~95. The two washing steps accounted for the removal 
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of ~75 % of the initially added tyrosine residues, whilst <5 % of the initially added 
( 0 - P - T y r ) 2 - residues were removed. Step-wise additions of ammonium carbonate 
solution were observed to displace bound (O-P-Tyr) 2 - residues, indicated by the 
consecutive decrease in the tyrosine/(0-P-Tyr) 2~ ratio of abstracted solutions to 
1.8 then 0.5. The latter analysis indicating that ( 0 - P - T y r ) 2 - was now in excess 
over tyrosine. The latter two washing steps accounted for the recovery of >90 % of 
the initially loaded (O-P-Tyr) 2 - residues, whilst ~20 % of initially loaded tyrosine 
was also recovered in these steps. 
Analysis of data from the control experiments showed that when using the 'un-
capped' resin a minor amount of non-specific retention of residues was observed. 
In contrast, neither tyrosine or (O-P-Tyr) 2 - were significantly retained on the 100 
% 'N-acetyl-capped' resin. For example, ~95 % of recovered (O-P-Tyr) 2 - residues 
were collected in the first two water washing steps. 
4.4 Conclusions 
The synthetic methodology described within this chapter afforded a simple route 
to the desired complex, [ E u L 6 2 ] 2 + , followed by conjugation to a variety of solid 
supports. The conjugation of the sensitiser-bearing complex, [ E u L 4 9 ] 2 + , enabled lu-
minescence methods to be used to probe the interaction of the immobilized complex 
with the carbonate anion. In addition, luminescence spectra of the immobilized 
complex were also obtained,. Although Eu(III) emission was partially masked by 
fluorescence attributed to the resin, this technique hinted that time-gated acquisition 
of Eu(III) emission spectra would reveal much about the coordination environment 
of this complex. 
Preliminary separation studies showed that the derivatised resin ( [ E u L 6 2 ] 2 + im-
mobilized on TentaGel™ S-NH2) selectively retained phospho-amino acid residues 
over non-phosphorylated residues. Subsequent displacement procedures yielded so-
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lutions where the relative concentration of ( 0 - P - T y r ) 2 - was significantly enhanced 
compared to that of the initial amino acid mixture. Control experiments revealed 
that the retention of (0-P-Tyr) 2 ~ residues was due to their binding to immobilized 
Eu(III) complexes, as the iV-acetyl capped resin exhibited no retention capability. 
The same control experiments revealed the need for the capping of residual N H 2 
groups on the resin, as this functionality, when protonated, was observed to play 
a minor role in non-specific amino acid retention. In summary, the results show 
that there is a promising future for immobilized Ln(III) complexes as chromato-
graphic materials that can selectively bind phosphate fragments, hence aiding their 
subsequent separation, analysis and identification. 
4.5 Future work 
There are a great many possibilities for future work within the area of synthesis and 
evaluation of novel ILAC media. The results reported herein constitute the first step 
in the evaluation of this particular ILAC methodology. Much work needs to be done 
to identify its scope and utility in the enrichment of phospho-peptides. In the longer 
term, its utility in isolating phospho-peptide fragments from protein digests needs 
to be addressed. Factors such as the reproducibility of separation results with a par-
ticular media, the working lifetime of the resin (number of useful separation cycles 
per resin sample, stability of the complex), and the analyte concentration ranges in 
which effective separations and analysis can be achieved, need to be examined and 
established. Al l of these conditions may be examined through analysis of mixtures 
of various amino acids. Next, conditions would need to be shown to be reproducible 
with peptide samples, containing certain phosphorylated residues. 
It is to be expected that different solid supports will uniquely influence the be-
haviour of the resulting functionalised resin, and that identical solid supports of dif-
ferent Eu(III) loadings will likewise behave differently. I t will therefore be essential 
to examine each system in detail, to determine its utility in phospho-peptide sepa-
rations. Because of the innumerable variations of solid support and Eu(III) loadings 
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possible, i t will be necessary to judiciously select suitable resins and Eu(III) loadings 
at the outset. Once the most promising resin has been identified, in terms of syn-
thetic behaviour, handling and separation utility, variations of Eu(III) loadings can 
be examined to identify the most applicable system for the widest range of samples. 
Eu(III) loadings could be easily modulated, as required. Of the novel conjugated 
media presented within this thesis, the samples of [ E u L 6 2 ] 2 + loaded Affi-Gel® 102 
and [ E u L 6 2 ] 2 + loaded SiMAG-Amino remain to be tested. 
The longer term aim of this work is to create ILAC media that can be used to 
isolate phospho-peptide fragments from digests of cell lysates. Further to the early 
characterisation experiments, the selectivity of retention between the various 0-
phosphorylated amino acids would need to be examined through similar separation 
experiments, as described earlier. In particular, the use of a phospho-peptide elution 
flow-system, using a buffer of increasing concentration to selectively displace weaker 
bound phospho-peptide fragments, should be investigated. Such a system can be 
tested initially with corresponding phosphorylated amino acid residues to determine 
the levels of discrimination likely to be achieved. As outlined in section 4.1, a whole 
cell lysate is likely to contain significant levels of TV-phosphorylated amino acids, for 
which methods of retention and analysis are under-represented. The mild elution 
conditions used with ILAC media may make the retention of these iV-phosphorylated 
amino acids more likely, as they are less likely to decompose than in the more acidic 
IMAC buffers. Because of this possibility, the association of the parent complex, 
[ E u L 2 4 ] 3 + , with these A^-phosphorylated amino acids needs to be examined to de-
termine if the retention of such species is significant. 
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Chapter 5 
Experimental 
5.1 Experimental procedures 
5.1.1 General procedures 
All commercially available reagents were used as received, from their respective 
suppliers. Solvents were dried using an appropriate drying agent when required 
((CH 3CN over CaH 2 , CH3OH over Mg(OMe)2). Reactions requiring anhydrous con-
ditions were carried out using Schlenk-line techniques under an atmosphere of dry 
argon. Water and H 2 0 refer to high purity water with conductivity <0.04 pS c m - 1 
obtained from the 'PuriteSTILL Plus' purification system. 
Thin-layer chromatography was carried out on neutral alumina plates (Merck Art 
5550) or silica plates (Merck 5554) and visualised under UV (254 nm) or by staining 
with iodine. Preparative column chromatography was carried out using neutral alu-
mina (Merck Aluminium Oxide 90, activity I I - I I I , 70230 mesh), pre-soaked in ethyl 
acetate, or silica (Merck Silica Gel 60, 230400 mesh). 
J H and 1 3 C-NMR spectra were recorded on a Varian VXR-400 ( J H at 399.97 MHz, 
1 3 C at 100.57 MHz), Varian Inova-500 ( ] H at 499.78 MHz, 1 3 C at 125.67 MHz, 1 9 F 
at 470.25 MHz, 3 1 P at 202.31 MHz) or a Varian VNMRS-700 ( J H at 699.73 MHz, 
1 3 C at 175.95 MHz, 1 9 F at 658.41 MHz) spectrometer. Spectra were referenced 
internally to the residual protio-solvent resonances. Immobilized Eu(III) complex 
XH-NMR spectra were recorded on the Varian Inova-500 machine using a 4 mm GHX 
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NanoProbe fitted with a MAS rotor. 
Electrospray mass spectra were recorded on a Thermo-Finnigan LTQ FT, Fisons VG 
Platform I I or Waters Micromass LCT instrument, operating in positive or negative 
ion mode as stated, with methanol as the carrier solvent. M A L D I mass spectra were 
recorded on the Thermo-Finnigan LTQ FT instrument. Accurate mass spectra were 
recorded using the Thermo Finnigan LTQ FT mass spectrometer. 
Melting points were recorded using a Reichart-Kofler block and are uncorrected. 
pH measurements used a Jenway 3020 or a Jenway 3320 pH meter attached to an 
Aldrich Chemical Company micro-pH combination electrode (three point calibra-
tion using pH = 4.0 ±0.02, pH = 7.00 ±0.02 and pH = 10.00 ±0.02 (T = 20°C) 
buffer solution supplied by Aldrich. The adjustment of pH was carried out using 
cone. NaOH and cone. HC1 (or NaOD and DC1 if required) solution to avoid any 
significant increase in sample volume. For measurements carried out in D 2 0 the 
pD was calculated using the actual pH meter reading and the equation: pD = pH 
(meter reading) + 0.41. 
Exchange of complex counterions to chloride anions was performed using 'DOWEX® 
1x8 200-400 mesh CI' ion exchange resin (Sigma-Aldrich®). Typically the resin (1 
g) was prepared by boiling in MeOH (50 ml) overnight followed by washing with 
H 2 0 (500 ml). The resin was then stirred in H C l ^ ) (1 M, 50 ml) for 2 h then washed 
with H 2 0 until the washings were pH 7. Suction dried resin was then added to a 
solution of the complex (H 20:MeOH, 50:50), the mixture was stirred for 2 h followed 
by filtration. MeOH was removed under reduced pressure, the aqueous phase was 
again filtered then dried under reduced pressure to yield the desired chloride salt of 
the complex. 
Excess LnCl 3 or Ln(OAc) 3 was removed from dimeric complex samples using benzoy-
lated dialysis tubing (9 mm flat width, MWCO 2000) (Sigma-Aldrich®). Typically 
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the dialysis tubing was washed with H 2 0 , the solid complex was dissolved in H 2 0 
(1 ml) and the solution was transferred to the tubing that was sealed by clamping 
at both ends. The tubing was submerged in stirring H 2 0 (500 ml) and the H 2 0 
was exchanged 4 times over 72 h followed by the removal and filtering of the tubing 
contents. The aqueous solution was then frozen and lyophilized to yield the desired 
complex. 
5.1.2 Relaxivity measurements 
Relaxivity measurements were carried out at 37°C and 60 MHz on a BrukerMinispec 
mq60 instrument. The mean value of three separate measurements was recorded. 
5.1.3 H P L C analysis of Ln(III) complexes 
Reverse phase HPLC analysis were performed at 298 K on a Perkin Elmer system, 
comprising of a Perkin Elmer Series 200 Pump, Perkin Elmer Series 200 Autosam-
pler, Perkin Elmer Series 200 Diode array detector and Perkin Elmer Series 200 
Fluorescence detector. Columns used were a 4.6 x 150 mm 4 |im Phenomenex Syn-
ergi Fusion RP 80A analytical column or a 4.6 x 150 mm 4 pm Phenomenex Synergi 
Polar-RP 80A analytical column. In each case an H 2 0 + 0.1 % HCOOH/MeCN + 
0.1 % HCOOH or H 2 0 + 0.1 % CF 3COOH/MeCN + 0.1 % CF 3COOH solvent sys-
tem was used (gradient elution) with a run time of 20 minutes. In each case, a single 
major product was observed in >95 % purity using a diode array UV-Vis detector 
operating at 255 nm, 335 nm or 375 nm. This corresponds to the absorption band 
of the appropriate aryl ring, azaxanthone or azathioxanthone used as the sensitizing 
moiety for each Eu(III) or Tb(III) complex, and, for the latter two wavelengths, is to 
longer wavelength of any organic contaminant. Such behaviour indicated that each 
of the species that was eluted bore this chromophore. A fluorescence detector was 
also connected to the HPLC, monitoring eluent from the column at a wavelength 
corresponding to the Eu(III) or Tb(III) centred emission (616 nm or 545 nm respec-
tively); again emission was seen for each of these peaks, suggesting that each peak 
corresponding to a chromophore bound species also was coordinated to Eu(III) or 
Tb(III) , in such a way that it was efficiently sensitized. For each Yb(III) or Gd(III) 
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complex, a UV-Vis detector was used operating with a LP 250 nm detection filter. 
Individual solvent systems are stated in Appendix A. 
5.1.4 Optical techniques 
UV/Vis absorbance spectra were recorded either on a Perkin Elmer Lambda 900 
UV/Vis /NIR spectrometer (using FL Winlab software) or a Unicam UV/Vis UV2. 
Emission spectra were measured on a ISA Joblin-Yvon Spex Fluorolog-3 lumines-
cent spectrometer (using DataMax v2.20 software) or a Perkin Elmer LS55 lumines-
cence spectrometer (using FL Winlab software), while lifetimes were measured on 
the Perkin Elmer LS55 luminescence spectrometer. Al l samples were contained in 
quartz cuvettes with a path length of 1 cm and polished base. Measurements were 
recorded at 298 K and were obtained relative to a reference of pure solvent contained 
in a matched cell, following indirect excitation of the Ln(III) ion at the stated wave-
length. An integration time of 0.5 seconds, increment of 0.5 nm and excitation and 
emission slit widths of 2 and 1 nm, respectively, were employed throughout. Lu-
minescent titrations were carried out by normalising the emission spectra with the 
absorption spectra in each point, in order to revise the decrease in the sample con-
centration caused by pH adjustment or addition of an anion stock solution, where 
appropriate. 
Lifetimes of Eu(III) and Tb(III ) complexes were measured by excitation of the sam-
ple using a short pulse of light (255, 335, 372 nm depending on the nature of the 
complex) followed by monitoring the integrated intensity of light (for Eu(III) 612-
618 nm, for Tb(II I ) 543-546 nm; depending on the measured species and the pH) 
emitted during a fixed gate time, t g , after a delay time, td. At least 20 delay times 
were used covering 3 or more lifetimes. A gate time of 0.1 ms was used, and the exci-
tation and emission slits were set to 10 nm and 2.5 nm band-pass respectively. The 
obtained exponential decay curves were fitted to the equation below, using Origin 
6.0 software (Data Analysis & Technical Graphics): 
I = A 0 + A i * exp(-kt) (eqn. 3) 
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where: I : intensity at time t after the flash; A 0 : intensity after the decay has finished; 
A i : pre-exponential factor; k: rate constant for decay of the excited state. 
A low temperature phosphorescence spectrum of (O-P-Tyr) 2 was recorded to en-
able the triplet energy to be determined. An Oxford Instruments optical cryostat 
operating at 77 K and LS 55B spectrometer were used. The sample was dissolved in 
EPA (diethyl ether-isopentane-ethanol, 5 : 5 : 2 ) and contained in 10 mm cuvettes. 
The triplet energy was considered as the highest energy (shortest wavelength) ob-
served phosphorescence band, corresponding to the 0-0 transition, using time-gated 
detection. 
CPL spectra were recorded on a custom modified Spex Fluoromax-2 spectrometer 
at the University of Glasgow, with the assistance of Dr. Bob Peacock. 
5.1.5 Determination of binding constants 
To examine the influence of some biologically common anions on Eu(III) and Tb(III) 
complexes, luminescent titrations were carried out examining separate solutions con-
taining either O-phospho-L-tyrosine, Na2C03, sodium lactate, NaH 2 P0 4 or trisod-
ium citrate. A l l of these measurements were carried out by adding the selected anion 
as liquid concentrated stock solution where the addition at each point was approx. 
0.1-0.5 % in volume of the original solution observed to avoid significant increase 
in sample volume. HSA was added as a solid. Each Eu(III) emission spectrum 
was corrected for dilution. The apparent binding constant of the selected anion was 
calculated using eqn. 4 in Origin 6.0 software (Data Analysis & Technical Graphics): 
where: X: the total concentration of anion in solution; K: binding constant; F: 
the ratio or intensity of the selected peak(s); F 0 : ratio or intensity of the selected 
peak(s) at the beginning of the titration; F^ the final ratio or intensity of the se-
[X] = 
[(F - F 0 ) / ( F ! - F 0 ) ] / K + [EuL] * (F - F 0 ) / ( F 1 - F 0 ) 
1 - [(F - F 0 ) / (F ! - F 0 )] 
[EuL] * [(F - F 0 ) / ( F 1 - Fp)] 2 
1 - [(F - F 0 ) / ( F 1 - F 0)] 
(eqn. 4) 
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lected peak(s); [EuL]: the total concentration of Eu(III) complex in solution. 
Alternatively, binding constants have been determined, where stated, by using the 
nonlinear least-squares program S P E C F I T / 3 2 ™ . 1 3 6 The fitting methodology, which 
relies on the use of various mathematical parameters, uses the Levenberg-Marquardt 
procedure to minimise the least-squares residuals between the data set and the model 
system. 1 3 7 , 1 3 8 This work was undertaken by Dr. Cidalia dos Santos (Trinity College 
Dublin). 
5.1.6 Cellular microscopy 
Epifluorescence images were taken on a Zeiss Axiovert 200M epifluorescence micro-
scope with objectives 63x/1.40 oil DIC and 40x/1.40 oil DIC respectively, equipped 
with an Axiocam CCD camera. For excitation a 340-390 nm (90 % transmission) 
band-pass (BP) filter was used. Ligand fluorescence were observed using a BP 445-
465 nm filter (80 % transmission), while Eu(III) emission was observed using a 570 
nm long-pass (LP) filter (85 % transmission). 
5.1.7 Cell Culture and Toxicity 
Two cell lines were selected for cell culture studies: CHO (Chinese Hamster Ovary) 
cells and NIH 3T3, mouse skin fibroblast (connective tissue) cells. Each line is trans-
formed, and compromise adherent cells, which grow in a monolayer. These cell lines 
were cultured in a copper jacket incubator at 37°C, average 20 % humidity and 5 % 
(v/v) CO2 in 50 mL volume plastic grow plates. Cells for microscopy were grown in 
a 24 well-plate using d = 13 mm glass cover slips (average thickness I = 0.1 mm). 
DMEM (Dulbeccos Modified Eagle Media), and F-12 (Ham) medias were used for 
NIH 3T3 and CHO cells respectively, each containing 10 % (v/v) NCS (Newborn 
Calf Serum) and 1 % (v/v) penicillin-streptomycin. Complexes were loaded onto 
cells using the appropriate growth medium. For flow cytometry measurements, cells 
were detached from the glass surface using 1 % (v/v) trypsin solution at 37°C for 
5 min. The solutions and washings were analysed in separate ICP-MS measure-
ments to measure any possible Eu(III) complex egress. I C 5 0 values were determined 
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using the M T T assay, as described by Carmichael et al97 which makes use of the 
conversion of M T T (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
to a purple formazan product by the mitochondrial dehydrogenase of viable cells. 
This insoluble formazan was quantified spectrophotometrically upon dissolution in 
DMSO. Approximately 5 x 10 3 N I H 3T3 cells in 100 j i L D M E M were seeded into 
each well of flat-bottomed 96-well plates and allowed to attach overnight. Complex 
solutions were added to triplicate wells to give final concentrations over a 2-log range. 
Following 24 h incubation, M T T (1.0 m M ) was added to each well, and the plates 
incubated for a further 4 h. The culture medium was removed, and DMSO (150 
\iL) was added. The plates were shaken for 20 seconds and the absorbance mea-
sured immediately at 540 nm in a microplate reader. I C 5 0 values were determined 
as the drug concentration required to reduce the absorbance to 50 % of that in the 
untreated, control wells, and represent the mean for data f rom three independent 
experiments. 
5.1.8 Microscopy under variable atmospheric CO2 levels 
The dependence of [ E u L 4 4 a ] 3 + emission intensity, localised wi th in the mitochondria 
of HeLa cells, as a funct ion of atmospheric CO2 concentration, was examined by 
Dr. Ga-Lai Law, using facilities at the Department of Biology and Chemistry, City 
University of Hong Kong. The cells were grown in 60 x 15 m m culture dishes at 2 
ml/dish, and were allowed to attach overnight. The cells were imaged in a tissue 
culture chamber (5 % to 3 % (v /v ) C 0 2 , 37°C) through a Zeiss 510 LSM (upright 
configuration) confocal microscope equipped wi th a femtosecond-pulsed Ti:Sapphire 
laser (Libra I I , Coherent). The excitation beam produced by the second harmonic 
generation of the femtosecond laser ( A e x c = 360 nm, ~ 4 m W ) was passed through 
the LSM 510 microscope w i t h H F T 650 dichroic (Carl Zeiss, Inc.) and focused onto 
the coverslip-adherent cells using a 63 x oil immersion objective. The images were 
obtained as a t ime series and cut by a band pass filter at 580-620 nm. The C 0 2 level 
(as a percentage value) was controlled by an interface programme w i t h each image 
and emission spectrum being obtained after 30 min of modifying the CO2 level inside 
the tissue chamber. Images were selected at 30 min time intervals after the change 
136 
in CO2 level to ensure to ta l equilibrium of the gas. The first time point was 30 min 
after addition of the complex starting wi th 5 % of C 0 2 . The total duration of the 
time series was wi th in l h 45 min, w i th images chosen at 30 min, 60 min, and 90 min 
intervals, corresponding to CO2 levels of 5 %, 4 % and 3 % respectively. 
5.1.9 Resin microscopy 
Resin samples (~2 mg) were mixed wi th H2O or aqueous anion solution (10 u-1, pH 
7.4), spread onto a glass slide then sealed under a glass cover slip. Slides were then 
mounted on a X Y microscope stage. Following laser excitation (Nd:YAG, UVFQ-
100-1-Y-335 - Elforl ight , 5 ns pulses at a 30 Hz repetition rate, A e x c = 355 nm), 
Eu ( I I I ) emission was detected through a fibre-coupled charge coupled device (CCD, 
Imagex-nannoCCD - Photonic research systems) camera connected to a Zeiss Axio 
vert inverted microscope. In a similar manner, the radiative decay curves of each 
sample were recorded, using a long pass filter to isolate Eu ( I I I ) emission. Mono-
exponential and bi-exponential decay curves were f i t ted to eqns. 3 and 5 respectively 
using Origin 6.0 software (Data Analysis & Technical Graphics): 
5.1.10 Inductively Coupled Plasma Mass Spectrometry 
A l l ICP-MS determination, including all E u ( I I I ) concentrations f rom cells and growth 
media, were carried out by Dr. Chris Ottley in the Department of Earth Sciences at 
Durham University using a Thermo Finningan E L E M E N T 2 High Resolution Select 
Field ICPMS. 
5.1.11 LCMS quantification of (0-P-Tyr) 2~ and tyrosine 
A l l amino acid calibration plots were determined using an LCMS method on a 
Thermo-Finnigan L T Q F T mass spectrometer coupled w i t h a 20 x 150 mm 4 \im 
Phenomenex Synergi Polar-RP 80A analytical column. A di lut ion series of (O-P-
T y r ) 2 - and tyrosine solutions at concentrations of 50 pg |0.1 _ 1 , 500 pg 5 ng (J .1 - 1 , 
I = A 0 - I - A i *exp(-kt) (eqn. 3) 
I = A 0 + A i *exp ( -k / t i ) + A 2 * exp ( -k / t 2 ) (eqn. 5) 
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50 ng and 500 ng were created f rom 1 mg m l - 1 stock solutions. Solutions 
were injected onto the column at a flow rate of 200 \xl m i n - 1 and resolved using the 
following elution system: 
T i m e A B Gradient 
0 - 5 min 100 % 0 % N / A 
5 - 8 min 100 % - > 5 % 0 % ^ 9 5 % Linear 
8 - 1 3 m i n 5 % 95 % N / A 
13 - 20 m i n 100 % 0 % N / A 
Table 5.1 - Solvent A: H 2 0 + 0.1 % HCOOH; Solvent B: MeCN. 
Eluted amino acids were detected using absorbance measurements at 214 nm, 254 
nm and 280 nm. ( 0 - P - T y r ) 2 ~ elution centred at ~2.2 min and tyrosine elution 
centred at ~3.3 min. 
Post-column MS detection was performed using three scan events: 1: Full scan 
in negative ion mode (100 - 500 m/z); 2: Negative ion mode (70-190 m/z) w i th 
MSMS on ions detected at 180 ± 2 m/z; 3: Negative ion mode (70-270 m/z) w i th 
MSMS on ions detected at 260 ± 2 m/z. Each ion chromatogram was extracted and 
the area under each region of interest was determined. 
Calibration plots were created using the U V or MS peak areas found. Each cal-
ibration point was recorded three times and at a different injection volume (2 p.1, 5 
|j.l or 10 u.1). Corresponding calibration plots were determined using the average of 
each of these three points. 
Each unknown sample was run alongside the calibration points and its con-
stituent amino acid concentrations determined using the calibration plot. 
5.1.12 Single crystal X-ray diffraction 
The crystal structure of 2-phthalimidomethyl-7-methoxycaxbonyl-l-azathioxanthone 
was determined. Data was collected using graphite monochromated Mo Koc radi-
ation (A=0.71073 A) on a Bruker SMART 6K CCD area detector. A series of 
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narrow u;-scans (0.3°), each run at a different ^-angle, were carried out to cover 
approximately a f u l l sphere of data. Cell parameters were determined and refined 
using S M A R T sof tware, 1 3 9 and raw frame data were integrated using the S A I N T 
program. 1 4 0 The structure was solved by direct methods and refined by ful l -matr ix 
least squares on F 2 using S H E L X T L software. 1 4 1 Further crystal data is given in 
Appendix C. 
5.2 Synthetic procedures 
5.2.1 Sensitised complexes and precursors 
2-Chloro - iV- [ (S ) - l -pheny le thy l ] e thanamide 1 4 2 
Chloroacetyl chloride (12.47 ml , 156.6 mmol) was added dropwise to a vigorously 
stirring solution of (S)-(-)-a-methylbenzylamine (10.63 ml , 82.5 mmol) and N E t 3 
(12.56 ml , 90.5 mmol) in dry E t 2 0 (200 ml) at -78°C. Following complete addition 
the solution was allowed to warm to room temperature over the course of 2 h yielding 
a yellow tinged solution containing a white precipitate. The suspension was washed 
wi th H C l ( a q ) (1M, 2 x 40 ml) followed by H 2 0 (2 x 100 ml) to yield a clear yellow 
tinged organic phase that was cooled at 4°C to precipitate the crude product as 
off-white needle-like crystals. The desired product was purified by recrystallisation 
f rom E t 2 0 and isolated as white needle-like crystals (14.52 g, 73.5 mmol, 89 % ) ; 
m.p. 101-103°C ( L i t . 1 4 3 101-102°C); J H - N M R (CDC1 3 , 400 MHz) S 7.32-7.38 (m, 
5H, A r ) , 6.82 (br, 1H, N H ) , 5.15 (m, 1H, CH), 4.06 (m, 2H, C H 2 ) , 1.55 (d, 3H, 
J=6.5 Hz, C H 3 ) ; 1 3 C - N M R (CDC1 3 , 100 MHz, lU decoupled 400 MHz) S 165.3 (1C, 
C = 0 ) , 142.6 (1C, A r ( q ) ) , 129.1 (2C, A r ( m ) ) , 128.0 (1C, A r ( p ) ) , 126.4 (2C, A r ( o ) ) , 49.6 
(1C, CH) , 43.0 (1C, C H 2 ) , 22.0 (1C, C H 3 ) ; MS (ES+) m/z 220.1 [M + Na]+ 100 %. 
H 
N 
' I CI 
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l ,4 ,7 ,10-Tetraaza-cyclododecane- l ,7-dicarboxyl ic acid dibenzyl ester 1 
Disodium hydrogen phosphate (14 g, 98.62 mmol) was added to a solution of 
cyclen (5 g, 29.02 mmol) i n distilled watendioxane (50:20, 70 ml) , followed by ad-
justment of the p H to between 2.5-3 wi th cone. HCl(aq). Benzyl chloroformate (10.0 
ml , 70.05 mmol) in dioxane (20 ml) was added dropwise to the solution over 2.5 h 
at room temperature, followed by stirring for a further 18 h to yield a colourless 
solution containing a white precipitate. Solvent was removed f rom the crude mix-
ture under reduced pressure to leave a viscous white gum. The gum was dissolved 
in water (100 ml) followed by adjustment of the pH to 7 wi th cone. K O H ( a q ) . The 
resultant solution was extracted wi th diethyl ether (3 x 50 ml) to remove reaction 
side products. The aqueous phase was then extracted w i t h dichloromethane (3 x 50 
ml) followed by the organic phase being dried under reduced pressure to give the 
desired product as a colourless viscous oil . The oil was redissolved in D C M (5 ml) 
followed by precipitation of the desired product via the addition of cold ether (60 
ml) to give a coarse white powder that was collected by centrifugation (8.97 g, 20.36 
mmol, 70 % ) ; m.p. 113-116°C; ' H - N M R (CDC1 3 , 500 MHz) 6 7.33-7.40 (m, 10H, 
A r ) , 5.18 (s, 4H, Cbz C H 2 ) , 3.47-3.79 (m br, 8H, cyclen C H 2 ) , 2.86-3.12 (m br, 8H, 
cyclen C H 2 ) , 2.05 (s br, 2H, 2 x NH) ; 1 3 C - N M R (CDC1 3 , 125 MHz, J H decoupled 
500 MHz) 8 156.5, 156.4 (2C, C = 0 ) , 136.2, 136.1 (2C, A r ( q ) ) , 129.1, 129.0, 128.8, 
128.7, 128.4, 128.3 (10C, A r ) , 68.2, 68.1 (2C, Cbz C H 2 ) , 50.9, 50.7, 50.5, 50.1, 49.9, 
49.4, 49.2 (16C, cyclen C H 2 ) ; MS (ES+) m/z 441.4 [M + H]+ 100 %. 
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4,10-Bis - [ ( (S) - l -phenyl -ethylcarbamoyl) -methyl ] - l ,4 ,7 ,10- tetraaza-
cyclododecane- l ,7-dicarboxyl ic ac id dibenzyl e s t e r 9 4 
JO H O 
. 9, r. j ° 
N 
O I J 
O 
N 
H 
A stirring mixture of 1,4,7,10-tetraaza-cyclododecane-l,7-dicarboxylic acid diben-
zyl ester (1.25 g, 2.84 mmol) , 2-chloro-7V-[(5 ,)-methylbenzyl]ethanamide (1.23 g, 6.22 
mmol), C s 2 C 0 3 (1.84 g, 5.65 mmol) and KI (10 mg) was boiled under reflux in dry 
MeCN for 24 h. The resultant orange tinged solution was allowed to cool to room 
temperature then dried under reduced pressure. The orange residue was taken up 
in D C M (15 ml ) , washed wi th sodium thiosulfate solution (0.01 M , 10 ml) then H 2 0 
(2 x 15 ml ) . The orange tinged organic layer was dried under reduced pressure to 
leave a viscous oi l . The oil was sonicated in diethyl ether (2 x 20 ml) , the insoluble 
material was collected by centrifugation, dissolved in D C M (10 ml) then dried under 
vacuum to give the desired product as a off-white glassy solid (1.70 g, 2.23 mmol, 
78 % ) ; m.p. 64-66°C; X H - N M R (CDC1 3 , 500 MHz) S 7.59 (s br, 2H, NH) , 7.20-7.35 
(m, 20H, amide arm and Cbz A r ) , 5.11 (m, 2H, CH) , 4.97 (s br, 4H, Cbz C H 2 ) , 3.43 
(m br, 8H, cyclen C H 2 ) , 3.15 (s br, 4H, C H 2 C O ) , 2.75 (m br, 8H, cyclen C H 2 ) , 1.44 
(s br, 6H, C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, X H decoupled 500 MHz) 6 170.2 (2C, 
amide arm C = 0 ) , 157.0 (2C, Cbz C = 0 ) , 143.8 (2C, amide arm A r ( q ) ) , 136.5 (2C, 
Cbz A r ( q ) ) , 128.8, 128.5, 128.4, 2 x 127.4, 126.5 (20C, amide arm and Cbz A r ) , 67.5 
(2C, Cbz C H 2 ) , 59.2 (2C, C H 2 C O ) , 54.9-56.3 (br, 4C, cyclen C H 2 ) , 48.7 (2C, CH), 
47.8-49.0 (br, 4C, cyclen C H 2 ) , 22.0 (2C, C H 3 ) ; MS ( E S + ) m/z 763.5 [M + H]+ 100 
%; HRMS (ES+) m/z found 763.4187 [M + H ] + C 44H550 6N 6 requires 763.4178. 
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AT-((S) - l -Phenyl -e thyl ) -2- (7- [ ( (S) - l -phenyl -e thylcarbamoyl ) -methyl ] -
l ,4 ,7 ,10- te traaza-cyc lododec- l -y l ) -acetamide 9 4 
4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecan-
e-l,7-dicarboxylic acid dibenzyl ester (1.69 g, 2.22 mmol) in H 2 0 : M e O H (1:3, 30 ml) 
was shaken in a Parr hydrogenation flask at 40 psi H 2 over P d ( O H ) 2 / C (0.15 g) for 
24 h. The resulting mixture was filtered through celite to leave a clear solution that 
was dried under reduced pressure to yield the desired product as a glassy white solid 
(1.05 g, 2.12 mmol, 96 % ) ; m.p. 140-143°C; X H - N M R ( C D 3 O D , 500 MHz) 6 7.28-
7.32 and 7.21-7.23 (m, 10H, A r ) , 5.04 (m, 2H, CH), 3.54 (d, 2H, J=17.0 Hz, CHCO), 
3.41 (d, 2H, J=16.5 Hz, CHCO), 2.88-3.18 (m br, 16H, cyclen C H 2 ) , 1.46 (d, 6H, 
J=7.0 Hz, C H 3 ) ; 1 3 C - N M R ( C D 3 O D , 125 MHz, X H decoupled 500 MHz) S 172.7 
(2C, C = 0 ) , 145.8 (2C, A r ( q ) ) , 130.5, 129.0, 128.0 (10C, A r ) , 57.2 (2C, C H 2 C O ) , 
52.4 (2C, CH) , 51.1, 50.7, 45.2 (br, 8C, cyclen C H 2 ) , 23.5 (2C, C H 3 ) ; MS (ES + ) 
m/z 495.3 [M + H]+ 100 %; HRMS (ES+) m/z 495.3447 [M + H]+ C 2 8 H 4 3 0 2 N 6 
requires 495.3442. 
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4,10-Bis - [ ( (S) - l -phenyl -ethylcarbamoyl) -methyl ] - l ,4 ,7 ,10- tetraaza-
cyc lododecane- l -carboxyl ic ac id tert-buty\ ester ( 4 5 ) 9 4 
\ 
H 
N 
C J 9\ N N „ 
X N cT H 
A solution of d i - ie r i -bu ty l dicarbonate (0.353 g, 1.61 mmol) in dry MeOH (6 ml) 
was added dropwise over 1 h, at room temperature, to a st irring solution of A^-((S)-1-
phenyl-ethyl)-2-(7-[((S)-l-phenyl-ethylcarbamoj'l)-methyl]-l,4,7,10-tetraaza-cyclod-
odec-l-yl)-acetamide (0.998 g, 2.02 mmol) and N E t 3 (0.560 ml , 4.04 mmol) in dry 
MeOH (30 ml ) . The reaction mixture was left to stir overnight then dried under 
reduced pressure. The crude yellow tinged viscous oil was purified by column chro-
matography on alumina (utilising an incremental solvent system of D C M / M e O H 
starting f rom 100 % D C M wi th 0.1 % MeOH increments) to yield, after drying, the 
desired product as a glassy white solid (0.573 g, 0.963 mmol, 60 % ) ; (Alumina, 
DCM-MeOH, 49:1) : 0.46; m.p. 98-101°C; *H-NMR (CDC1 3 , 500 MHz) 6 7.86 (s 
br, 1H, cyclen N H ) , 7.20-7.33 (m, 10H, A r ) , 5.13 (m br, 2H, CH), 3.09 (m br, 4H, 
C H 2 C O ) , 2.53-3.37 (m br, 16H, cyclen C H 2 ) , 1.50 (d, 6H, J=7 .0 Hz, amide arm 
C H 3 ) , 1.39-1.41 (m br, 9H, 4 B u C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, *H decoupled 
500 MHz) 5 170.5 (2C, amide C = 0 ) , 156.7 (1C, 'Boc C = 0 ) , 143.8 (2C, A r ( q ) ) , 128.8, 
127.5, 126.8 (10C, A r ) , 80.3 (1C, ' B o c ^ ) , 59.6 (2C, C H 2 C O ) , 49.0-53.8 (m br, 8C, 
cyclen C H 2 ) , 48.7 (2C, CH) , 28.8 (3C, f Boc C H 3 ) , 22.0 (2C, amide arm C H 3 ) ; MS 
( E S + ) m/z 595.4 [M + H ] + 100 %; HRMS ( E S + ) m/z found 595.3972 [M + H]+ 
C 3 3 H 5 i 0 4 N 6 requires 595.3966. 
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7-Ethoxycarbonylmethyl -4 ,10-bis - [ ( (S) - l -phenyl -e thylcarbamoyl ) -
methyl] - l ,4 ,7 ,10-tetraaza-cyclododecane- l -carboxyl ic ac id t e r £ - b u t y l es-
t e r 9 4 
o n H 
U 
N v c J 9\ N „ 
! 6 X N cT H 
A mixture of 4,10-bis-[((S)-l-phenyl-e'thylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododecane-l-carboxylic acid ier i -butyl ester (0.224 g, 0.377 mmol), ethyl bro-
moacetate (0.035 ml , 0.316 mmol) and C s 2 C 0 3 (0.123 g, 0.378 mmol) in MeCN 
(10 ml) was heated at reflux and stirred vigorously for 12 h then allowed to cool 
to room temperature. The mixture was dried under reduced pressure, dissolved in 
D C M then extracted wi th saturated NaHC0 3(aq) solution (10 ml) followed by H 2 0 
(2 x 10 ml ) . The yellow tinged organic layer was dried under reduced pressure to 
leave a yellow tinged oil . The desired product was isolated f rom the oil by column 
chromatography on alumina (using D C M / M e O H starting f rom 100 % D C M wi th 
0.1 % MeOH increments) as a clear glassy solid (0.151 g, 0.222 mmol, 70 % ) ; RF 
(Alumina, D C M - M e O H , 95:5) : 0.61; m.p. 39-41°C; 1 H - N M R (CDC1 3 ) 500 MHz) 8 
7.87 (s br, 1H, N H ) , 7.59 (s br, 1H, N H ) , 7.21-7.33 (m, 10H, A r ) , 5.16 (m, 2H, CH), 
4.07 (m, 2H, ethyl C H 2 ) , 2.18-3.36 (m, 22H, cyclen C H 2 , amide arms C H 2 and ester 
arm C H 2 ) , 1.51 (d br, 6H, J=13.0 Hz, amide arm C H 3 ) , 1.42 (m br, 9H, lBu C H 3 ) , 
1.24 (t, 3H, J=7 Hz, ethyl C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, J H decoupled 500 
MHz) 8 171.0 (1C, ethyl ester C = 0 ) , 170.9, 170.3 (2C, amide C = 0 ) , 156.2 (1C, f Boc 
C = 0 ) , 144.2, 143.1 (2C, A r ( q ) ) , 129.0, 128.8, 127.9, 127.3, 127.0, 126.6 (10C, A r ) , 
80.1 (1C, 'Boc^) ) , 60.7 (1C, ethyl C H 2 ) , 59.5 (1C, ethyl ester C H 2 C O ) , 53.3-55.0 
(m br, 8C, cyclen C H 2 ) , 54.3 (2C, amide arm C H 2 C O ) , 48.5, 48.3 (2C, CH), 28.8 
(3C, 'Boc C H 3 ) , 22.3, 21.2 (2C, amide arm C H 3 ) , 14.6 (1C, ethyl C H 3 ) ; MS (ES+) 
m/z 344.1 i [ M + H + L i ] 2 + 100 %, 681.4 [M + H]+ 10 %; HRMS ( E S + ) m/z found 
681.4341 [ M + H]+ C 3 7 H 5 7 0 6 N 6 requires 681.4334. 
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7-Carboxymethyl -4 ,10-bis - [ ( (S) - l -phenyl -e thylcarbamoyl) -methyl ] -
1 ,4 ,7 ,10-tetraaza-cyclododecane-l-carboxyl icacid tert-butyl ester (46) 
7-Ethoxycarbonylmethyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-
1,4,7,10-tetraaza-cyclododecane-l-carboxylic acid tert-butyl ester (0.135 g, 0.198 
mmol) and L i O H . H 2 0 (0.025 g, 0.596 mmol) in H 2 0 : M e O H (100 ml , 50:50) were 
heated at reflux for 12 h. The solution was allowed to cool then MeOH was removed 
under reduced pressure. The aqueous solution was neutralised w i t h dilute HCl ( a q ) 
then extracted w i t h D C M (3 x 20 ml) after the addition of brine (20 ml) . The 
combined organic washings were dried under reduced pressure to leave the desired 
product as a glassy white solid (0.127 g, 0.195 mmol, 98 % ) . J H - N M R (CDC1 3 , 400 
MHz) S 7.18-7.32 (m, 10H, A r ) , 5.10 (m br, 2H, CH) , 2.31-3.22 (m br, 22H, cyclen 
C H 2 , amide arms C H 2 C O and acid arm C H 2 C O ) , 1.46 (d, 6H, / = 4 . 8 Hz, amide 
arm C H 3 ) , 1.35 (m br, 9H, J B u C H 3 ) ; 1 3 C - N M R (CDC1 3 , 100 MHz, X H decoupled 
400 MHz) 5 170.7 (br, 2C, amide C = 0 ) , 159.9 (br, 1C, l Boc C = 0 ) , 143.9 (br, 2C, 
A r ( q ) ) , 128.9, 127.4, 126.8 (10C, A r ) , 80.4 (1C, ' B o c ^ ) , 58.4 (1C, acid arm C H 2 C O ) , 
53.7 (m br, 10C, cyclen C H 2 and amide arm C H 2 C O ) , 49.1 (2C, CH), 28.7 (3C, f Boc 
C H 3 ) , 22.2 (2C, amide arm C H 3 ) ; MS (ES+) m/z 653.4 [M + H ] + 100 %; HRMS 
( E S + ) m/z found 653.4029 [M + H]+ C 3 5 H 5 3 0 6 N 6 requires 653.4021. 
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Methyl -4-hydroxybenzoate 144 
E D 
B A 
HO COpMe 
E D 
H2SO4 (7 ml) was slowly added dropwise to a solution of 4-hydroxybenzoic acid 
(10 g, 72.4 mmol) in dry methanol (50 ml) . The solution was heated to reflux 
(65°C) wi th st irr ing for 2 h, then allowed to cool. The pH of the cooled solution was 
carefully adjusted to 5 by the addition of 40% NaOH(aq) solution, at which point a 
white precipitate formed. The white precipitate was isolated on a sinter then washed 
thoroughly w i t h water. The white solid obtained was dissolved in ethyl acetate, the 
solution was dried w i t h magnesium sulfate then filtered. The filtrate was dried under 
reduced pressure to yield the t i t le compound as a crystalline white solid (8.5 g, 55.9 
mmol, 77%); m.p. 127-129°C ( L i t . 1 4 5 1 23-124°C); ! H - N M R ( C D 3 O D , 500 MHz) 6 
7.89 (d, 2H, J=7 .0 Hz, H D ) , 6.85 (d, 2H, J=6.5 Hz, H ^ ) , 4.93 (s br, 1H, H G ) , 3.86 
(s, 3H, H A ) ; 1 3 C - N M R ( C D 3 O D , 125 MHz, ! H decoupled 500 MHz) 8 169.5 (1C, 
C B ) , 164.3 (1C, C F ) , 133.6 (2C, CD), 123.0 (1C, C c ) , 117.0 (2C, CE), 53.1 (1C, 
C A ) ; MS (ES~) m/z 151.1 [ M - H ] " 100 %. 
2- (4-Methoxy car bony lphenoxy )-6-methylnicotinic a c i d 5 4 
Methyl-4-hydroxybenzoate (12.6 g, 82.8 mmol) was added to a solution of sodium 
metal (0.84 g, 36.54 mmol) in dry methanol (15 ml) to form a viscous light yellow 
solution. Methanol was removed f rom the solution under reduced pressure to leave a 
white glassy solid. 2-Chloro-6-methylnicotinic acid (3.00 g, 17.48 mmol) was added 
to the solid which was heated for 25 h at 155°C to form a brown solution. After 
25 h the mixture was allowed to cool to 120°C then poured into water (80 ml) to 
form a yellow tinged solution containing an insoluble brown residue. The aqueous 
o 
OH 
N 
OMe 
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suspension was extracted w i t h ether (3 x 50 ml) then acidified wi th glacial acetic acid 
to precipitate the crude product. The precipitate was isolated by f i l t ra t ion, washed 
thoroughly w i t h water then dried under vacuum to yield the desired product as 
a fibrous white solid (1.8 g, 6.27 mmol, 36%); m.p. 122-123°C ( L i t . 5 4 118-120°C); 
! H - N M R (CDC1 3 , 500 MHz) S 8.38 (d, 1H, J=7.5 Hz, H K ) , 8.11 (d, 2H, J=9.0 Hz, 
H D ) , 7.22 (d, 2H, J=8.5 Hz, EE), 7.06 (d, 1H, J=8.0 Hz, H j ) , 3.94 (s, 3H, UA), 
2.42 (s, 3H, H / ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, *H decoupled 500 MHz) S 166.8 (1C, 
CB), 166.8 (1C, C M ) , 163.5 (1C, C H ) , 160.5 (1C, C G ) , 157.2 (1C, C F ) , 143.8 (1C, 
C K ) , 131.6 (2C, CD), 127.3 (1C, C c ) , 121.5 (2C, CE), 119.8 (1C, Cj), 111.2 (1C, 
C L ) , 52.5 (1C, CA), 24.7 (1C, C j ) ; MS (ES+) m/z 288.1 [M + H]+ 90 %. 
7-Methoxycarbonyl -2 -methy l - l -azaxanthone 5 4 
0 o 
N 
Polyphosphoric acid (70 g) and 2-(4-methoxycarbonylphenoxy)-6-methylnicotinic 
acid (1.30 g, 4.53 mmol) were heated together for 18 h, at 120°C, under argon. The 
resulting brown l iquid was cooled to 0°C followed by the addition of cold methanol 
(100 ml) w i t h s t i rr ing unt i l the mixture homogenised. The apparent pH of the re-
sulting brown solution was adjusted to 7 by the addition of concentrated K O H ( a q ) 
solution, at 0°C, to yield an off-white suspension. The suspension was extracted 
wi th dichloromethane (4 x 25 cm 3 ) , the solvent was removed f rom the combined 
organic washings to yield the desired product as a yellow solid (0.391 g, 1.45 mmol, 
32%). m.p. 198-199°C ( L i t . 5 4 194-196°C); J H - N M R ( C D C l 3 l 500 MHz) 5 8.99 (d, 
1H, J=2.0 Hz, H 0 ) , 8.60 (d, 1H, J=8.0 Hz, HK), 8.41 (dd, 1H, .7=9.0, 2.0 Hz, H D ) , 
7.65 (d, 1H, J=9 .0 Hz, EE), 7.34 (d, 1H, J=8.0 Hz, H j ) , 3.98 (s, 3H, H ^ ) , 2.72 (s, 
3H, H / ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, lH decoupled 500 MHz) 6 177.2 (1C, C M ) . 
166.0 (1C, C B ) , 166.0 (1C, C t f ) , 160.2 (1C, C G ) , 158.6 (1C, CF), 137.8 (1C, C K ) , 
136.3 (1C, CD), 129.5 (1C, Co), 127.0 (1C, C c ) , 122.1 (1C, Cj), 121.7 (1C, C N ) , 
119.3 (1C, CE), 114.6 (1C, CL), 52.8 (1C, CA), 25.5 (1C, C j ) ; MS (ES+) m/z 291.9 
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[M + Na]+ 50 %, 561.4 [2M + N a ] + 100 %. 
7-Methoxycarbonyl-2-bromomethyl- l -azaxanthone l 
o o 
N 
Br 
7-Methoxycarbonyl-2-methyl-l-azaxanthone (1.12 g, 4.16 mmol) was stirred in 
CC1 4 (10 ml) under reflux (100°C). NBS (0.37 g, 2.08 mmol) and A I B N (2 mg) 
were added to the mixture, at reflux, to form a sparingly soluble suspension of the 
reactants in C C I 4 (an identical addition was repeated 2 h later) and the reaction 
micture was left to stir and reflux. Af te r 12 h the yellow solution was allowed to 
cool to room temperature then filtered, solvent was removed f rom the fil trate under 
reduced pressure to leave a yellow powder. The desired product was isolated f rom 
the crude reaction mixture by column chromatography on silica gel ( D C M with 
0.1% increments of MeOH per 50 ml of solvent) as a fine white powder (200 mg, 
0.57 mmol, 14 % ) ; m.p. 172-173°C ( L i t . 5 4 156-158°C); RF ( S i 0 2 , DCM-MeOH, 93:7) 
: 0.45; J H - N M R (CDC1 3 , 400 MHz) S 8.92 (dd, 1H, 7=2.0, 0.5 Hz, H 0 ) , 8.68 (d, 
1H, J=8 .0 Hz, H * ) , 8.38 (dd, 1H, 7=9.0, 2.0 Hz, H 0 ) , 7.62 (dd, 1H, J=9.0, 0.5 
Hz, H e ) , 7.59 (d, 1H, J=8.0 Hz, H j ) , 4.59 (s, 2H, H 7 ) , 3.95 (s, 3H, EA); 1 3 C - N M R 
(CDC1 3 , 100 MHz, L H decoupled 400 MHz) 6 176.7 (1C, C w ) , 165.8 (1C, CB), 162.7" 
(1C, CH), 159.8 (1C, CG), 158.4 (1C, C F ) , 139.1 (1C, C K ) , 136.6 (1C, C D ) , 129.4 
(1C, Co), 127.3 (1C, C c ) , 121.6 (1C, Cj), 121.5 (1C, C N ) , 119.2 (1C, C E ) , 116.2 
(1C, C L ) , 52.8 (1C, 0 0 , 32.3 (1C, C 7 ) ; MS (ES+) m/z 371.2 [M + Na]+ 100 %, 
719.0 [2M + N a ] + 45 %. 
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7-Methoxycarbonyl-2-phthal imidomethyI- l -azaxanthone l 
o 
N 
o o 
7-Methoxycarbonyl-2-bromomethyl-l-azaxanthone (0.061 g, 0.175 mmol) and 
potassium phthalimide (0.130 g, 0.702 mmol) in D M F (5 ml) were stirred, under 
argon, for 12 h at room temperature. The resulting solution was poured into ice 
water (500 ml) to yield a yellow/orange precipitate that was isolated by centrifuga-
tion. The f i l t rate was further cooled in the fridge yielding further precipitate which 
too was isolated. The solids were combined and recrystallised f rom DCM:Ether to 
yield the product as a yellow/orange crystalline solid (0.065 g, 0.157 mmol, 90 % ) ; 
m.p. >250°C; J H - N M R (CDC1 3 ) 500 MHz) 5 8.96 (d, 1H, .7=2.0, H 0 ) , 8.68 (d, 1H, 
.7=8.0 Hz, H / f ) , 8.39 (dd, 1H, 7=9.0, 2.0 Hz, H D ) , 7.93 (dd, 2H, 7=5.5, 3.0 Hz, H f i ) , 
7.79 (dd, 2H, .7=5.5, 3.0 Hz, H 5 ) , 7.60 (d, 1H, .7=9.0 Hz, HE), 7.42 (d, 1H, J=8.0 Hz, 
Hj), 5.14 (s, 2H, Hi), 3.97 (s, 3H, H * ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, X H decoupled 
500 MHz) 6 177.0 (1C, C M ) , 168.2 (2C, C P ) , 165.9 (1C, C s ) , 162.1 (1C, CH), 160.3 
(1C, C c ) , 158.5 (1C, C F ) , 138.8 (1C, C K ) , 136.5 (1C, C D ) , 134.7 (2C, C s ) , 132.4 
(2C, C Q ) , 129.5 (1C, Co), 127.2 (1C, C c ) , 124.1 (2C, CR), 121.6 (1C, C N ) , 119.5 
(1C, Cj), 119.3 (1C, CE), H 6 . 1 (1C, CL), 52.9 (1C, C^) , 43.1 (1C, C/) ; MS (ES+) 
m/z 437.3 [M + Na]+ 100 %, 851.2 [2M + N a ] + 50 %; HRMS (ES+) m/z found 
437.0741 [M + Na]+ C 2 3 H 1 4 0 6 N 2 N a requires 437.0744. C 2 3 H 1 4 N 2 0 6 . | C H 2 C l 2 (%): 
calcd C 64.93 H 3.37 N 6.54; found C 65.09 H 3.34 N 6.48. 
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7-Methoxycarbonyl -2-aminomethyl - l -azaxanthone (47) 
o o 
N 
NH 
A solution of 7-methoxycarbonyl-2-phthalimidomethyl-l-azaxanthone (0.061 g, 
0.147 mmol) and N H 2 N H 2 . H 2 0 (0.014 ml , 0.297 mmol) in D C M : M e O H (50:50, 8 
ml) was heated at 50°C followed by further additions of N H 2 N H 2 . H 2 0 (0.014 ml , 
0.297 mmol) at 3 h intervals unt i l T L C analysis showed all starting 7-methoxycarb-
onyl-2-phthalimidomethyl-l-azaxanthone to have been consumed. The clear yellow 
solution was allowed to cool followed by the addition of cone. HCl(aq) unt i l a pH 
of 2 was reached. The resultant solution containing a white precipitate was heated 
at 50°C for 2 h then allowed to cool to room temperature, the solution was filtered 
followed by the drying of the yellow fi l trate under vacuum to yield a yellow powder. 
Immediately prior to use the solid was dissolved in H 2 0 containing 1 eq. NaOMe 
then extracted w i t h D C M (5 ml) , the organic phase was dried under reduced pressure 
to leave the t i t le product as a pale green solid (0.029 g, 0.102 mmol, 69 %) ; X H - N M R 
(CDC1 3 , 500 MHz) S 9.00 (d, 1H, J=2.0 Hz, H 0 ) , 8.69 (d, 1H, J=8.0 Hz, H * ) , 8.43 
(dd, 1H, J=9.0 , 2.5 Hz, H D ) , 7.60 (d, 1H, J=8.5 Hz, H E ) , 7.52 (d, 1H, 7=8.0 Hz, 
Ej), 4.16 (s, 2H, H 7 ) , 3.99 (s, 3H, H ^ ) , 1.84 (s br, 2H, N H 2 ) ; 1 3 C - N M R (CDC1 3 , 125 
MHz, X H decoupled 500 MHz) 8 177.2 (1C, C M ) , 169.3 (1C, CH), 166.0 (1C, C B ) , 
160.4 (1C, C G ) , 158.5 (1C, CF), 138.1 (1C, C K ) , 136.2 (1C, CD), 129.3 (1C, C 0 ) , 
127.0 (1C, C N ) , 121.5 (1C, C c ) , 119.4 (1C, C j ) , 119.0 (1C, CE), 115.3 (1C, CL), 
52.7 (1C, C A ) , 45.0 (1C, C 7 ) ; MS (ES+) m/z 285.2 [M + H]+ 100 %; HRMS (ES+) 
m/z found 285.0869 [ M + H ] + C 1 5 H i 3 0 4 N 2 requires 285.0870. 
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2-[(2-(7-<eri-Butoxycarbonyl-4 ,10-bis- [ ( (S)- l -phenyl-ethylcarbamoyl)-
methyl]-1,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-
10i2"-9-oxa-l-aza-anthracene-6-carboxylic acid methyl e s t e r 9 2 
Ph 
) ii 
O o HN 
N 
H 
N N 
o 
> f ° °-( 
NH 
I I 
Ph 
7-Carboxymethyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-
tetra- aza-cyclododecane-l-carboxylic acid tert-buty\ ester (0.128 g, 0.196 mmol), 
EDC.HC1 (0.037 g, 0.193 mmol) , H O B t . H 2 0 (10 mg) and N E t 3 (0.082 ml, 0.588 
mmol) in chloroform (2 ml) were stirred for 20 min at room temperature to form 
a yellow tinged solution. 7-Methoxycarbonyl-2-aminomethyl-l-azaxanthone (0.042 
g, 0.148 mmol) in chloroform (3 ml) was then added to form a orange solution that 
was left to stir for 12 h at room temperature. The resulting yellow solution was 
extracted wi th sat. N a H C 0 3 solution (2 x 15 ml) then H 2 0 (10 ml) , the organic 
phase was dried under reduced pressure to leave an orange foam. The desired 
product was purified via alumina column chromatography (using a graduated 
solvent system starting f rom 100% D C M wi th 0 .1% MeOH increments every 100 
ml) yielding a glassy orange residue (0.073 g, 0.079 mmol, 53 % ) ; m.p. 70-72°C; 
RF (alumina, D C M - M e O H , 99:1) : 0.16; *H-NMR (CDC1 3 , 500 MHz) 5 8.95 (d, 
1H, J=2.5 Hz, H 0 ) , 8.60 (d, 1H, J=8.0 Hz, EK)y 8.39 (dd, 1H, 7=8.5, 2.0 Hz, 
H D ) , 8.00 (s br, 1H, linker amide N H ) , 7.58 (d, 1H, J=8.5 Hz, H ^ ) , 7.32 (d, 1H, 
J=6.5 Hz, H j ) , 7.19-7.25 (m, 10H, amide arm A r ) , 5.08 (m, 2H, arm CH), 4.54 
(m, 2H, H 7 ) , 3.97 (s, 3H, H,t) , 2.40-3.16 (m br, 22H, cyclen C H 2 and amide arms 
C H 2 C O ) , 1.43 (d, 6H, J=6.5 Hz, amide arms C H 3 ) , 1.37-1.41 (m br, 9H, f B u 
C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, *H decoupled 500 MHz) 5 176.8 (1C, C M ) , 
171.4 (1C, linker amide C = 0 ) , 170.4 (2C br, amide arm C = 0 ) , 165.8 (1C, CB), 
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163.9 (1C, C w ) , 160.1 (1C, C G ) , 158.3 (1C, CF), 156.0 (1C, 'Boc C = 0 ) , 143.7, 
143.1 (2C br, amide arm A r ( q ) ) , 138.3 (1C, C K ) , 136.5 (1C, C D ) , 129.4 (1C, Co) , 
126.5-128.8 (10C, amide arm A r ) , 127.5 (1C, C N ) , 121.6 (1C, C c ) , 120.1 (1C, Cj), 
119.0 (1C, CE), H5.6 (1C, CL), 80.3 (1C, ' B o c ^ ) , 60.0, 59.4, 54.6, 53.4 (8C, cyclen 
C H 2 ) , 52.8 (1C, CM), 48.7 (2C, amide arms C H ) , 47.8 (3C, amide arms and linker 
C H 2 C O ) , 44.6 (1C, C/) , 28.7 (3C, f Boc C H 3 ) , 21.9, 21.5 (2C, amide arms C H 3 ) ; MS 
(ES+) m/z 919.7 [M + H]+ 100 %; HRMS (ES+) m/z found 919.4726 [M + H ] + 
CsoHesOgNs requires 919.4713. 
2-[(2-(4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-10ff-9-oxa-l-aza-
anthracene-6-carboxylic acid methyl ester ( L 4 4 a ) 9 2 
Ph 
> 
HN O O 
O N 
H 
N N C ST 
N H 
3 NH 
< 
Ph 
2- [(2- (7- f eri-Butoxycarbonyl-4,10-bis- [((S)- l-phenyl-ethylcarbamoyl)-methyl]-
l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-107/-9-oxa-l-aza-
anthracene-6-carboxylic acid methyl ester (72 mg, 0.078 mmol) in D C M . T F A (50:50, 
4 ml) was stirred in a sealed flask for 12 h yielding a yellow solution. Solvent was 
then removed under reduced pressure to yield the desired product as its TFA salt 
as a glassy yellow solid in quantitative yield; ^ - N M R (CDC1 3 , 500 MHz) 6 9.39 (s, 
1H, linker N H ) , 8.86 (d, 1H, J=1.5 Hz, H 0 ) , 8.56 (d, 1H, J=8 .0 Hz, H * ) , 8.34 (dd, 
1H, J=8.5 Hz 1.5 Hz, H D ) , 8.10 (s br, 1H, arm N H ) , 7.87 (s br, 1H, arm NH) , 7.54 
(d, 1H, 7=9.0 Hz, HE), 7.36 (d, 1H, 7=8.0 Hz, H , ) , 7.15-7.23 (m br, 10H, arm A r ) , 
4.85-4.95 (m br, 2H, arm CH), 4.59 (m br, 2H, H / ) , 3.94 (s, 3H, KA), 3.00-3.66 (m br, 
22H, cyclen, arm and linker C H 2 ) , 1.40 (s br, 6H, arm C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 
MHz, lE decoupled 500 MHz) 6 176.9 (1C, C M ) , 171.1, 170.1 (3C, amide arm C = 0 
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and linker arm C = 0 ) , 165.9 (1C, C B ) , 163.6 (1C, C H ) , 161.6 (q, 1C, TFA C = 0 ) , 
160.1 (1C, C G ) , 158.3 (1C, C F ) , 143.6 (2C, arm A r ( q ) ) , 138.5 (1C, C * ) , 136.5 (1C, 
CD), 129.3 (1C, Co), 128.9, 127.7, 126.5, 126.4 (10C, arm A r ) , 127.1 (1C, C N ) , 
121.5 (1C, C c ) , 119.4 (1C, Cj), 119.2 (1C, CE), 115.7 (1C, CL), 115.4 (q, 1C, TFA 
C F 3 ) , 55.4, 53.8, 52.4 (br, 8C, cyclen C H 2 ) , 52.9 (1C, CA), 49.8 (br, 2C, arm CH), 
45.0 (br, 1C, C ; ) , 43.5 (br, 3C, arm and linker C H 2 ) , 22.2, 21.9 (br, 2C, amide arm 
C H 3 ) ; MS (ES+) m/z 819.5 [M + H ] + 100 %, 841.5 [M + N a ] + 40 %; HRMS (ES+) 
m/z found 819.4198 [ M + H]+ C 4 5 H 5 5 0 7 N 8 requires 819.4188. 
Eu(III) complex of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-
methyl]-l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-
10i/-9-oxa-l-aza-anthracene-6-carboxylic acid methyl ester ( [ E u L 4 4 a ] 3 + ) 9 2 
A solution of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tet-
raaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-10^T-9-oxa-l-aza-anthracene-6-
carboxylic acid methyl ester as its T F A salt (46 mg, 0.049 mmol) and E u ( O T f ) 3 
(26 mg, 0.043 mmol) in MeCN (1 ml) was heated at reflux under argon, in Schlenk 
apparatus, for 48 h. Solvent was removed under reduced pressure to leave a orange 
glassy solid. D C M (5 ml) was added to the solid which was sonicated for 5 min, 
solvent was then decanted to leave a orange residue. The sonication process was 
repeated followed by drying of the remaining residue, under reduced pressure, to 
yield the tr if late salt of the desired product as a fine cinder coloured powder (50 mg, 
0.034 mmol, 79 % ) . The solid was made water soluble by the exchange of trifiate 
anions for chloride anions using D O W E X 1x8 200-400 mesh CI ion exchange resin, 
3+ 3Cl 
N 
NH 
H Ph 
H 20 H \ / 
N Ph H OH 
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as described earlier, to yield the complex as a cinder coloured powder in quantitative 
yield; ^ - N M R (as tri-chloride salt, D 2 0 , 500 MHz, part ial data and assignment) 5 
25.1 (1H, N H ) , 16.9 (1H, Km), 15.2 (1H, H a x ) , 14.0 (1H, H ^ ) , 11.7 (1H, H J ; MS 
(ES+) m/z 508.3 [M + H C 0 2 ] 2 + 100 %, 1015.2 [M + H C 0 2 - H]+ 10 %; HRMS (ES+) 
m/z found 1027.3359 [M + C H 3 C 0 2 - H ] + C 4 7 H 5 6 0 9 N 8 1 5 1 E u requires 1027.3363; 
A a bs(H 2 0) : 333 nm; T ( H 2 o ) : 0.38 ms, T ( D 2 0 ) : 0.60 ms; H P L C (solvent system B, 4.6 
x 150 m m 4 u.m Phenomenex Synergi Fusion RP 80A analytical column): tR = 10.8 
Tb(III) complex of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-
methyl]-l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-
10i?-9-oxa-l-aza-anthracene-6-carboxylic acid methyl ester ( [ T b L 4 4 a ] 3 + ) 9 2 
A solution of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tet-
raaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-10//-9-oxa-l-aza-anthracene-6-
carboxylic acid methyl ester (28 mg, 0.034 mmol) and T b ( O T f ) 3 (17 mg, 0.028 
mmol) in M e C N (1 ml) was heated at reflux under argon, in Schlenk apparatus, for 
48 h. Solvent was removed under reduced pressure to leave a orange glassy solid. 
D C M (5 ml) was added to the solid which was sonicated for 5 min, solvent was then 
decanted to leave a orange residue. The sonication process was repeated followed by 
drying of the remaining residue, under reduced pressure, to yield the triflate salt of 
the desired product as a fine cinder coloured powder (34 mg, 0.024 mmol, 86 % ) . The 
solid was made water soluble by the exchange of t r i f late anions for chloride anions 
using D O W E X 1x8 200-400 mesh CI ion exchange resin, as described previously, 
min. 
3+ 3CI 
N 
NH 
1 H Ph 
N 
5 i \ J j ~ 0 
N N x H,0 H N Ph H OH 
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to yield the cinder coloured complex in quantitative yield; MS ( E S + ) m/z 511.3 
[M + H C 0 2 ] 2 + 100 %, 1021.2 [M + H C 0 2 - H]+ 25 %; HRMS ( E S + ) m/z found 
1035.3409 [ M + C H 3 C 0 2 - H ] + C 4 7 H 5 6 0 9 N 6 1 5 9 T b requires 1035.3418; A a b s ( H 2 0 ) : 
332 nm; T ( H 2 o ) : 1-17 ms, r^2oy. 2.07 ms; HPLC (solvent system A, 4.6 x 150 mm 
4 u.m Phenomenex Synergi Polar-RP 80A analytical column): t R = 9.5 min. 
2-[(2-(7-teri-Butoxycarbonyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-
methyl]-l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-
10if-9-oxa-l-aza-anthracene-6-carboxylic acid 
Ph 
) 
HN 0 0 
O N 
H 
N N C ST 
/ N / O o N 
NH 
< if 
A sparingly soluble solution of 2-[(2-(7-£er£-butoxycarbonyl-4,10-bis-[((S)-l-
phen- yl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-
methyl]-10-oxo-10//-9-oxa-l-aza-anthracene-6-carboxylic acid methyl ester (0.053 g, 
0.058 mmol) and L i O H . H 2 0 (0.005 g, 0.119 mmol) in M e O H : H 2 0 (2:1, 3 ml) was 
stirred overnight in a sealed flask to form a dark orange solution. The pH of the 
solution was subsequently adjusted to 5 wi th HCl(aq) (1 M ) followed by removal of 
MeOH under reduced pressure to yield a light yellow solution. The aqueous solution 
was extracted w i t h CHCI3 ( 2 x 5 ml ) , the orange organic phases were combined then 
dried under reduced pressure to leave the desired product as a glassy dark orange 
solid (0.044 g, 0.049 mmol, 84 % ) ; ^ - N M R (CDCI3, 500 MHz) S 8.85 (s br, 1H, 
amide N H ) , 8.49, 8.30 (m br, 3H, azaxanthone protons), 7.20-7.32 (m br, 14H, amide 
arm Ar , azaxanthone protons and amide N H protons), 5.08 (m, 2H, arm CH), 4.69 
(br, 1H, H / ) , 4.36 (br, 1H, H 7 ) , 2.48-3.47 (m br, 22H, cyclen C H 2 and amide arms 
C H 2 C O ) , 1.50 (d, 6H, J=7 .0 Hz, amide arms C H 3 ) , 1.41 (s, 9H, 4 B u C H 3 ) ; 1 3 C - N M R 
(CDCI3, 125 MHz, J H decoupled 500 MHz) S 176.5 (1C, C M ) , 171.0 (1C, linker amide 
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C = 0 ) , 169.8 (2C br, amide arm C = 0 ) , 164.1, 159.4, 156.9 (3C, azaxanthone C), 
155.7 (1C, J B O C C = 0 ) , 143.4 (2C br, amide arm A r ( q ) ) , 137.8, 136.8, 128.8 (3C, 
azaxanthone C), 126.4, 127.6, 128.8 (IOC, amide arm A r ) , 127.8, 120.4, 118.3, 118.2, 
114.8 (5C, azaxanthone C), 80.8 (1C, ' B O C ^ ) , 59.1, 57.7, 52.9 (8C, cyclen C H 2 ) , 
49.1 (2C, amide arms CH), 46.8 (3C, amide arms and linker C H 2 C O ) , 44.8 (1C, C ; ) , 
28.6 (3C, ' B O C C H 3 ) , 21.8 (2C, amide arms C H 3 ) ; MS (ES~) m/z 903.5 [M - H]~ 
100 %; HRMS (ES~) m/z found 903.4411 [M - H]~ C 4 9 H 5 9 0 9 N 8 requires 903.4411. 
2-[(2-(4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-10fl"-9-oxa-l-aza-
anthracene-6-carboxylic acid ( L 4 9 ) 
h i 
o o HN 
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2-[(2-(7-fert-Butoxycarbonyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-
l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-10//-9-oxa-l-aza-
anthracene-6-carboxylic acid (0.030 g, 0.033 mmol) in D C M : T F A (1:1, 2 ml) was 
stirred in a sealed flask for 2 h. The resultant dark yellow solution was dried under 
reduced pressure to yield the TEA salt of the desired product, as a orange glassy 
solid, in quantitative yield; J H - N M R ( C D 3 C N , 700 MHz) 5 8.67 (d, 1H, J=1.5 Hz, 
H 0 ) , 8.52 (d, 1H, J=8 .0 Hz, HK), 8.32 (dd, 1H, J=8.5, 2.0 Hz, H 0 ) , 7.90-8.01 (s br, 
3H, arm N H ) , 7.62 (d, 1H, J=9 .0 Hz, KE), 7.44 (d, 1H, J=8.5 Hz, H , ) , 7.17-7.32 (m 
br, 10H, arm A r ) , 4.96 (m, 1H, arm CH), 4.88 (m, 1H, arm CH), 4.58 (m, 2H, H / ) , 
3.91 (m, 2H, linker arm C H 2 C O ) , 2.93-3.59 (m br, 20H, cyclen and amide arm C H 2 ) , 
1.38 (d br, 3H, J=6 .0 Hz, arm C H 3 ) , 1.35 (d br, 3H, 7=5.5 Hz, arm C H 3 ) ; 1 3 C - N M R 
( C D 3 C N , 175 MHz, X H decoupled 700 MHz) 5 177.5 (1C, C M ) , 171.0 (br, 2C, amide 
arm C = 0 ) , 166.6 (1C, CB), 165.6 (1C, linker C = 0 ) , 164.4 (1C, CH), 160.8 (1C, 
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C G ) , 160.3 (q, 1C, T F A C = 0 ) , 159.1 (1C, C F ) , 144.7, 144.5 (2C, arm A r ( q ) ) , 138.7 
(1C, C K ) , 137.0 (1C, CD), 127.0, 128.0, 129.5 (10C, arm A r ) , 129.3 (1C, CL), 127.9 
(1C, Co), 122.3 (1C, C c ) , 120.5 (1C, Cj), 120.0 (1C, CE), 116.4 (1C, C N ) , 117.0 
(q, 1C, T F A C F 3 ) , 56.3, 55.8, 53.2, 51.1 (br, 8C, cyclen C H 2 ) , 49.8 (1C, A r m CH), 
45.6 (1C, C/) , 43.9 (br, 3C, arm and linker C H 2 ) , 22.6, 22.2 (br, 2C, amide arm 
C H 3 ) ; MS (ES+) m/z 805.4 [M + H ] + 100 %; HRMS (ES+) m/z found 805.4029 [M 
+ H]+ C 4 4 H 5 3 0 7 N 8 requires 805.4032. 
Eu(III) complex of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-
methyl]-l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-
10ff-9-oxa-l-aza-anthracene-6-carboxylic acid ( [EuL 4 9 ] 2 + ) 
A solution of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tet-
raaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-10/f-9-oxa-l-aza-anthracene-6-
carboxylic acid (34.8 mg, 0.038 mmol) and E u ( O T f ) 3 . 5 H 2 0 (16.5 mg, 0.023 mmol) 
in MeCN (1 ml) was heated at reflux for 48 h. The resultant yellow solution was 
cooled followed by removal of solvent under reduced pressure. The resultant yellow 
residue was sonicated in D C M (2 x 10 ml) w i th the solid collected each time by 
centrifugation. The isolated complex was made water soluble by the exchange of 
triflate anions for chloride anions using D O W E X 1x8 200-400 mesh CI ion exchange 
resin, as described earlier, to yield the complex as a pale yellow solid (22 mg, 0.020 
mmol, 87 % ) ; MS ( E S + ) m/z 478.1 [2M - 2 H ] 4 + 100 %; HRMS ( E S + ) m/z found 
477.1535 [2M - 2 H ] 4 + C 8 8 H 1 0 2 O 1 4 N 1 6 1 5 1 E u 2 requires 477.1534; A a b s ( H 2 0 ) : 336 nm; 
r ( H 2 o ) : 0-30 ms, r ( D 2 o ) : 0-60 ms; HPLC (solvent system A, 4.6 x 150 mm 4 u.m 
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Phenomenex Synergi Fusion RP 80A analytical column): tR = 8.0 min. 
Solid phase supported Eu(III) complex of 2-[(2-(4,10-bis-[((S)-l-
phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododec-l-yl)-
acetylamino)-methyl]-10-oxo-10ff-9-oxa-l-aza-anthracene-6-carboxylic 
acid 
Eu(III) complex of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-
l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-methyl]-10-oxo-10//-9-oxa-l-aza-
anthracene-6-carboxylic acid (18 mg, 0.016 mmol), TBTU (7 mg, 0.022 mmol) and 
NEt 3 (0.0049 ml, 0.035 mmol) were stirred for 5 min in anhydrous DMF (0.5 ml). N-
Hydroxysuccinimide (2.5 mg, 0.021 mmol) was then added and the yellow solution 
was allowed to stir for 30 min. TentaGel™ S-NH2 (44 mg) was added to the solution 
and the suspension was stirred for 2 h followed by the removal of solvent under 
reduced pressure. The crude resin was washed with H 2 0 ( 2 x 2 ml) and MeOH (2 x 
2 ml), each time the resin was isolated by centrifugation, then dried under reduced 
pressure. Elemental analysis determined Eu(III) content to be 0.64 % or 0.042 mmol 
g _ 1 , this corresponds to 9.3 % derivatization as the resin N H 2 content is stated as 
~0.45 mmol g - 1 . 
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2-Bromomethyl-7-methoxycarbonyl-l-azathioxanthonel 
N 
Br 
7-Methoxycarbonyl-2-methyl-l-azathioxanthone (594 mg, 2.08 mmol) and NBS 
(370 mg, 2.08 mmol) were heated to reflux in CC1 4 (10 ml ) , under argon, followed 
by the addition of dibenzoyl peroxide (5 mg) after 0, 3 and 6 h. After reflux for a 
total of 24 h the bright orange solution was allowed to cool then CCU was removed 
under reduced pressure. The desired mono-brominated product was isolated f rom 
the crude orange residue by column chromatography on silica gel ( D C M wi th 0.05% 
increments of MeOH per 50 ml of solvent) as a fine white powder (125 mg, 0.34 
mmol, 16 % ) ; m.p. 194-196°C ( L i t . 5 4 sublimes 186-190°C); RF ( S i 0 2 , DCM-MeOH, 
96:4) : 0.7; *H-NMR (CDC1 3 , 500 MHz) S 9.23 (d, 1H, J=1.5 Hz, H 0 ) , 8.85 (d, 1H, 
J=8.0 Hz, H / f ) , 8.30 (dd, 1H, 7=8.5, 2.0 Hz, H D ) , 7.74 (d, 1H, J=8.5 Hz, KE), 
7.62 (d, 1H, J=8 .0 Hz, H , ) , 4.61 (s, 2H, H / ) , 4.00 (s, 3H, H ^ ) ; 1 3 C - N M R (CDC1 3 , 
125 MHz, *H decoupled 500 MHz) 6 180.0 (1C, C M ) , 166.2 (1C, C B ) , 161.7 (1C, 
C H ) , 158.1 (1C, C G ) , 142.5 (1C, C F ) , 139.5 (1C, C * ) , 133.3 (1C, C D ) , 131.9 (1C, 
Co), 129.2 (1C, CJV), 129.1 (1C, C c ) , 127.2 (1C, C E ) , 125.8 (1C, C L ) , 122.4 (1C, 
C j ) , 52.9 (1C, CA), 32.5 (1C, C/) ; MS (ES+) m/z 418.1 [M + Na + M e O H ] + 95 
%; HRMS (ES+) m/z found 417.9723 [M + Na + MeOH]+ C 1 6 H i 4 0 4 N 7 9 B r N a 3 2 S 
requires 417.9719. 
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2-Phthalimidomethyl-7-methoxycarbonyl-l-azathioxanthone94 
N 
o o 
2-Bromomethyl-7-methoxycarbonyl-l-azathioxanthone (0.125 g, 0.343 mmol) and 
potassium phthalimide (0.191 g, 1.03 mmol) in D M F (10 ml) were stirred, under ar-
gon, for 12 h at room temperature. The resulting brown product mixture was poured 
onto ice water (200 ml) forming a brown solution containing a yellow oily precip-
itate that was extracted w i t h D C M (5 x 50 ml) . The crude organic extracts were 
combined and dried under reduced pressure yielding the desired product as a crude 
yellow-brown solid. The crude solid was dissolved in boiling ethyl acetate (50 ml) 
then hot filtered, the solution volume was reduced (10 ml) then left to cool to room 
temperature. The desired product precipitated as a crystalline yellow solid that 
was collected by f i l t ra t ion , washed wi th cold ethyl acetate (3 ml) , then dried under 
reduced pressure (0.136 g, 0.316 mmol, 92 % ) ; m.p. 246-247°C; X H - N M R (CDC1 3 , 
500 MHz) 8 9.19 (d, 1H, J=2 .0 Hz, H 0 ) , 8.79 (d, 1H, J=8 .0 Hz, HK), 8.26 (dd, 1H, 
7=8.5, 2.0 Hz, ED), 7.93 (dd, 2H, J=5.5, 3.0 Hz, HR), 7.79 (dd, 2H, J=5.5, 3.0 
Hz, H s ) , 7.65 (d, 1H, J=8.5 Hz, H E ) , 7.40 (d, 1H, J=8.0 Hz, H j ) , 5.13 (s, 2H, H 7 ) , 
3.98 (s, 3H, H ^ ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, J H decoupled 500 MHz) 5 180.1 (1C, 
C M ) , 168.3 (2C, C P ) , 166.2 (1C, C s ) , 160.5 (1C, C H ) , 158.3 (1C, C G ) , 142.7 (1C, 
CF), 139.1 (1C, C * ) , 134.7 (2C, C s ) , 133.2 (1C, CD), 132.4 (2C, C Q ) , 131.8 (1C, 
Co), 129.1 (2C, C C l N ) , 127.1 (1C, CE), 125.7 (1C, CL), 124.1 (2C, CR), 120.1 (1C, 
Cj), 52.9 (1C, CA), 43.1 (1C, C/) ; MS ( M A L D I , pencil matr ix, FTMS+) m/z 430.9 
[M + H ] + , 452.9 [ M + N a ] + ; HRMS ( M A L D I , pencil matr ix, FTMS+) m/z found 
431.0700 [M + H]+ C 2 3 H 1 5 0 5 N 2 3 2 S requires 431.0696; C 2 3 H 1 4 N 2 0 5 S . i C 4 H 8 0 2 (%): 
calcd C 63.86 H 3.47 N 6.29; found C 63.70 H 3.26 N 6.25; Structure confirmed by 
single crystal X-ray diffract ion. 
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2-Aminomethyl-7-methoxycarbonyl-l-azathioxanthone (48) 
o o 
N 
NH 
A solution of 2-phthalimidomethyl-7-methoxycarbonyl-l-azathioxanthone (0.055 
g, 0.128 mmol) and N H 2 N H 2 . H 2 0 (0.5 ml , 10.3 mmol) in D C M : M e O H (3:7, 10 ml) 
was heated at 50°C for 2 h at which point T L C analysis showed all starting 2-
phthalimidomethyl-7-methoxycarbonyl-l-azathioxanthone to have been consumed. 
The clear yellow solution was allowed to cool followed by the addition of cone. 
HCl(aq) un t i l a p H of 2 was reached. The resultant solution containing a white 
precipitate was heated at 60°C for 2 h then allowed to cool to room temperature, 
the solution was filtered followed by the drying of the yellow filtrate under reduced 
pressure to yield a yellow powder. The yellow solid was dissolved in H 2 0 containing 
1 eq. NaOMe then extracted wi th D C M (5 ml) , the organic phase was dried under 
reduced pressure to leave the desired product as a white powder (0.037 g, 0.123 
mmol, 96 % ) ; *H-NMR (CDC1 3., 500 MHz) S 9.21 (d, 1H, 7=2.0 Hz, H 0 ) , 8.78 (d, 
1H, J=8.0 Hz, H,c), 8.27 (dd, 1H, 7=8.0, 1.5 Hz, H D ) , 7.71 (d, 1H, J=8.0 Hz, 
H s ) , 7.47 (d, 1H, 7=8.0 Hz, H / ) , 4.12 (s, 2H, H 7 ) , 3.99 (s, 3H, H ^ ) , 1.78 (s br, 2H, 
N H 2 ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, lE decoupled 500 MHz) 5 180.3 (1C, C M ) , 167.4 
(1C, C ^ ) , 166.3 (1C, C B ) , 158.1 (1C, C G ) , 142.7 (1C, CF), 138.7 (1C, C^ ) , 133.1 
(1C, CD), 131.8 (1C, Co), 129.2 (1C, C N ) , 129.0 (1C, C c ) , 127.1 (1C, CE), 125.3 
(1C, C L ) , 120.4 (1C, C j ) , 52.8 (1C, CA), 48.0 (1C, C/) ; MS (ES+) m/z 301.0 [M + 
H]+ 100 %; HRMS ( E S + ) m/z found 301.0642 [M + H]+ C 1 5 H 1 3 0 3 N 2 3 2 S requires 
301.0641. 
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2-[(2-(7-iert-Butoxycarbonyl-4,10-bis-[((S)-l-phenyI-ethyIcarbamoyI)-
methyl]-l-yl)-acetylamino)-methyl]-5-oxo-5H-[l]benzothiopyrano[2,3-
6]pyridine-7-carboxylic acid methyl ester9 4 
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7-Carboxymethyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetra 
aza-cyclododecane-l-carboxylic acid tert-butyl ester (0.109 g, 0.167 mmol), EDC.HC1 
(0.031 g, 0.162 mmol) , H O B t . H 2 0 (5 mg) and N E t 3 (0.093 ml , 0.668 mmol) in CHC1 3 
(5 ml) were stirred for 45 min at room temperature to form a yellow tinged solu-
tion. 2-Aminomethyl-7-methoxycarbonyl-l-azathioxanthone (0.033 g, 0.110 mmol) 
in CHC1 3 (5 ml) was then added to form a dark yellow solution that was left to 
stir for 12 h at room temperature. The resulting yellow solution was extracted wi th 
HCl ( a q ) (0.025 M , 10 ml) then H 2 0 (5 ml) , the combined aqueous fractions were 
backwashed w i t h CHC1 3 (5 ml) then the combined organic layers were dried under 
reduced pressure to leave the crude product as a yellow-brown foam. The desired 
product was isolated via alumina column chromatography (using a graduated sol-
vent system starting f rom 100% D C M wi th 0 .1% MeOH increments every 50 ml) as 
a pale yellow glassy solid (0.060 g, 0.064 mmol, 58 % ) ; RF (alumina, DCM-MeOH, 
98.5:1.5) : 0.25; J H - N M R (CDC1 3 , 500 MHz) 5 9.14 (s, 1H, H 0 ) , 8.68 (d, 1H, J=8.5 
Hz, HK), 8.22 (dd, 1H, 7=8.5, 1.5 Hz, H D ) , 7.65 (d, 1H, J=8.5 Hz, H ^ ) , 7.15-7.30 
(m, 13H, amide arms Ar , amide arms N H and H j ) , 5.93 (s br, 1H, linker amide NH) , 
5.07 (m, 2H, arm CH) , 4.49 (m, 2H, H 7 ) , 3.94 (s, 3H, HA), 2.40-3.30 (m br, 22H, 
cyclen C H 2 and amide arms C H 2 C O ) , 1.43 (d, 6H, J=7 .0 Hz, amide arms C H 3 ) , 
1.37 (s, 9H, <Bu C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, *H decoupled 500 MHz) 5 179.9 
(1C, C M ) , 170.1 (3C, amide arms and linker C = 0 ) , 166.1 (1C, C B ) , 162.6 (1C, CH), 
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157.8 (1C, CG), 156.1 (1C, 'Boc C = 0 ) , 143.5 (2C br, amide arms A r ( q ) ) , 142.1 (1C, 
C F ) , 138.8 (1C, C K ) , 133.1 (1C, CD), 131.7 (1C, Co) , 129.2 (1C, C N ) , 129.1 (1C, 
C c ) , 128.9, 127.6, 126:5 (IOC, amide arms A r ) , 127.1 (1C, CB), 125.4 (1C, CL), 
120.9 (1C, Cj), 80.2 (1C, *Boc ( q ) ) , 60.0, 58.0, 54.7, 53.6 (8C, cyclen C H 2 ) , 52.8 (1C, 
CA), 49.0 (2C, amide arms CH), 48.7, 48.2 (3C, amide arms and linker C H 2 C O ) , 44.6 
(1C, C/) , 28.8 (3C, *Boc C H 3 ) , 22.0 (2C, amide arms C H 3 ) ; MS (ES+) m/z 935.2 [M 
- I - H ] + 100 %; HRMS (ES+) m/z found 935.4495 [M + H ] + C 5 0 H 6 3 O 8 N 8 3 2 S requires 
935.4484. 
2-[(2-(4,10-Bis-[((S)-l-phenyl-ethylcarbarnoyl)methyl]-l-yl)acetylamino)-
methyl]-5-oxo-5if-[l]benzothiopyrano[2,3-6]pyridine-7-carboxylic acid 
methyl ester ( L 4 4 b ) 9 4 
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2-[(2-(7-teri-Butoxycarbonyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l-
yl)-acetylamino)-methyl]-5-oxo-5/f-[l]benzothiopyrano[2,3-6]pyridine-7-carboxylic 
acid methyl ester (36 mg, 0.038 mmol) in D C M . T F A (1:1, 2 ml) was stirred in a 
sealed flask overnight at room temperature yielding a dark yellow solution. Solvent 
was removed under reduced pressure to yield the T F A salt of the desired product 
as a glassy orange solid in quantitative yield; ^ - N M R ( C D 3 C N , 500 MHz) 6 8.99 
(s, 1H, H 0 ) , 8.67 (d, 1H, 7=8.0 Hz, H * ) , 8.24 (dd, 1H, 7=8.5 Hz 1.5 Hz, H c ) , 7.81 
(d, 1H, 7=8.5 Hz, Hi?), 7.47 (d, 1H, 7=8.0 Hz, H j ) , 7.24-7.34 (m br, 10H, arm A r ) , 
4.88-4.96 (m br, 2H, arm CH), 4.57 (m br, 2H, H / ) , 3.95 (s, 3H, KA), 2.91-3.57 (m br, 
22H, cyclen, arm and linker C H 2 ) , 1.40 (d, 6H, 7=7.0 Hz, amide arms C H 3 ) ; 1 3 C -
N M R ( C D 3 C N , 125 MHz, J H decoupled 500 MHz) 6 180.5 (1C, C M ) , 171.3 (1C, 
linker arm C = 0 ) , 170.9, 170.4 (2C, amide arm C = 0 ) , 166.6 (1C, CB), 162.9 (1C, 
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C H ) , 160.3 (q, 1C, T F A C = 0 ) , 158.3 (1C, C G ) , 144.8, 144.5 (2C, arm A r ( q ) ) , 142.9 
(1C, C F ) 139.1 (1C, C K ) , 133.6 (1C, CD), 131.3 (1C, C0), 129.8, 129.7 (2C, C C 
and CAT) 129.4, 127.9, 126.9 (10C, arm A r ) , 128.2 (1C, CB), 126.1 (1C, C L ) , 121.3 
(1C, Cj), 116.9 (q, 1C, T F A C F 3 ) , 55.5, 51.0, 50.0 (br, 8C, cyclen C H 2 ) , 53.2 (1C, 
C A ) , 49.8 (br, 2C, arm CH), 45.6 (1C, C/) , 43.7 (br, 3C, arm and linker C H 2 ) , 22.7, 
22.6 (br, 2C, amide arm C H 3 ) ; MS (ES+) m/z 835.4 [M + H]+ 25 %; HRMS (ES+) 
m/z found 835.3959 [M + H ] + C 4 5 H 5 5 0 6 N 8 3 2 S requires 835.3960. 
Eu(III) complex of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)methyl]-
l-yl)acetylamino)-methyl]-5-oxo-5if-[l]benzothiopyrano[2,3-6]pyridine-7-
carboxylic acid methyl ester ( [ E u L 4 4 b ] 3 + ) 9 4 
A solution of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)methyl]l-yl)acetyla-
mino)-methyl]-5-oxo-5i/-[l]benzothiopyrano[2,3-6]pyridine-7-carboxylic acid methyl 
ester (43 mg, 0.051 mmol) and E u ( O T f ) 3 . 6 H 2 0 (21 mg, 0.030 mmol) in MeCN (1.5 
ml) was heated at reflux under argon, in a Schlenk tube, for 48 h. Solvent was 
removed under reduced pressure to leave a yellow glassy solid. Dichloromethane 
(5 ml) was added to the solid which was sonicated for 5 min, solvent was then 
decanted to leave a orange residue. The sonication process was repeated followed 
by drying of the remaining residue, under reduced pressure, to yield the trifiate salt 
of the desired product as a fine yellow coloured powder (36 mg, 0.025 mmol, 83 
% ) . The solid was made water soluble by the exchange of tr i f iate anions for chloride 
anions using D O W E X 1x8 200-400 mesh CI ion exchange resin, as described earlier, 
to yield the du l l yellow coloured complex in quantitative yield; 1 H - N M R (as t r i -
3+ 3Cf 
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chloride salt, D 2 0 , 500 MHz, partial data and assignment) 5 24.7 (1H, NH) , 16.6 
(1H, H ^ ) , 16.2 (1H, Ha,,), 13.7 (1H, H ^ ) , 11.5 (1H, H ^ ) ; MS (ES+) m/z 515.3 
[M + H C 0 2 ] 2 + 50 %; HRMS (ES+) m/z found 1043.3146 [M + C H 3 C 0 2 - H]+ 
C 4 7H560 8 N8 3 2 S 1 5 1 Eu requires 1043.3135; A a b s ( H 2 0 ) : 372 nm; r ( H 2 o ) : 0.33 ms, r ( D 2 0 ) : 
0.65 ms; HPLC (solvent system A, 4.6 x 150 m m 4 (j.m Phenomenex Synergi Fusion 
RP 80A analytical column): t R = 9.7 min. 
Gd(III) complex of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)methyl]-
l-yl)acetylamino)-methyl]-5-oxo-5i?'-[l]benzothiopyrano[2,3-6]pyridine-7-
carboxylic acid methyl ester ( [ G d L 4 4 b ] 3 + ) 9 2 
A solution of 2-[(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)methyl]l-yl)acetyla-
mino)-methyl]-5-oxo-5/^-[l]benzothiopyrano[2,3-6]pyridine-7-carboxylic acid methyl 
ester (13 mg, 0.016 mmol) and G d ( O A c ) 3 . 4 H 2 0 (4 mg, 0.012 mmol) in M e O H : H 2 0 
(1:1, 1 ml) was heated at reflux under argon for 48 h. The solution was allowed to cool 
then solvent removed under reduced pressure. The residue was redissolved in water 
(2 ml) , filtered then dried under reduced pressure leaving the desired complex as a 
pale yellow solid (11 mg, 0.009 mmol, 56 % ) ; MS (ES+) m/z 525.5 [M + C H 3 C 0 2 ] 2 + 
100 %; HRMS (ES+) m/z found 1050.3180 [M + C H 3 C 0 2 - H]+ C 4 7 H 5 6 0 8 N 8 3 2 S G d 
requires 1050.3198; A a b s ( H 2 0 ) : 375 nm; HPLC (solvent system A, 4.6 x 150 mm 4 
urn Phenomenex Synergi Polar-RP 80A analytical column): t R = 18.8 min. 
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2-(7-ieri-Butoxycarbonyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-
methyl]-l-ylmethyl)-5-oxo-5if-[l]benzothiopyrano[2,3-6]pyridine-7-
carboxylic acid methyl ester 9 2 
Q 
HN 
X, N N . IN M . 
N 
N M N 
0 
B X OMe NH 
b 
4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododeca-
ne-l-carboxylic acid fer£-butyl ester (77 mg, 0.130 mmol) , 2-bromomethyl-7-methox-
ycarbonyl-l-azathioxanthone (47 mg, 0.129 mmol) and K 2 C O 3 (18 mg, 0.130 mmol) 
in dry MeCN (5 ml) were heated at reflux, under argon, for 12 h. The resultant 
yellow mixture was dried under reduced pressure, the residue taken up in D C M (5 
ml) then extracted w i t h H C l ( a q ) (0.05 M , 10 ml) then H 2 0 (2 x 10 ml) . The organic 
phase was dried under reduced pressure followed by isolation of the desired product 
f rom the yellow residue by column chromatography (alumina using a D C M / M e O H 
solvent system starting f rom 100 % D C M then increasing the volume of MeOH by 0.1 
% every 100 ml thereafter) to yield the desired product as a clear yellow glassy solid 
(100 mg, 0.114 mmol, 88 % ) ; m.p. 56-58°C; RF (Alumina, D C M - M e O H , 98.5:1.5) : 
0.33; 2 H - N M R (CDC1 3 , 500 MHz) 6 9.24 (d, 1H, J=1.5 Hz, H 0 ) , 8.66 (d, 1H, 7=8.5 
Hz, H / f ) , 8.32 (dd, 1H, 7=8.0, 1.5 Hz, H D ) , 7.73 (d, 1H, 7=8.5 Hz, H E ) , 7.64 (br, 
1H, amide arm N H ) , 7.36 (br, 1H, amide arm N H ) , 7.31 (d, 1H, 7=8.5 Hz, Uj), 
7.19-7.28 (m, 10H, amide arms A r ) , 5.17 (m, 2H, amide arms CH) , 4.02 (s, 3H, HA), 
3.58 (m, 2H, H / ) , 2.41-3.48 (br m, 20H, cyclen and amide arms C H 2 ) , 1-48 (m, 15H, 
amide arms and f B u C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, : H decoupled 500 MHz) 
5 179.8 (1C, C M ) , 170.4, 169.9 (2C, amide arms C = 0 ) , 165.9 (1C, C B ) , 163.8 (1C, 
CH), 157.7 (1C, CG), 155.9 (1C, ' B u C = 0 ) , 143.5, 142.6 (2C, amide arms A r ( q ) ) , 
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142.1 (1C, C F ) , 138.1 (1C, C K ) , 132.9 (1C, CD), 131.5 (1C, C 0 ) , 128.9, 128.8 (2C, 
Cyv.c), 126.8 (1C, CE), 128.5, 127.2, 126.5, 126.3 (IOC, amide arms A r ) , 125.0 (1C, 
C L ) , 121.7 (1C, Cj), 80.0 (1C, f B u ( q ) ) , 60.2 (2C, amide arms C H 2 ) , 59.2 (1C, C/) , 
54.1-52.9 (8C, cyclen C H 2 ) , 52.6 (1C, C „ ) , 48.1, 47.9, 47.6 (2C, amide arms CH), 
28.6 (3C, ' B u C H 3 ) , 21.6, 20.9 (2C, amide arms C H 3 ) ; MS ( E S + ) m/z 877.9 [M + 
H ] + 100 %, 899.9 [M + N a ] + 40 %. HRMS (ES+) m/z found 878.4266 [M + H ] + 
C 4 8 H 6 o 0 7 N 7 3 2 S requires 878.4270. 
2-(4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l-ylmethyl)-5-oxo-
5i/-[l]benzothiopyrano[2,3-6]pyridine-7-carboxylic acid methyl ester 
( L 5 1 b ) 9 2 
N N 
,N N 
2-(7-^e7i-Butoxycarbonyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l-yl-
methyl)-5-oxo-5i/-[l]benzothiopyrano[2,3-6]pyridine-7-carboxylic acid methyl ester 
(0.100 g, 0.114 mmol) was dissolved in D C M : T F A (1:1, 2 ml) then stirred overnight 
in a stoppered flask to yield a bright yellow solution. The solution was dried under 
reduced pressure to yield the desired product, as a glassy yellow solid, in quantitative 
yield; a H - N M R ( C D 3 C N , 500 MHz) 5 8.81 (d, 1H, J=2.0 Hz, H 0 ) , 8.50 (d, 1H, J=8.5 
Hz, H t f ) , 8.06 (dd, 1H, J=8.5, 2.0 Hz, H D ) , 7.51 (d, 1H, J=8.5 Hz, H £ ) , 7.24 (d, 
1H, J=8.0 Hz, H , ) , 6.92-7.08 (m, 10H, amide arms A r ) , 4.71 (m, 1H, amide arm 
CH), 4.63 (m, 1H, amide arm CH), 4.24 (m, 2H, H 7 ) , 3.80 (s, 3H, H ^ ) , 2.77-3.60 (br 
m, 20H, cyclen and amide arms C H 2 ) , 1.16 (m, 6H, amide arms C H 3 ) ; 1 3 C - N M R 
( C D 3 C N , 125 MHz, a H decoupled 500 MHz) 5 180.2 (1C, C M ) , 171.5, 170.4 (2C, 
amide arms C = 0 ) , 166.6 (1C, C B ) , 160.4 (q, 1C, T F A C = 0 ) , 158.3 (1C, CH), 156.3 
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(1C, C G ) , 144.5, 144.4 (2C, amide arms A r ( q ) ) , 142.5 (1C, C F ) , 139.7 (1C, C * ) . 
133.9 (1C, C D ) , 131.4 (1C, C 0 ) , 130.1 (2C, C N i C ) , 128.2 (1C, CJS) , 129.4, 128.0, 
126.7 (10C, amide arms A r ) , 127.0 (1C, CL), 123.7 (1C, Cj), 116.9 (q, 1C, TFA 
C F 3 ) , 57.8 (2C, amide arms C H 2 ) , 55.6 (1C, C 7 ) , 43.9, 50.7, 51.1, 52.8, 53.6 (8C, 
cyclen C H 2 ) , 53.2 (1C, CA), 50.2, 49.7 (2C, amide arms CH) , 22.5, 22.4 (2C, amide 
arms C H 3 ) ; MS ( E S + ) m/z 778.7 [M + H]+ 100 %, 800.7 [M + N a ] + 15 %. HRMS 
(ES+) m/z found 778.3740 [M + H ] + a i 3 H 5 2 0 5 N 7 3 2 S requires 778.3745. 
Eu(III) complex of 2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l-
ylmethyl)-5-oxo-5if-[l]benzothiopyrano[2,3-6]pyridine-7-carboxylic acid 
methyl ester ( [ E u L 5 1 b ] 3 + ) 9 2 
3+ 3CI Ph 
N H 
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A solution of 2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l-ylmethyl)-5-
oxo-5#-[l]benzothiopyrano[2,3-6]pyridine-7-carboxylic acid methyl ester (15.4 mg, 
0.020 mmol) and E u ( O T f ) 3 . 6 H 2 0 (13.4 mg, 0.019 mmol) i n MeCN (1 ml) was heated 
at 70°C for 72 h. The resultant orange solution was dried under reduced pressure to 
yield a glassy orange solid that was sonicated in D C M (5 ml) followed by decanting 
of the solvent. The remaining solid was further sonicated in D C M (5 ml) followed 
by decanting of the solvent to yield a orange solid that was dried under reduced 
pressure. The solid was made water soluble by the exchange of triflate anions for 
chloride anions using D O W E X 1x8 200-400 mesh CI ion exchange resin, as described 
earlier, to yield the complex as a orange solid (15.5 mg, 0.015 mmol, 79 % ) ; ^ - N M R 
(as tri-chloride salt, D 2 0 , 700 MHz) 8 Broadened resonances between +43 and -21 
ppm; MS ( E S + ) m/z 1048.3 [M + 2 C H 3 C 0 2 ] + 100 %; HRMS (ES+) m/z found 
1048.3126 [M + 2 C H 3 C 0 2 ] + C 4 7 H 5 7 0 9 N 7 1 5 3 E u 3 2 S requires 1048.3145; A a b s ( H 2 0 ) : 
168 
375 nm; T( H 2 o) : 0.32 ms, T( D 2 o) : 0.62 ms; HPLC (solvent system A, 4.6 x 150 mm 
4 yim Phenomenex Synergi Fusion RP 80A analytical column): tR = 9.9 min. 
2-(7-iert-Butoxycarbonyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-
methyl]-l,4,7,10-tetraaza-cyclododec-l-ylmethyl)-10-oxo-10if-9-oxa-
l-aza-anthracene-6-carboxylic acid methyl ester 9 2 
4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododeca-
ne-l-carboxylic acid ie r i -buty l ester (56 mg, 0.094 mmol) , 7-methoxycarbonyl-2-
bromomethyl-l-azaxanthone (33 mg, 0.095 mmol) and K2CO3 (13 mg, 0.094 mmol) 
in dry MeCN (2 ml) were heated at reflux, under argon, for 12 h. The resultant 
orange mixture was dried under reduced pressure, the residue taken up in D C M 
(10 ml) then extracted w i t h H 2 0 (2 x 10 ml) . The organic phase was dried under 
reduced pressure followed by isolation of the desired product f rom the yellow residue 
by column chromatography (alumina using a D C M / M e O H solvent system starting 
from 100 % D C M then increasing the volume of MeOH by 0.1 % every 100 ml 
thereafter) to yield the desired product as a clear yellow glassy solid (62 mg, 0.072 
mmol, 77 % ) ; m.p. 84-86°C; RF (Alumina, D C M - M e O H , 97.5:2.5) : 0.51; X H - N M R 
( C D C I 3 , 700 MHz) 8 8.99 (d, 1H, J=2.0 Hz, H 0 ) , 8.48 (d, 1H, J=7.5 Hz, H ^ ) , 8.42 
(dd, 1H, J=8.5, 2.0 Hz, HD), 7.64 (d, 1H, J=8.5 Hz, KE), 7.64 (br, 1H, amide arm 
NH) , 7.31 (br, 1H, amide arm N H ) , 7.14-7.27 (m, 11H, amide arms Ar and H j ) , 5.16 
(m, 2H, amide arms CH) , 3.98 (s, 3H, H ^ ) , 3.57 (m, 2H, H , ) , 3.41 (br, 4H, amide 
arms C H 2 ) , 2.40-3.13 (br m, 16H, cyclen C H 2 ) , 1.43-1.48 (m, 15H, amide arms and 
4 B u C H 3 ) ; 1 3 C - N M R (CDC1 3 , 175 MHz, X H decoupled 700 MHz) 5 176.9 (1C, C M ) , 
Q 
HN O 
N 
N N 
o 
B 
X O M e NH 
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170.4, 170.1 (2C, amide arms C = 0 ) , 165.9 (1C, C s ) , 165.4 (1C, CH), 160.0 (1C, 
C G ) , 158.5 (1C, CF), 156.3 (1C, <Bu C = 0 ) , 142.8, 143.9 (2C, amide arms A r ( q ) ) , 
137.9 (1C, C K ) , 136.5 (1C, C D ) , 129.5 (1C, C 0 ) , 127.3 (1C, C c ) , 129.0, 128.8, 126.8, 
126.5 (10C, amide arms A r ) , 121.7 (1C, C N ) , 121.1 (1C, C , ) , 119.2 (1C, CE), 115.6 
(1C, C L ) , 80.3 (1C, ' B u ( q ) ) , 60.6 (2C, amide arms C H 2 ) , 59.7 (1C, C 7 ) , 54.6-53.4 
(8C, cyclen C H 2 ) , 52.9 (1C, CA), 48.5 (2C, amide arms CH), 28.9 (3C, f B u C H 3 ) , 
22.0, 21.3 (2C, amide arms C H 3 ) ; MS ( E S + ) m/z 862.4 [M + H]+ 100 %. HRMS 
(ES+) m/z found 862.4503 [M + H ] + C 4 8 H 6 o 0 8 N 7 requires 862.4498. 
2-(4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododec-l-ylmethyl)-10-oxo-10ff-9-oxa-l-azaanthracene-6-carboxylic 
acid methyl ester ( L 5 1 a ) 9 2 
2-(7-ierf-Butoxycarbonyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-
1,4,7,10-tetraaza-cyclododec-l-ylmethyl)-10-oxo-10//'-9-oxa-l-aza-anthracene-6-car-
boxylic acid methyl ester (25 mg, 0.029 mmol) was dissolved in D C M : T F A (1:1, 2 
ml) then stirred for 12 h in a stoppered flask to yield a bright yellow solution. The 
solution was dried under reduced pressure to yield the desired product, as a glassy 
yellow solid, i n quantitative yield; ^ - N M R ( C D 3 C N , 700 MHz) 6 8.74 (d, 1H, J=2.0 
Hz, H 0 ) , 8.58 (d, 1H, J=8.5 Hz, H * ) , 8.28 (dd, 1H, J=8.5, 2.0 Hz, U D ) , 7.52 (d, 
1H, J=9.0 Hz, H E ) , 7.31 (d, 1H, J=7.5 Hz, H / ) , 7.03-7.27 (m, 12H, amide arms 
Ar and NH) , 4.81 (m, 1H, amide arm CH), 4.75 (m, 1H, amide arm CH), 4.35 (m, 
2H, H 7 ) , 3.94 (s, 3H, H ^ ) , 2.94-3.80 (br m, 20H, cyclen and amide arms C H 2 ) , 1.26 
(d, 6H, J=6 .5 Hz, amide arms C H 3 ) ; 1 3 C - N M R ( C D 3 C N , 175 MHz, : H decoupled 
HN 
N M N 
X 
H \ I 
B 
O M e NH 
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700 MHz) 5 177.2 (1C, C m ) , 171.5, 170.5 (20, amide arms 0 = 0 ) , 166.2 (10, CB), 
160.3 (q, 10, T F A C = 0 ) , 158.8 (10, C G ) , 156.8 (20, C H , F ) , 144.6, 144.3 (20, amide 
arms A r ( q ) ) , 139.4 (10, C K ) , 136.9 (10, CD), 128.9 (10, 0 o ) , 128.1 (10, C c ) , 129.4, 
129.2, 127.8, 126.9, 126.7 (IOC, amide arms A r ) , 122.8 (10, C j ) , 122.2 (10, C N ) , 
120.1 (1C, C E ) , 117.3 (10, C L ) , 116.9 (q, 1C, TFA C F 3 ) , 57.4 (1C, C/) , 56.5, 55.6 
(20, amide arms C H 2 ) , 43.9, 50.5, 51.2, 53.5 (80, cyclen C H 2 ) , 53.1 (10, CA), 50.1, 
(20, amide arms CH) , 22.5, 22.3 (20, amide arms C H 3 ) ; MS (ES+) m/z 762.3 [M 
+ H]+ 100 %. HRMS (ES+) m/z found 762.3972 [M + H ] + C43H 5 20 6 N 7 requires 
762.3974. 
Eu(III) complex of 2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-
l,4,7,10-tetraaza-cyclododec-l-ylmethyl)-10-oxo-10.ff-9-oxa-l-aza-
anthracene-6-carboxylic acid methyl ester ( [ E u L 5 1 a ] 3 + ) 9 2 
3+ 3CI 
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A solution of 2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-
tetraaza-cyclododec-l-ylmethyl)-10-oxo-10//-9-oxa-l-aza-anthracene-6-carboxylic 
acid methyl ester (16 mg, 0.021 mmol) and E u ( O T f ) 3 . 6 H 2 0 (11 mg, 0.018 mmol) in 
MeCN (1 ml) was heated at 90°C for 48 h. The resultant yellow solution was dried 
under reduced pressure to yield a glassy orange solid that was sonicated in C H C I 3 (5 
ml) followed by decanting of the solvent. The remaining solid was further sonicated 
in C H C I 3 (5 ml) followed by decanting of the solvent to yield a orange solid that was 
dried under reduced pressure. The solid was made water soluble by the exchange of 
tr if late anions for chloride anions using D O W E X 1x8 200-400 mesh CI ion exchange 
resin, as described earlier, to yield the complex as a pale yellow powder (15 mg, 
0.014 mmol, 78 % ) ; ^ - N M R (as tri-chloride salt, D 2 0 , 700 MHz) 5 Broadened 
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resonances between +51 and -21 ppm; MS ( E S + ) m/z 479.9 [M + H C 0 2 ] 2 + 100 %, 
958.3 [M + H C 0 2 - H ] + 70 %• HRMS (ES+) m/z found 956.3007 [M + H C 0 2 - H ] + 
C 4 4 H 5 i 0 8 N 7 1 5 1 E u requires 956.2992; A a b s ( H 2 0 ) : 333 nm; r ( H 2 o ) : 0.26 ms, r ( D 2 o ) : 
0.60 ms; H P L C (solvent system A, 4.6 x 150 mm 4 |a.m Phenomenex Synergi Fusion 
RP 80A analytical column): t R = 10.7 min. 
4,7,10-Tris-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododecane-l-carboxylic acid tert-butyl ester 
> 
HN 
H 
N Ph N 
> N — ' ° 
Y3 <h 
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Ph 
4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododecane-l-carboxylic acid tert-bntyl ester (0.169 g, 0.284 mmol), 2-
chloro-A r-[(S)-l-phenyleth- yljethanamide (0.067 g, 0.339 mmol) and K 2 C 0 3 (0.047 
g, 0.340 mmol) in MeCN (15 ml) were heated at reflux, under argon, for 12 h. 
Solvent was removed under reduced pressure to leave a crude orange coloured 
residue that was dissolved in D C M (10 ml) then washed wi th H 2 0 (2 x 10 ml) . 
The organic phase was dried under reduced pressure, the desired product was then 
isolated by column chromatography on alumina (utilising an incremental solvent 
system of D C M / M e O H starting f rom 100 % D C M w i t h 0.1 % MeOH increments) 
to yield, after drying, the desired product as a glassy colourless solid (0.193 g, 0.255 
mmol, 90 % ) ; RF (Alumina, DCM-MeOH, 49:1) : 0.55; m.p. 59-62°C; J H - N M R 
(CDC1 3 , 500 M H z ) 8 7.26-7.39 (m br, 16H, Ar and amide NH) , 7.03 (br, 1H, amide 
NH), 7.02 (br, 1H, amide NH) , 5.17 (m, 3H, CH) , 2.40-3.30 (m br, 22H, cyclen and 
arm C H 2 ) , 1.45-1.56 (m, 18H, arm and lBu C H 3 ) ; 1 3 C - N M R (CDCI3, 125 MHz, ! H 
decoupled 500 MHz) 5 170.4, 169.9 (3C, amide C = 0 ) , 156.0 (1C, 'BOC C = 0 ) , 
143.9, 143.3 (3C, A r ( q ) ) , 129.0, 128.8, 127.8, 127.4, 126.7, 126.5 (15C, A r ) , 80.1 (1C, 
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'BOC(q)), 53.9 (3C, C H 2 C O ) , 47.9-59.7 (m br, 8C, cyclen C H 2 ) , 48.6 (3C, CH), 28.7 
(3C, f B O C C H 3 ) , 22.1, 21.5 (3C, amide arm C H 3 ) ; MS ( E S + ) m/z 756.3 [M + H]+ 
100 %; HRMS-(ES + ) m/z found 756.4794 [M + H ] + C 4 3 H 6 2 0 5 N 7 requires 756.4807. 
2-(4,7-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododec-l-yl)-7V-((S)-l-phenyl-ethyl)acetamide 
Ph 
H N 
H 
N Ph N 
H 
3 o 
N H 
in 
4,7,10-Tris-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclodode-
cane-l-carboxylic acid tert-buty\ ester (0.109 g, 0.144 mmol) was dissolved in 
D C M : T F A (3 ml , 2:1) then stirred for 2 h in a stoppered flask to yield a yellow 
tinged solution. The solution was dried under reduced pressure to yield the desired 
product as its T F A salt, as a glassy yellow solid, in quantitative yield. Immediately 
prior to further modification the solid was dissolved in D C M (10 ml) and washed 
wi th sat. N a H C 0 3 solution (10 ml) followed by the drying of the organic phase 
under reduced pressure to yield the desired product as its free base; 1 H - N M R 
( C D 3 C N , 500 MHz) 8 7.47 (s br, 1H, NH) , 7.23-7.35 (m br, 17H, Ar and amide 
NH) , 4.97 (m, 3H, CH), 3.78 (m, 2H, arm C H 2 ) , 2.87-3.41 (m br, 20H, cyclen and 
arm C H 2 ) , 1.41 (br, 9H, arm C H 3 ) ; 1 3 C - N M R ( C D 3 C N , 125 MHz, J H decoupled 
500 MHz) 5 171.0, 170.6 (2C, amide C = 0 ) , 163.9 (1C, amide C = 0 ) , 160.3 (q, 1C, 
TFA C = 0 ) , 144.7, 144.5, 144.2 (3C, A r ( q ) ) , 129.6, 129.5, 128.3, 128.1, 127.1, 127.0 
(15C, A r ) , 116.8 (q, 1C, T F A C F 3 ) , 56.3, 55.8, 53.1, 43.8, 43.6 (m br, 11C, cyclen 
and arm C H 2 ) , 50.7, 49.9 (3C, CH) , 22.6, 22.3 (3C, amide arm C H 3 ) ; MS (ES + ) 
m/z 359.7 [M + C u ] 2 + 60 %, 656.3 [M - I - H ] + 100 %; HRMS (ES+) m/z found 
656.4276 [M + H]+ C3BH54O3N7 requires 656.4283. 
173 
4,7,10-Tris-[((S)-l-phenyl-ethylcarbamoyI)-methyI]-l,4,7,10-tetraaza-
cyclododecane-l-carboxylic acid teri-butyl ester 
Ph 
HN 
H 
Ph N N 
3 
NH 
in 
A solution of 2-(4,7-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-
tetraaza-cyclododec-l-yl)-W-((S)-l-phenyl-ethyl)acetamide (338 mg, 0.52 mmol), 
terf-butyl bromoacetate (0.076 ml , 0.51 mmol) and N E t 3 (0.29 ml , 2.08 mmol) in 
MeCN (10 ml) was heated at reflux for 12 h under argon. Af te r 12 h a further 
addition of tert-buty\ bromoacetate (0.3 eq, 0.023 ml) was added to the reaction 
solution and the reaction was allowed to reflux for a further 6 h. The reaction 
was allowed to cool to room temperature, solvent was removed under reduced 
pressure and the residue was taken up in D C M (20 ml) followed by washing of 
the organic solution wi th H 2 0 (20 ml) . The organic phase was collected and dried 
under reduced pressure to leave a crude yellow residue. The desired product was 
isolated by column chromatography on alumina (utilising an incremental solvent 
system of D C M / M e O H starting f rom 100 % D C M w i t h 0.1 % MeOH increments) 
to yield, after drying, the desired product as a glassy colourless solid (0.110 g, 0.143 
mmol, 28 % ) ; RF (Alumina, DCM-MeOH, 95:5) : 0.53; m.p. 53-56°C; l H - N M R 
(CDC1 3 , 700 MHz) 6 7.51 (s br, 1H, NH) , 7.18-7.35 (m br, 17H, A r and amide NH) , 
5.06-5.13 (m br, 3H, CH), 2.50-3.02 (m br, 24H, cyclen and arm C H 2 ) , 1.44-1.50 
(m, 18H, arm and <Bu C H 3 ) ; 1 3 C - N M R (CDCI3, 175 MHz, J H decoupled 700 MHz) 
5 170.4, 170.0 (3C, amide C = 0 ) , 155.6 (1C, f B u C = 0 ) , 143.5 (3C, A r ( q ) ) , 129.1, 
129.0, 127.8, 126.8, 126.7 (15C, A r ) , 81.9 (1C, ' B u ^ ) ) , 59.9, 58.8, 56.2, 54.4, 54.0, 
53.1, 48.6 (m br, 15C, cyclen and arm C H 2 and CH) , 28.5 (3C, 4 B u C H 3 ) , 21.8, 
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21.6 (3C, amide arm C H 3 ) ; MS (ES+) m/z 792.2 [M + N a ] + 100 %; HRMS (ES+) 
m/z found 770.4967 [ M + H ] + C 4 4H640 5 N 7 requires 770.4964. 
(4,7,10-Tris-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododec-l-yl)-acetic acid 
A solution of 4,7,10-tris-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetra-
aza-cyclododecane-l-carboxylic acid tert-buty\ ester (0.11 g, 0.142 mmol) in 
D C M : T F A (3 ml , 2:1) was stirred at room temperature for 3 h. The solution was then 
dried under reduced pressure to leave a glassy yellow solid. The solid was redissolved 
in D C M (10 ml) , the solution washed wi th sat. NaHCOa solution (10 ml) followed by 
the separation and drying of the organic phase under reduced pressure to leave the 
desired product as a glassy colourless solid (0.092 g, 0.129 mmol, 91 % ) ; *H-NMR 
(CDC1 3 ) 500 MHz) 5 8.07 (s br, 2H, NH) , 7.75 (s br, 1H, N H ) , 7.17-7.36 (m, 15H, 
A r ) , 5.04 (m, 3H, CH) , 2.63-3.35 (m br, 24H, cyclen and arm C H 2 ) , 1.45-1.51 (m, 
9H, arm C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, *H decoupled 500 MHz) 5 169.5, 169.2 
(3C, amide C = 0 ) , 144.1, 144.0 (3C, A r ( q ) ) , 128.9, 127.7, 127.5, 126.9, 126.7 (15C, 
A r ) , 58.7 (1C, acid arm C H 2 ) , 57.4, 57.2, 54.1, 52.8, 51.9, 50.0 (m, 11C, cyclen and 
amide arm C H 2 ) , 49.1, 49.0 (3C, CH), 22.2, 22.0 (3C, C H 3 ) ; MS (ES+) m/z 388.9 
[M + C u ] + 100 %, 714.5 [M + H]+ 25 %; HRMS (ES+) m/z found 714.4333 [M + 
H]+ C 4 o H 5 6 0 5 N 7 requires 714.4337. 
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10-Oxo-2-[(2-(4,7,10-tris-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-
l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-methyl]-10/f-9-oxa-l-
aza-anthracene-6-carboxylic acid methyl ester ( L 5 0 ) 
Ph 
) HI 
HN O 
O N 
H 
N N 
0 
Ph 
3 H 
N H 
i i 
Ph 
T B T U (34 mg, 0.106 mmol) and H O B t . x H 2 0 (2 mg, 0.015 mmol) were added 
to a st irring solution of (4,7,10-tris-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-
tetraaza-cyclododec-l-yl)-acetic acid (76 mg, 0.106 mmol) and N E t 3 (0.03 ml , 
0.215 mmol) in anhydrous MeCN (1 ml) and allowed to stir for 15 min. A solu-
tion of 7-methoxycarbonyl-2-aminomethyl-l-azaxanthone (24 mg, 0.084 mmol) in 
MeCN:CHCl3 (1.5 ml , 1:0.5) was added to the solution and the reaction was allowed 
to stir, under argon, for 16 h. The dark orange solution was then dried under reduced 
pressure, taken up in D C M (10 ml) and washed w i t h sat. N a H C 0 3 (10 ml) , HCl(aq) 
(0.1 M , 10 ml) then H 2 0 (10 ml) . The organic phase was separated then dried un-
der reduced pressure. The desired product was isolated by column chromatography 
on alumina (utilising an incremental solvent system of D C M / M e O H starting f rom 
100 % D C M w i t h 0.1 % MeOH increments) to yield, after drying, the product as 
a orange colourless solid. A remaining contaminant was removed by sonication of 
the solid w i t h benzene followed by the decanting of the solvent and drying of the 
remaining solid to yield a glassy orange material (40 mg, 0.041 mmol, 49 % ) ; Rp 
(Alumina, D C M - M e O H , 24:1) : 0.43; m.p. 75-77°C; ! H - N M R (CDC1 3 , 700 MHz) 5 
8.96 (d, 1H, .7=1.5 Hz, H 0 ) , 8.57 (d, 1H, J=8.5 Hz, H*-), 8.37 (d, 1H, J=8.5 Hz, 
H D ) , 8.23 (s br, 1H, arm N H ) , 7.56 (d, 1H, J=8.5 Hz, HE), 6.98-7.36 (m br, 19H, 
arm Ar , H j and amide N H ) , 5.05-5.09 (m br, 3H, arm CH), 4.50 (m, 2H, H 7 ) , 3.98 
(s, 3H, HA), 2.60-3.05 (m br, 24H, cyclen, arm and linker C H 2 ) , 1.42-1.47 (m, 9H, 
176 
arm C H 3 ) ; 1 3 C- .NMR (CDC1 3 , 175 MHz, X H decoupled 700 MHz) 6 176.9 (1C, C M ) , 
171.9, 170.0 (4C, amide arm C = 0 and linker arm C = 0 ) , 165.9 (1C, C B ) , 164.8 
(1C, C H ) , 160.2 (1C, CG), 158.4 (1C, C F ) , 143.6, 143.3 (3C, arm A r ( q ) ) , 138.2 (1C, 
C K ) , 136.4 (1C, C D ) , 129.5 ( 1 C , C 0 ) , 129.0, 128.9, 128.8, 128.7, 127.8, 126.7, 126.6, 
126.5 (15C, arm A r ) , 127.2 (1C, C N ) , 121.7 (1C, C c ) , 120.1 (1C, Cj), 119.1 (1C, 
CE), 115.6 (1C, C L ) , 59.8, 59.7, 59.2, 53.8, 53.6 (br, 12C, cyclen, arm and linker 
C H 2 ) , 52.9 (1C, C m ) , 48.7 (br, 3C, arm CH), 44.9 (1C, C/) , 21.9 (br, 3C, amide arm 
C H 3 ) ; MS ( E S + ) m/z 980.9 [M + H]+ 100 %; HRMS (ES+) m/z found 980.5037 [M 
+ H]+ C 5 5 H 6 6 0 8 N 9 requires 980.5029. 
Eu(III) complex of 10-Oxo-2-[(2-(4,7,10-tris-[((S)-l-phenyl-ethyI-
carbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-
methyl]-10if-9-oxa-l-aza-anthracene-6-carboxyIic acid methyl ester 
([EuL 5 0] 3+) 
10-Oxo-2-[(2-(4,7,10-tris-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraa-
za-cyclododec-l-yl)-acetylamino)-methyl]-10fl r-9-oxa-l-aza-anthracene-6-carboxylic 
acid methyl ester (14 mg, 0.014 mmol) and E u ( O T f ) 3 (8 mg, 0.013 mmol) in MeCN 
(1 ml) were heated at reflux for 24 h. The solution was then dried under reduced 
pressure and the residue sonicated in D C M (10 ml) followed by centrifugation to 
isolate the solid, this washing procedure was repeated twice. The dried isolated solid 
was made water soluble by the exchange of the tr if late anions for chloride anions 
using ' D O W E X 1x8 200-400 mesh CI ' ion exchange resin, as described previously, 
3+ 3CI 
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to yield the desired complex as its trichloride salt as a white powder (11 mg, 0.009 
mmol, 69 % ) ; ! H - N M R ( D 2 0 , 500 MHz, partial data and assignment) 5 28.1 (1H, 
H ^ ) , 26.6 (1H, H ^ ) , 26.3 (1H, H^. ) , 25.4 (1H, H „ ) , 8.5 (2H), 8.4 (1H), 7.9 (1H), 
7.6 (1H), further resonances between 5.5 and -14.8 ppm; MS ( E S + ) m/z 588.7 [M 
+ H C 0 2 ] 2 + 55 %, 1130.4 [M - 2H]+ 5 %, 1175.8 [M - H + H C 0 2 ] + 5 %; HRMS 
(ES+) m/z found 376.8047 [ M ] 3 + C 5 5 H 6 5 0 8 N 9 1 5 1 E u requires 376.8046. A a b s ( H 2 0 ) : 
332 nm; T ( H 2 O ) : 0-58 ms, r^D2oy. 2.27 ms; HPLC (solvent system A, 4.6 x 150 mm 
4 p m Phenomenex Synergi Polar-RP 80A analytical column): tR = 12.0 min. 
5.2.2 Dimeric complexes and precursors 
Bis-7-[(lS,2S)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-bis-[((S)-l-
phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane-l-
carboxylic acid tert-buty\ ester 
Ph Ph 
NH NH 
3 H n N 
> "1 S T Y ? ~ 
N Ph N 
H 
HN HN 
Ph Ph 
7-Carboxymethyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetra 
aza-cyclododecane-l-carboxylic acid tert-butyl ester (0.166 g, 0.254 mmol), 
EDC.HC1 (0.054 g, 0.282 mmol) , H O B t . x H 2 0 (10 mg) and N E t 3 (0.1 ml , 0.717 
mmol) in CHCI3 (5 ml) were stirred at room temperature. Af te r 25 min ( l5 ,25)- ( - ) -
1,2-diphenylethylen- ediamine (0.024 g, 0.113 mmol) was added to the solution which 
was stirred for a further 10 h then extracted wi th sat. NaHC03(aq) (10 ml) followed 
by H 2 0 (10 ml ) . The clear organic solution was dried under reduced pressure then 
purified by column chromatography (alumina using a D C M / M e O H solvent system 
starting f rom 100 % D C M then increasing the volume of MeOH by 0.5 % every 50 
ml thereafter) to yield the desired product as a clear glassy solid (0.126 g, 0.085 
mmol, 75 % ) ; RF (Alumina, DCM-MeOH, 99:1) : 0.80; m.p. 89-91°C; X H - N M R 
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(CDC1 3 , 400 MHz) 5 9.82 (s br, 1H, NH) , 9.08 (s br, 1H, NH) , 7.88 (s br, 4H, arm 
N H ) , 7.18-7.28 (m br, 30H, arm and linker Ar protons), 5.39 and 5.53 (s br, 2H, 
linker CH) , 5.01 (s br, 4H, arm CH), 2.03-3.30 (m br, 44H, cyclen C H 2 , amide arm 
C H 2 C O and linker C H 2 C O ) , 1.39 (m br, 30H, amide arm C H 3 and *Bu C H 3 ) ; 1 3 C -
N M R (CDC1 3 , 100 MHz, X H decoupled 400 MHz) 5 170.8 (m br, 6C, amide arms 
C = 0 and linker C = 0 ) , 156.1 (2C, *Boc C = 0 ) , 143.6 (6C, amide arms and linker 
P h ( q ) ) , 128.9, 127.6, 126.6 (br, 30C, amide arm and linker Ph), 80.0 (2C, ' B o c ( q ) ) , 
46.9-62.6 (br, 24C, cyclen C H 2 , amide arm C H 2 , linker C H 2 and linker stereocentre 
C), 28.7 (6C, <Boc C H 3 ) , 22.3 (4C, amide arm C H 3 ) . MS (ES~) m/z 1480.4 [M -
H ] " 35 %, 1517.5 [M + C I ] - 50 %; HRMS ( E S + ) m/z found 1481.9108 [M + H]+ 
C B 4 Hii70ioN 1 4 requires 1481.9072. 
Bis-7-[(lS,2S)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-bis-[((S)-l-
phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane ( L 5 7 ) 
A colourless solution of bis-7-[(lS,2S)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-
bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane-l-carb-
oxylic acid te r i -buty l ester (0.093 g, 0.063 mmol) in D C M : T F A (50:50, 5 ml) was 
stirred for 12 h in a sealed flask. The resultant yellow tinged solution was dried under 
reduced pressure to yield the TFA salt of the desired product, as a glassy yellow 
solid, in quantitative yield; J H - N M R ( C D 3 C N , 500 MHz) S 9.77 (d, 2H, J=9.5 Hz, 
cyclen N H ) , 7.77 (s br, 4H, arm NH) , 7.04-7.48 (m, 30H, arm and linker A r ) , 5.67 
(d, 2H, J=9 .0 Hz, linker CH) , 5.05 (m, 2H, arm CH), 4.69 (m, 2H, arm CH), 3.92 
(d, 2H, .7=15.5 Hz, linker C H 2 ) , 3.71 (d, 2H, J=15.5 Hz, linker C H 2 ) , 2.62-3.29 
(m, 40H. cyclen C H 2 and arm C H 2 ) , 1.46 (d, 6H, J=7.0 Hz, arm C H 3 ) , 1.24 (d, 6H, 
Ph Ph 
NH NH 
3 H n N Ph N H 
N N Ph H N 
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J=7.0 Hz, arm C H 3 ) ; 1 3 C - N M R ( C D 3 C N , 125 MHz, »H decoupled 500 MHz) 6 170.7 
(4C, arms C = 0 ) , 164.4 (2C, linker C = 0 ) , 160.4 (q, 2C, T F A C = 0 ) , 144.7, 144.4 
(4C, arm A r ( q ) ) , 139.8 (2C, linker A r ( q ) ) , 129.7, 129.5, 129.3, 128.8, 2 x 128.0, 127.1, 
127.0 (30C, arm and linker A r ) , 115.7 (q, 2C, TFA C F 3 ) , 58.7 (2C, linker CH), 56.7, 
55.9, 53.0, 52.3, 51.8, 50.8, 49.1, 48.4 (16C, cyclen C H 2 ) , 55.4 (2C, linker C H 2 ) , 
49.8, 49.7 (4C, arm CH), 43.8, 43.7 (4C, arm C H 2 ) , 22.6, 22.1 (4C, arm C H 3 ) . MS 
(ES+) m/z 641.4 [M + 2 H ] 2 + 100 %; HRMS (ES+) m/z found 641.4055 [M + 2 H ] 2 + 
C74Hio20 6 N 1 4 requires 641.4048. 
Eu(III) complex of bis-7-[(lS,2S)-l,2-diphenyl-ethylcarbamoyl]-methyl-
4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododecane ( [ E u 2 L 5 7 ] 6 + ) 
Bis-7-[(lS,2S)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-bis-[((S)-l-phenyl-
ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane as its TFA salt (0.082 g, 
0.064 mmol, molar mass of ligand as its free base used) and Eu(OTf ) 3 (0.230 g, 0.384 
mmol) in dry MeCN (1.75 ml) were heated at reflux for 36 h, in Schlenk apparatus, 
under an atmosphere of argon. The solution was then cooled to room temperature 
followed by removal of the solvent under reduced pressure. The solid was sonicated 
in D C M ( 2 x 5 ml) followed by solid collection by centrifugation and decanting of 
the D C M phase, the solid was dried under reduced pressure. The grey solid left was 
sonicated in water (5 ml) , the water was then decanted followed by the drying of the 
remaining solid under reduced pressure. The solid was made water soluble by the 
exchange of the t r i f la te anions for chloride anions using ' D O W E X 1x8 200-400 mesh 
CI ' ion exchange resin (0.2 g) as described earlier. The crude complex was isolated 
6+ 6CI 
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f rom excess E u C l 3 using benzoylated dialysis tubing, as described earlier, to yield 
the desired product as a white powder (0.089 g, 0.047 mmol, 74 % ) ; MS (ES + in the 
presence of excess ammonium acetate) m/z 567.1 [M + 2 C H 3 C 0 2 - H ] 3 + 95 %, 850.2 
[M + 2 C H 3 C 0 2 - 2 H ] 2 + 100%; HRMS ( E S + ) m/z found 849.3217 [M + 2 C H 3 C 0 2 -
2H] 2 + C 7 8H 1 o40 1 oN 1 4 1 5 1 Eu 2 requires 849.3223; HPLC (solvent system B, 4.6 x 150 
m m 4 pm Phenomenex Synergi Fusion RP 80A analytical column): tR = 8.5 min. 
Tb(III) complex of bis-7-[(lS,2S)-l,2-diphenyl-ethylcarbamoyl]-methyl-
4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododecane ( [ T b 2 L 5 7 ] 6 + ) 
Bis-7-[(lS,2S)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-bis-[((S)-l-phenyl-
ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane as its T F A salt (0.017 g, 
0.013 mmol, molar mass of ligand as its free base used) and T b C l 3 . 6 H 2 0 (0.031 
g, 0.083 mmol) in dry MeOH (1.5 ml) were heated at reflux for 36 h, in Schlenk 
apparatus, under an atmosphere of argon. The solution was then cooled to room 
temperature followed by removal of the solvent under reduced pressure. The solid 
was sonicated in D C M ( 2 x 5 ml) followed by solid collection by centrifugation and 
decanting of the D C M phase, the solid was dried under reduced pressure. The grey 
solid left was sonicated in water (5 ml) , the water was then decanted followed by 
the drying of the remaining solid under reduced pressure. The complex was isolated 
f rom excess T b C l 3 using benzoylated dialysis tubing (9 mm flat width) , as described 
earlier, to yield the desired product as a white powder (0.020 g, 0.010 mmol, 80 % ) ; 
MS ( E S + in the presence of excess ammonium acetate) m/z 571.7 [M - I - 2 C H 3 C 0 2 -
H ] 3 + 90 %, 857.2 [M + 2 C H 3 C 0 2 - 2 H ] 2 + 100 %; HRMS (ES+) m/z found 857.3270 
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[M + 2CH3CO2 - 2 H ] 2 + C 7 8 H 1 o40 1 oN 1 4 1 5 9 Tb 2 requires 857.3278; HPLC (solvent 
system B, 4.6 x 150 m m 4 \im Phenomenex Synergi Fusion RP 80A analytical 
column): t R = 8.7 min. 
Yb(III) complex of bis-7-[(lS,2S)-l,2-diphenyl-ethylcarbamoyl]-methyl-
4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododecane ( [ Y b 2 L 5 7 ] 6 + ) 
Bis-7-[(lS,2S)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-bis-[((S)-l-phenyl-
ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane as its T F A salt (0.044 g, 
0.034 mmol, molar mass of ligand as free base used) and Y b ( O A c ) 3 . 4 H 2 0 (0.086 g, 
0.20 mmol) in M e O H : H 2 0 (2 ml , 50:50) were heated at reflux for 48 h, in Schlenk 
apparatus, under an atmosphere of argon. The solution was then cooled to room 
temperature followed by removal of the solvent under reduced pressure. The complex 
was isolated f r o m excess Y b ( O A c ) 3 using benzoylated dialysis tubing, as described 
earlier, to yield the desired product as a white solid (0.055 g, 0.028 mmol, 82 % ) ; 
m.p. 191-192°C (decomposition point); MS ( E S + in the presence of excess ammo-
nium acetate) m/z 581.6 [M + 2 C H 3 C 0 2 - H ] 3 + 100 %, 872.2 [M + 2 C H 3 C 0 2 - 2 H ] 2 + 
5%; HRMS ( E S + ) m/z found 869.3400 [M + 2 C H 3 C 0 2 - 2 H ] 2 + C 7 8 H 1 0 4 0 1 o N 1 4 Y b 2 
requires 869.3391; H P L C (solvent system B, 4.6 x 150 m m 4 u.m Phenomenex Syn-
ergi Fusion RP 80A analytical column): t R = 8.4 min. 
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Bis-7-[(lS,2R)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-bis-[((S)-l-
phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane-l-
carboxylic acid teri-butyl ester 
7-Carboxymethyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-
tetra-aza-cyclododecane-l-carboxylic acid ier t -butyl ester (0.070 g, 0.107 mmol), 
T B T U (0.034 g, 0.106 mmol) , H O B t . x H 2 0 (0.014 g, 0.104 mmol) and N E t 3 (0.03 
ml , 0.215 mmol) in MeCN (1.5 ml) were stirred, under argon, at room temperature 
for 15 min followed by the addition of raeso-l,2-diphenylethylenediamine (0.011 g, 
0.052 mmol) . The pale yellow solution was stirred at room temperature for 24 h 
followed by the removal of solvent under reduced pressure. The remaining yellow 
residue was taken up in D C M (10 ml) to give a solution that was extracted wi th 
HCl(aq) (0.1 M , 20 ml ) , sat. N a H C 0 3 (10 ml) then H 2 0 (10 ml) . The organic 
solution was concentrated to a volume of 1 m l under reduced pressure then dripped 
into cold diethyl ether (15 ml) . The pale yellow precipitate was collected by 
centrifugation then dried under reduced pressure to yield the desired product as 
a cream coloured powder (0.042 g, 0.028 mmol, 54 % ) ; m.p. 92-94°C; J H - N M R 
(CDC1 3 , 500 MHz) 5 7.73 (s br, 1H, amide NH) , 7.14-7.29 (m br, 35H, arm and 
linker Ar protons and amide NH) , 5.40 (m, 2H, linker CH) , 5.12 (m br, 4H, arms 
CH), 2.25-3.23 (m br, 44H, cyclen C H 2 , arms C H 2 C O and linker C H 2 C O ) , 1.46 
(m br, 12H, arms C H 3 ) , 1.41 (m br, 18H, ( B u C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, 
1H decoupled 500 MHz) 6 170.6 and 170.5 (br, 6C, arms and linker C = 0 ) , 156.3 
(2C, f Boc C = 0 ) , 143.5 and 138.8 (br, 6C, arms and linker P h ( q ) ) , 128.9, 128.5, 
127.9, 126.8, 126.6 (30C, arms and linker Ph), 80.1 (2C, ' B o c ^ ) , 60.3, 58.0, 57.2, 
54.3, 53.2, 48.7 (br, 28C, cyclen C H 2 , arms C H 2 , linker C H 2 and arms and linker 
Ph Ph -< 
NH NH 
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CH), 28.8 (6C, <Boc C H 3 ) , 22.3, 21.7 (4C, amide arm C H 3 ) ; MS ( E S + ) m/z 742.0 
[M + 2 H ] 2 + 100 %, 1481.8 [M + H ] + 5 %, 1503.8 [M + N a ] + 3 %; HRMS (ES+) 
m/z found 1481.9060 [M + H]+ C ^ H m O i o N ^ requires 1481.9072. 
Bis-7-[(lS,2R)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-bis-[((S)-l-
phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraeiza-cyclododecane ( L 5 8 ) 
Ph Ph 
NH NH 
rv °1 rv H N Ph H N > nfT Tf* 1 
N H N Ph N 
H 
HN HN 
>- Ph Ph 
A colourless solution of bis-7-[(lS,2R)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-
bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane-l-carb-
oxylic acid i e r i -bu ty l ester (0.038 g, 0.026 mmol) in D C M / T F A (2:1, 3 ml) was 
stirred for 12 h in a sealed flask. The resultant' yellow tinged solution was dried 
under reduced pressure to yield the T F A salt of the desired product, as a glassy 
yellow solid, in quantitative yield; ^ - N M R ( C D 3 C N , 500 MHz) 5 7.93 (d, 1H, 
J=9.0 Hz, linker amide N H ) , 7.86 (d, 1H, J=9.0 Hz, linker amide NH) , 7.00-7.59 
(m, 34H, arm and linker Ar and arm NH) , 5.32 (m, 2H, linker CH), 5.08 (m, 1H, 
amide arm CH) , 4.90 (m, 1H, amide arm CH), 4.77 (m, 1H, amide arm CH), 4.66 
(m, 1H, amide arm CH), 2.45-3.62 (m, 44H, cyclen C H 2 , arm C H 2 and linker C H 2 ) , 
1.49, 1.44, 1.22 (m, 12H, arm C H 3 ) ; 1 3 C - N M R ( C D 3 C N , 125 MHz, : H decoupled 
500 MHz) 5 171.2, 170,8 (4C, arms C = 0 ) , 163.6, 163.5 (2C, linker C = 0 ) , 159.7 (q, 
4C, T F A C = 0 ) , 144.8, 144.3 (4C, arm A r ( q ) ) , 139.5, 139.2 (2C, linker A r ( q ) ) , 129.8, 
129.5, 129.4, 129.2, 129.1, 128.1, 128.0, 127.1 (30C, arm and linker A r ) , 116.4 (q, 4C, 
TFA C F 3 ) , 58.8 (2C, linker CH), 47.0-56.6 (m br, 22C, cyclen C H 2 ) linker C H 2 ) arm 
CH), 44.0 (4C, arm C H 2 ) , 22.9, 22.6, 22.1, 22.0 (4C, arm C H 3 ) . MS (ES+) m/z 641.6 
[M + 2 H ] 2 + 100 %; HRMS (ES+) m/z found 641.4038 [M + 2 H ] 2 + C74H 1o 2OeN 14 
requires 641.4048. 
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Eu(III) complex of bis-7-[(lS,2R)-l,2-diphenyl-ethylcarbamoyl]-methyl-
4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododecane ( [ E u 2 L 5 8 ] 6 + ) 
Bis-7-[(lS,2R)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-bis-[((S)-l-phenyl-
ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane as its TFA salt (0.019 g, 
0.015 mmol, molar mass of ligand as its free base used) and E u ( O T f ) 3 (0.053 g, 0.088 
mmol) in dry MeCN (1.75 ml) were heated at reflux for 72 h, in Schlenk apparatus, 
under an atmosphere of argon. The solution was then cooled to room temperature 
followed by removal of the solvent under reduced pressure. The solid was sonicated 
in D C M ( 2 x 5 ml) followed by solid collection by centrifugation and decanting of 
the D C M phase, the solid was dried under reduced pressure. The resultant cream 
coloured solid was sonicated in ether (5 ml) , the ether was then decanted followed 
by the drying of the remaining solid. The solid was made water soluble by the 
exchange of the t r i f la te anions for chloride anions using ' D O W E X 1x8 200-400 mesh 
CI ' ion exchange resin as described earlier. The complex was isolated f rom excess 
E u C l 3 using benzoylated dialysis tubing, as described previously, to yield the desired 
product as a white solid (10 mg, 0.005 mmol, 33 % ) ; MS ( E S + in the presence of 
excess ammonium acetate) m/z 567.3 [M + 2 C H 3 C 0 2 - H ] 3 + 100 %, 850.5 [M + 
2 C H 3 C 0 2 - 2 H ] 2 + 50%; HRMS (ES + ) m/z found 849.3222 [M + 2 C H 3 C 0 2 - 2 H ] 2 + 
C 7 8 H 1 o 4 0 1 o N 1 4 1 5 1 E u 2 requires 849.3223; HPLC (solvent system B, 4.6 x 150 mm 4 
u.m Phenomenex Synergi Fusion RP 80A analytical column): t R = 8.8 min. 
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Tb(III) complex of bis-7-[(lS,2R)-l,2-diphenyl-ethylcarbamoyl]-methyl-
4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-
cyclododecane ( [ T b 2 L 5 8 ] 6 + ) 
^ 
H . r \ \ L 
Ph 
6+ 6CI" 
H 2 0' 
NH 
S r\\>, 
-N 
HN 
0 
O H 2 
H 
HN 
Bis-7-[(lS,2R)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-bis-[((S)-l-phenyl-
ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane as its TFA salt (0.008 g, 
0.006 mmol, molar mass of ligand its free base used) and T bCi3 .6H 2 0 (0.014 g, 0.037 
mmol) in dry M e O H (1 ml) were heated at reflux for 48 h, i n Schlenk apparatus, 
under an atmosphere of argon. The solution was then cooled to room temperature 
followed by removal of the solvent under reduced pressure. The solid was sonicated in 
D C M ( 2 x 1 ml ) , the D C M was each time decanted followed by the further sonication 
then drying of the solid under reduced pressure. The complex was isolated f rom 
excess TbCl3 using benzoylated dialysis tubing, as described earlier, to yield the 
desired product as a white powder (0.007 g, 0.0036 mmol, 60 % ) ; MS ( E S + in the 
presence of excess ammonium acetate) m/z 572.3 [M + 2 C H 3 C 0 2 - H ] 3 + 83 %, 857.6 
[M + 2 C H 3 C 0 2 - 2 H ] 2 + 100 %; HRMS (ES+) m/z found 857.3284 [M + 2 C H 3 C 0 2 
- 2 H ] 2 + C 7 8 H 1 0 4 0 i o N i 4 1 5 9 T b 2 requires 857.3278; HPLC (solvent system B, 4.6 x 150 
mm 4 (xm Phenomenex Synergi Fusion RP 80A analytical column): t R = 8.9 min. 
186 
Yb(III) complex of bis-7-[(lS,2R)-l,2-diphenyl-ethylcarbamoyl]-methyl-
4,10-bis- [((S)- 1-pheny 1-ethylcarbamoy l)-methyl]-1,4,7,1O-tetraaza-
cyclododecane ( [ Y b 2 L 5 8 ] 6 + ) 
Bis-7-[(lS,2R)-l,2-diphenyl-ethylcarbamoyl]-methyl-4,10-bis-[((S)-l-phenyl-
ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane as its TFA salt (0.063 g, 
0.049 mmol, molar mass of ligand its free base used) and Y b ( O A c ) 3 . 4 H 2 0 (0.123 g, 
0.29 mmol) in M e O H : H 2 0 (2 ml , 50:50) were heated at reflux for 48 h, in Schlenk 
apparatus, under an atmosphere of argon. The solution was allowed to cool to 
room temperature followed by removal of the solvent under reduced pressure. The 
complex was isolated f rom excess Yb(OAc )3 using benzoylated dialysis tubing, as 
described earlier, to yield the desired product as a white solid (0.065 g, 0.031 mmol, 
64 % ) ; m.p. 196-197°C (decomposition point); MS ( E S + in the presence of ex-
cess ammonium acetate) m/z 581.6 [M + 2 C H 3 C 0 2 - H ] 3 + 100 %, 872.0 [M + 
2 C H 3 C 0 2 - 2H] 2 + 15%; HRMS (ES+) m/z found 869.3392 [M + 2 C H 3 C 0 2 - 2 H ] 2 + 
C 7 8 H i 0 4 O 1 0 N 1 4 Y b 2 requires 869.3391; HPLC (solvent system B, 4.6 x 150 mm 4 \im 
Phenomenex Synergi Fusion RP 80A analytical column): t R = 8.7 min. 
6+ 6(OAc • 
Ph Ph 
NH NH 
5 o H 
N Ph N \ N—v OH 
J Ph N V H 
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5.2.3 Solid phase supported complex 
AT-[(S)-l-(4-Bromo-phenyl)-ethyl]-2,2,2-trifluoro-acetamide 
H 
1° I" c / S c C F : i 
N.G T 
C F 
B B 
Br 
(S)-(-)-a-methylbenzylamine (13.4 ml , 105.3 mmol) in C H 2 C 1 2 (25 ml) was added 
dropwise to a st irr ing solution of trifluoroacetic anhydride (14.8 ml , 106.5 mmol) in 
C H 2 C 1 2 (70 ml ) , under argon, at 0°C. After the addition was complete the solution 
was allowed to warm to room temperature then stirred for a further 3 h. The solution 
was further cooled to 0°C followed by the addition of 70% methanesulfonic acid (22.9 
ml, 314.3 mmol) then l,3-dibromo-5,5-dimethylhydantoin (15 g, 52.5 mmol). The 
suspension was allowed to warm to room temperature then stir for 18 h to yield a 
bright orange solution that was washed w i t h aq. NaHSOa solution (1 M , 700 ml) 
then H 2 0 (500 ml ) . The resultant colourless organic layer was evaporated to dryness 
under reduced pressure to yield a crude white product that was twice recrystallised 
from diethyl ether/hexane to yield the desired product as white needle-like crystals 
(7.2 g, 24.3 mmol, 23 % ) ; m.p. 154-156°C ( L i t . 1 4 6 153-155°C); : H - N M R (CDC1 3 , 
700 MHz) S 7.51 (d, 2H, J=7.5 Hz, H s ) , 7.20 (d, 2H, J=8.5 Hz, H c ) , 6.38 (s br, 1H, 
NH) , 5.11 (m, 1H, H e ) , 1.58 (d, 3H, J=7.0 Hz, H F ) ; 1 3 C - N M R (CDC1 3 , 175 MHz, 
*H decoupled 700 MHz) 6 156.8 (1C, C G ) , 140.3 (1C, C D ) , 132.5 (2C, C B ) , 128.3 (2C, 
Cc), 122.5 (1C, CA), 49.6 (1C, CE), 21.4 (1C, C F ) ; 1 9 F - N M R (CDC1 3 , 658 MHz) 6 
-75.9 (3F, C F 3 ) ; MS (ES+) m/z 318.1 [M + N a ] + 100 %; HRMS (ES+) m/z found 
317.9713 [M + Na]+ C 1 0 H 9 O N 7 9 B r F 3 2 3 N a requires 317.9712; C i 0 H 9 B r F 3 N O (%): 
calcd C 40.57, H 3.06, N 4.73; found C 40.47, H 3.03, N 4.67. 
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JV-[(S)-l-(4-Cyano-phenyl)-ethyl]-2,2,2-trifluoro-acetamide 
CuCN (1.46 g, 16.3 mmol) was added to a stirring solution of JV-[(S)-l-(4-bromo-
phenyl)-ethyl]-2,2,2-trifluoro-acetamide (3.72 g, 12.56 mmol) in anhydrous D M F (15 
ml) followed by the reflux of the resultant mixture at 150°C for 96 h. The resultant 
dark green solution was left to cool to room temperature followed by removal of 
solvent under reduced pressure. The crude residue was taken up in D C M (100 ml) 
then washed w i t h aq. HC1 (1 M , 2 x 100 ml) , sodium bisulfite solution (1 M , 100 
ml) then H 2 0 (100 ml) . The organic layer was dried under reduced pressure to leave 
the desired product as a crystalline brown solid (2.13 g, 8.79 mmol, 70 % ) ; m.p. 
98-99°C; ^ - N M R (CDC1 3 , 500 MHz) 6 7.68 (d, 2H, J=6.5 Hz, H s ) , 7.43 (d, 2H, 
7=8.0 Hz, H c ) , 6.56 (s br, 1H, N H ) , 5.16 (m, 1H, H # ) , 1.60 (d, 3H ,V=7.5 Hz, 
H F ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, X H decoupled 500 MHz) 8 156.7 (1C, C G ) , 146.6 
(1C, CD), 133.2 (2C, C B ) , 127.2 (2C, C c ) , 118.7 (1C, -CN), 112.4 (1C, 0 0 , 49.9 
(1C, CE), 21.5 (1C, C F ) ; 1 9 F - N M R (CDC1 3 , 470 MHz, T H decoupled 500 MHz) 5 
-76.1 (3F, C F 3 ) ; MS (ES~) m/z 241.1 [M - H]~ 100 %; HRMS (ES~) m/z found 
241.0594 [M - H ] - C i i H 8 O N 2 F 3 requires 241.0594; C n H 9 F 3 N 2 0 (%): calcd C 54.55, 
H 3.75, N 11.57; found C 54.48, H 3.85, N 11.65. 
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(S)-iV-Ethanoyl-l-(4-bromophenyl)ethyiamine' 
Acetyl chloride (0.231 ml , 3.25 mmol) was added dropwise to a vigorously stirring 
anhydrous solution of 5-(-)-l-(4-bromophenyl)ethylamine (0.365 ml , 2.50 mmol) and 
N E t 3 (0.452 m l , 3.25 mmol) in diethyl ether (30 ml) at -10°C. The solution was 
allowed to warm to room temperature then stir for a further 2 h. The resultant 
cloudy white mixture was washed wi th H 2 0 (100 ml) then HCl(aq) (0.1 M , 30 ml) , the 
ether layer was separated, dried wi th sodium sulfate then evaporated under reduced 
pressure to leave the desired product as a white solid (0.606 g, 2.50 mmol, 100 
% ) . A small amount of product recrystallised f rom diethyl ether for characterisation 
purposes was isolated as white needle-like crystals; m.p. 127-129°C ( L i t . 6 8 127-
130°C); J H - N M R (CDC1 3 , 400 MHz) 5 7.45 (dd, 2H, J=6.5 , 1.5 Hz, H B ) , 7.19 (dd, 
2H, J=6.5, 2.5 Hz, H c ) , 5.64 (s br, 1H, NH) , 5.08 (m, 1H, EE), 1.96 (s, 3H, H „ ) , 
1.46 (d, 3H, J=7 .0 Hz, H F ) ; 1 3 C - N M R (CDC1 3 , 100 MHz, *H decoupled 400 MHz) 
6 169.3 (1C, C G ) , 142.5 (1C, C D ) , 132.0 (2C, C B ) , 128.2 (2C, C c ) , 121.4 (1C, CA), 
48.5 (1C, CE), 23.7 (1C, CH), 21.9 (1C, C F ) ; MS (ES+) m/z 264.0 [M + N a ] + 15 
%, 296.0 [M + Na + M e O H ] + 100 %; HRMS ( E S + ) m/z found 263.9994 [M + Na]+ 
C 1 0 H 1 2 O N 7 9 B r 2 3 N a requires 263.9995; C 1 0 H 1 2 B r N O (%): calcd C 49.61, H 5.00, N 
5.79; found C 49.48, H 4.98, N 5.52. 
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(5)-AT-Ethanoyl-l-(4-cyanophenyl)ethylamine' 
H 
N.G T H 
B B 
III 
N 
CuCN (0.29 g, 3.24 mmol) was added to a stirring solution of (S ,)-7V-ethanoyl-
l-(4-bromophenyl)ethylamine (0.606 g, 2.50 mmol) i n anhydrous D M F (30 ml) fol -
lowed by the reflux of the resultant mixture at 150°C for 96 h. The resultant dark 
green solution was left to cool to room temperature followed by the addition of 
HCl(aq) (6M, 40 ml) in a well ventilated fumehood. The resulting solution was ex-
tracted w i t h D C M (2 x 20 ml) followed by washing of the obtained organic phase 
wi th H 2 0 (2 x 30 ml ) . The organic layer was dried under reduced pressure followed 
by recrystallisation of the crystalline brown solid obtained f rom ethyl acetate/hexane 
to give the desired product as rectangular white crystals (0.228 g, 1.21 mmol, 48 % ) ; 
m.p. 188-190°C ( L i t . 6 8 187-189°C); J H - N M R (CDC1 3 , 500 MHz) 6 7.64 (dd, 2H, 
J=6.5, 1.5 Hz, H f l ) , 7.42 (d, 2H, J=8.5 Hz, H c ) , 5.71 (s br, 1H, NH) , 5.14 (m, 1H, 
RE), 2.03 (s, 3H, H w ) , 1.48 (d, 3H, J=7.0 Hz, H F ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, 
X H decoupled 500 MHz) 6 169.6 (1C, C G ) , 149.1 (1C, C D ) , 132.9 (2C, CB), 127.2 
(2C, C c ) , H 9 . 1 (1C, -CN), 111.5 (1C, CA), 49.0 (1C, CE), 23.7 (1C, C„), 21.9 (1C, 
C F ) ; MS (ES+) m/z 189.1 [M + H]+ 65 %; HRMS (ES+) m/z found 189.1023 [M + 
H ] + C n H 1 3 O N 2 requires 189.1022; C i i H 1 2 N 2 0 (%): calcd C 70.19, H 6.43, N 14.88; 
found C 70.05, H 6.49, N 15.00. 
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(5)-4-(l-Aminoethyl)benzoic acid' 
NH 
B 
C 0 2 H 
A solution of (5)-Af-ethanoyl-l-(4-cyanophenyl)ethylamine (0.228 g, 1.21 mmol) 
in HCl ( a q ) (6M, 50 ml) was heated at reflux for 96 h. The solution was left to cool 
then solvent was removed under reduced pressure to leave the hydrochloride salt of 
the desired product, as an off-white crystalline solid, in quantitative yield. *H-NMR 
( D 2 0 , 500 MHz) 5 7.86 (dd, 2H, J=7.0, 2.0 Hz, H B ) , 7.37 (dd, 2H, J=6.5, 1.5 Hz, 
H c ) , 4.48 (q, 1H, J=7 .0 Hz, H £ ) , 1.52 (d, 3H, J=7.0 Hz, H F ) ; 1 3 C - N M R ( D 2 0 , 125 
MHz, X H decoupled 500 MHz) 6 170.2 (1C, C 0 2 H ) , 143.1 (1C, CD), 132.3 (1C, CA), 
130.6 (2C, C B ) , 126.9 (2C, C c ) , 50.8 (1C, CE), 19.4 (1C, C F ) ; MS (ES~) m/z 164.4 
[M - H]~ 100 %; HRMS (ES") m/z found 164.0715 [M - H]~ C 9 H 1 0 O 2 N requires 
164.0717. 
(5)-4-(l-Aminoethyl)benzoic acid was also obtained via the reflux of iV-[(S)-l-(4-
cyano-phenyl)-ethyl]-2,2,2-trifluoro-acetamide (2.13 g, 8.79 mmol) in HCl ( a q ) (6M, 
50 ml) for 72 h. The solution was allowed to cool, filtered then dried under reduced 
pressure to leave the hydrochloride salt of the desired product in quantitative yield. 
Spectral properties of the product were identical to those reported in the above 
method. 
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(S)-Methyl-4-(l-aminoethyl)benzoate (59) 
B B 
C0 2Me 
Concentrated HCl(aq) (12M, 2.5 ml) was added dropwise to a solution of the hy-
drochloride salt of (5)-4-(l-aminoethyl)benzoic acid (0.243 g, 1.21 mmol) in anhy-
drous methanol (15 ml) and heated at reflux, under argon, for 24 h. The solution was 
allowed to cool to room temperature then dried under reduced pressure to leave the 
desired product, as its hydrochloride salt, in quantitative yield. 1 H - N M R ( C D 3 O D , 
400 MHz) 5 8.10 (d, 2H, J=8.5 Hz, H B ) , 7.59 (dd, 2H, J=9.0, 0.5 Hz, H c ) , 4.56 
(q, 1H, J=7 .0 Hz, H s ) , 3.92 (s, 3H, OMe), 1.66 (d, 3H, J=7.0 Hz, H F ) ; 1 3 C - N M R 
( C D 3 O D , 100 MHz, *H decoupled 400 MHz) 6 168.6 (1C, C 0 2 M e ) , 145.4 (1C, C D ) , 
132.8 (1C, CU), 132.1 (2C, CB), 128.8 (2C, Cc), 53.6 (1C, OMe), 52.7 (1C, CB), 
21A (1C, C F ) ; MS ( E S + ) m/z 180.0 [M + H ] + 100 %; HRMS (ES+) m/z found 
180.1019 [ M + H ] + C 1 0 H 1 4 O 2 N requires 180.1019. 
193 
7-([(S)-l-(4-Methoxycarbonyl-phenyl)-ethylcarbamoyl]-methyl)-4,10-bis-
[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane-
1-carboxylic acid tert-butyl ester (60) 
A solution of 7-carboxymethyl-4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-
1,4,7,10-tetraaza-cyclododecane-l-carboxylic acid tert-butyl ester (0.164 g, 0.267 
mmol) , EDC.HC1 (0.056 g, 0.292 mmol), H O B t . H 2 0 (20 mg) and N E t 3 (0.11 ml , 
0.789 mmol) in chloroform (10 ml) was stirred for 20 minutes at room temperature. 
(i?)-Methyl-4-(l-aminoethyl)benzoate (0.057 g, 0.318 mmol) in chloroform (2 ml) 
was then added to fo rm a yellow tinged solution that was stirred for a further 12 
hours. The resultant solution was extracted wi th sat. N a H C 0 3 solution (10 ml) 
then H 2 0 (30 ml) followed by drying of the organic phase under reduced pressure 
to leave a yellow tinged glassy residue. The desired product was isolated f rom the 
crude solid by column chromatography (alumina using a D C M / M e O H solvent sys-
tem starting f rom 100 % D C M then increasing the volume of MeOH by 0.1 % every 
100 ml thereafter) to yield the desired product as a clear glassy solid (167 mg, 0.205 
mmol, 77 % ) ; RF (Alumina, DCM-MeOH, 98.5:1.5) : 0.51; m.p. 43-46°C; J H - N M R 
(CDC1 3 , 500 MHz) 6 7.93 (d, 2H, J=8.5 Hz, H B ) , 7.21-7.30 (m, 13H, H c , arm Ar 
and linker amide N H ) , 6.99 (s br, 2H, arm amide N H ) , 5.10 (m, 3H, arm and linker 
CH), 3.87 (s, 3H, OMe), 2.36-3.26 (m br, 22H, cyclen, linker and arm C H 2 ) , 1.46 
(d, 6H, J=7 .0 Hz, amide arm C H 3 ) , 1.43 (d, 3H, 7=7.0 Hz, linker C H 3 ) , 1.39 (s, 
9H, { B u C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 MHz, X H decoupled 500 MHz) 5 170.4, 170.2, 
169.9 (3C, arm and linker amide C = 0 ) , 167.0 (1C, methyl ester C = 0 ) , 156.1 (1C, 
4 B u C = 0 ) , 148.7 (1C, C D ) , 143.9, 143.3 (2C, arm A r ( q ) ) , 130.3 (2C, C B ) , 129.5 (1C, 
CA), 129.0, 128.9, 127.9, 127.5, 126.8 (10C, arm A r ) , 126.6 (2C, C c ) , 80.2 ( ' B u ( q ) ) , 
HN O HN 
1 L , / 
NH 
r Ph 
B 
Ph 
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59.7, 58.9 (2C, amide arm C H 2 ) , 57.8 (1C, linker C H 2 ) , 54.1, 53.9, 53.2 (br, 8C, 
cyclen C H 2 ) , 52.5 (1C, OMe), 48.5, 48.1, 47.8 (3C, amide arm and linker CH), 28.8 
(3C, 4 B u C H 3 ) , 22.2, 21.7 (3C, amide arm and linker C H 3 ) ; MS ( E S + ) m/z 814.5 
[M + H]+ 100 %. HRMS ( E S + ) m/z found 814.4870 [M + H ] + C 4 5 H 6 4 0 7 N 7 requires 
814.4862. 
4-[(S)-l-(2-(4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-
tetraaza-cyclododec-l-yl)-acetylamino)-ethyl]-benzoic acid methyl ester 
(L 6 1 ) 
Me0 2 C 
HN O HN 
O K N i IN H 
;—NH 
Ph 
Ph 
A solution of 7-([(S)-l-(4-methoxycarbonyl-phenyl)-ethylcarbamoyl]-methyl)-
4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane-l-
carboxylic acid tert-butyl ester (114 mg, 0.160 mmol) in D C M : T F A (3 ml , 50:50) 
was left to stir, in a sealed flask at room temperature, for 12 hours. The resultant 
solution was dried under reduced pressure to leave the T F A salt of the desired 
product, as a colourless glassy solid, in quantitative yield; *H-NMR ( C D 3 C N , 500 
MHz) 6 7.95 (d, 2H, J=8.5 Hz, H B ) , 7.81 (d, 1H, J=7.5 Hz, linker amide NH) , 7.41 
(d, 2H, J=8.0 Hz, H c ) , 7.23-7.30 (m, 12H, amide arms Ar and N H ) , 4.97 (m, 3H, 
arm and linker CH) , 3.84 (s, 3H, OMe), 2.84-3.38 (m br, 22H, cyclen, linker and 
arm C H 2 ) , 1.38-1.41 (m, 9H, arm and linker C H 3 ) ; 1 3 C - N M R ( C D 3 C N , 125 MHz, 
*H decoupled 500 MHz) S 171.0, 170.5 (2C, arm amide C = 0 ) , 167.4 (1C, methyl 
ester C = 0 ) , 164.1 (1C, linker amide C = 0 ) , 160.7 (q, 1C, T F A C = 0 ) , 149.7 (1C, 
C D ) , 144.8, 144.6 (2C, amide arm A r ( q ) ) , 130.6 (2C, C B ) , 130.2 (1C, CA), 129.5, 
129.4, 128.1, 128.0, 127.0 (10C, amide arm A r ) , 127.2 (2C, C c ) , H5.9 (q, 1C, TFA 
C F 3 ) , 56.4, 55.8 (2C, amide arm C H 2 ) , 55.4 (1C, linker C H 2 ) , 53.0, 50.9, 50.4, 49.9, 
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49.7, 49.3 (11C br, cyclen C H 2 and arm and linker CH), 52.7 (1C, OMe), 22.6, 22.3 
(3C, arm and linker C H 3 ) ; MS (ES+) m/z 714.5 [M + H ] + 100 %; HRMS (ES + ) 
m/z found 714.4346 [ M + H ] + C 4 0 H 5 6 O 5 N 7 requires 714.4337. 
Eu(III) complex of 4-[(S)-l-(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-
methyl]-l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-ethyl]-benzoic 
acid methyl ester ( [EuL 6 1 ] 3 + ) 
Ph 
NH 
H2Q 
A HJ N—v N.V 
X L 
N. J H20 \—w N 
H 
OMe HN 
Ph 
3+ 3CI" 
A solution of 4-[(S)-l-(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-
l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-ethyl]-benzoic acid methyl ester as 
its TFA salt (115 mg, 0.139 mmol) and E u ( O T f ) 3 (74 mg, 0.124 mmol) in MeCN (1 
ml) was heated at reflux, under argon, for 48 hours. The resultant yellow solution 
was dried under reduced pressure to leave a yellow glassy solid. D C M (2 ml) was 
added to the solid and the mixture sonicated for 5 minutes followed by the decanting 
of solvent, this procedure was repeated followed by the drying of the resultant solid 
to yield the tr if late salt of the desired product as a pale brown powder (109 mg, 0.081 
mmol, 65 % ) . The complex was further obtained as its chloride salt by the stirring of 
the tr if late salt in a H 2 0 : M e O H solution (5 ml , 50:50) containing Dowex 1x8 200-400 
mesh CI ion exchange resin, as described earlier, to yield the desired chloride salt as 
a white powder (74 mg, 0.073 mmol, 90 % ) ; m.p. (chloride salt) >250°C; J H - N M R 
(as tri-chloride salt, D 2 0 , 500 MHz, partial data and assignment) 6 26.8 (1H, NH) , 
17.7 (1H, H ^ ) , 15.2 (1H, H ^ ) , 11.3 (1H, H ^ ) , 10.7 (1H, H ^ ) , -3.3 (1H), -3.9 (1H), 
-4.4 (1H), -4.8 (1H), -5.2 (1H), -5.3 (1H), -7.4 (1H), -9.0 (1H), -9.8 (1H), -10.2 (1H), 
-11.3 (1H), -13.9 (1H), -14.1 (1H), -15.5 (1H), -15.8 (1H), -18.8 (1H); MS (ES+) (as 
triflate salt) m/z 1014.4 [M - H + C F 3 S 0 3 ] + 100 %, 1164.4 [M + 2 C F 3 S 0 3 ] + 10 % 
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(cone-voltage of 90V), 488.7 [M + C F 3 C 0 2 ] 2 + 75 %, 507.7 [ M + C F 3 S 0 3 ] 2 + 100 %, 
1014.5 [M - H + C F 3 S 0 3 ] + 15 %, 1128.5 [M + C F 3 S 0 3 + C F 3 C 0 2 ] + 85 %, 1164.5 
[M + 2 C F 3 S 0 3 ] + 90 % (cone-voltage of 30V); HRMS ( E S + ) m/z found 1164.2542 
[M + 2 C F 3 S 0 3 ] + C 4 2 H 5 5 0 1 1 E u N 7 F 6 S 2 requires 1164.2512; r ( H 2 o ) : 0.28 ms, r ( D 2 0 ) : 
0.61 ms; H P L C (solvent system B, 4.6 x 150 m m 4 |j.m Phenomenex Synergi Fusion 
RP 80A analytical column): t R = 10.5 min. 
7-([(S)-l-(4-Carboxy-phenyl)-ethylcarbamoyl]-methyl)-4,10-bis-[((S)-
l-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-tetraaza-cyclododecane-l-
carboxylic acid tert-buty\ ester 
7-([(S)-l-(4-Methoxycarbonyl-phenyl)-ethylcarbamoyl]-methyl)-4,10-bis-[((S)-l-
phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododecane-l-carboxylic acid 
tert-butyl ester (40 mg, 0.049 mmol) and L i O H . H 2 0 (6 mg, 0.143 mmol) were dis-
solved in H 2 0 : M e O H (50:50, 4 ml) and heated at reflux for 12 h wi th vigorous 
stirring. The solution was allowed to cool then MeOH was removed under reduced 
pressure, the p H of the remaining aqueous phase was adjusted to 7 wi th dilute 
HCl(aq) followed by extraction wi th CHC1 3 (3 x 10 ml) . The combined organic ex-
tracts were dried under reduced pressure to leave the desired product as a white 
glassy solid (39 mg, 0.049 mmol, 100 % ) ; X H - N M R (CDC1 3 , 500 MHz) 8 7.86 (d, 
2H, J=6 .0 Hz, H s ) , 7.43 (d, 2H, J=7.0 Hz, H c ) , 7.23-7.35 (m, 12H, amide arms Ar 
and N H ) , 5.77 (s br, 1H, acid arm NH) , 5.14 (m, 1H, acid arm CH), 4.98 (m, 2H, 
amide arms CH) , 2.91-3.70 (m br, 22H, cyclen and arms C H 2 ) , 1.50 (d, 9H, J=7.0 
Hz, acid arm and amide arms C H 3 ) , 1.40 (s, 9H, ' B u C H 3 ) ; 1 3 C - N M R (CDC1 3 , 125 
MHz, *H decoupled 500 MHz) 8 168.9, 167.5 (3C, acid and amide arm amide C = 0 ) , 
Ph 
O HN HN X , N—v O 
\ _ K , ) ^ N ? V > ° o 
o NH 
r Ph 
B 
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156.0 (1C, f B u C = 0 ) , 143.9 (2C, amide arm A r ( q ) ) , 143.4 (1C, C D ) , 130.6 (2C, CB), 
129.0 (1C, CU), 128.9, 127.8, 126.5 (10C, arm A r ) , 126.7 (2C, C c ) , 81.5 ( ' B u ^ ) , 
56.7, 53.8 (br, 8C, cyclen C H 2 ) , 49.8 (2C, amide arms CH) , 49.2 (1C, acid arm CH), 
46.7 (3C, acid and amide arm C H 2 ) , 28.7 (3C, £ B u C H 3 ) , 22.6 (2C, amide arm C H 3 ) , 
22.0 (1C, acid arm C H 3 ) ; MS (ES~) m/z 797.6 [M - H ] ~ 100 %, 833.5 [M + C I ] - 60 
%. HRMS (ES+) m/z found 800.4690 [M + H ] + C 4 4 H 6 2 0 7 N 7 requires 800.4705. 
4-[(S)-l-(2-(4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-
tetraaza-cyclododec-l-yl)-acetylamino)-ethyl]-benzoic acid ( L 6 2 ) 
B 
Ph 
HN HN X . N—v O 
\ _ M NX Q N H 
NH 
Ph 
A solution of 7-([(S)-l-(4-carboxy-phenyl)-ethylcarbamoyl]-methyl)-4,10-bis-
[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l ,4,7,10-tetraaza-cyclododecane-l-carboxy-
lic acid tert-butyl ester (41 mg, 0.051 mmol) in DCM:CHC1 3 :TFA (1:1:1, 3ml) was 
stirred in a sealed flask overnight at room temperature. The resulting yellow tinged 
solution was dried under reduced pressure to yield the TEA salt of the desired 
product, as a colourless glassy solid, in quantitative yield. X H - N M R ( C D 3 C N , 500 
MHz) 6 8.31 (s br, 1H, acid arm N H ) , 8.00 (d, 2H, J=8.5 Hz, H B ) , 7.60, 7.55 (s br, 
2H, amide arms N H ) , 7.45 (d, 2H, J=8.0 Hz, H c ) , 7.27-7.39 (m, 10H, amide arms 
A r ) , 5.02 (m, 3H, acid and amide arm CH), 3.82 (m, 2H, acid arm C H 2 ) , 2.92-3.40 
(m br, 20H, cyclen and amide arm C H 2 ) , 1.47 (d, 3H, J=7 .0 Hz, acid arm C H 3 ) , 1.43 
(d, 6H, J=7 .0 Hz, amide arm C H 3 ) ; 1 3 C - N M R ( C D 3 C N , 125 MHz, X H decoupled 
500 MHz) S 171.3, 170.8, 170.5 (3C, acid and amide arm amide C = 0 ) , 168.1 (1C, 
COOH), 161.0 (q, 1C, TEA C = 0 ) , 149.7 (1C, CD), 144.6 (2C, amide arm A r ( q ) ) , 
130.9 (2C, C B ) , 130.3 (1C, CA), 129.5, 128.1, 127.1 (10C, amide arm A r ) , 127.8 (2C, 
C c ) , H5 .9 (q, 1C, T F A C F 3 ) , 56.7, 56.3 (2C, amide arm C H 2 ) , 55.3 (1C, acid arm 
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C H 2 ) , 53.0, 51.2 (8C br, cyclen C H 2 ) , 50.5, 50.0, 49.8 (3C, acid and amide arm CH), 
22.9, 22.7, 22.3 (3C, arm and linker C H 3 ) ; MS (ES+) m/z 381.9 [M + C u ] 2 + 100 
%, 700.4 [M + H]+ 40 %; HRMS (ES+) m/z found 700.4171 [M + H ] + C 3 9 H 5 4 0 5 N 7 
requires 700.4181. 
Eu(III) complex of 4-[(S)-l-(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-
methyl]-l,4,7,10-tetraaza-cyclododec-l-yl)-acetyl-amino)-ethyl]-benzoic 
acid ( [EuL 6 2 ] 2 + ) 
Ph -< 
NH 
H2Q 
A HJ N—\ 
" v . M V N . J H,0 \ — M N 
H 
O 
O HN 
Ph 
2+ 2cr 
A solution of 4-[(S)-l-(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-
l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-ethyl]-benzoic acid as its TFA salt 
(115 mg, 0.141 mmol) and E u ( O T f ) 3 (70 mg, 0.115 mmol) in MeCN (3 ml) was 
heated at reflux, under argon, for 48 h. The resultant yellow tinged solution was 
dried under reduced pressure to leave a yellow glassy solid. D C M (2 ml) was added 
to the solid and the mixture sonicated for 5 minutes followed by the decanting of 
solvent, this procedure was repeated wi th D C M then diethyl ether (3 ml) followed 
by the drying of the resultant solid to yield the triflate salt of the desired product as 
a pale brown powder. The solid was made water soluble by the exchange of triflate 
anions for chloride anions using D O W E X 1x8 200-400 mesh CI ion exchange resin, 
as described earlier, to yield the complex as its chloride salt (100 mg, 0.101 mmol, 
88 % ) ; : H - N M R (as tri-chloride salt, D 2 0 , 500 MHz, partial data and assignment) 
5 26.9 (1H, N H ) , 17.9 (1H, H ^ ) , 15.3 (1H, H ^ ) , 11.4 (1H, H ^ ) , 10.7 (1H, H a x ) , 7.6 
(1H), -3.2 (1H), -4.1 (1H), -4.6 (1H), -4.8 (1H), -5.2 (1H), -5.4 (1H), -7.4 (1H), -9.1 
(1H), -9.9 (1H), -10.3 (1H), -11.3 (1H), -13.9 (1H), -14.3 (1H), -15.6 (1H), -16.0 (1H), 
-18.9 (1H); MS ( E S + ) (in the presence of excess ammonium acetate) m/z 455.9 [M 
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+ C H 3 C 0 2 ] 2 + 100 %, 910.3 [M + C H 3 C 0 2 - H]+ 5 %; HRMS (ES+) m/z found 
908.3371 [M + C H 3 C 0 2 - H ] + C 4 i H 5 5 0 7 N 7 1 5 1 E u requires 908.3356. 
E u ( I I I ) complex of 4 - [ (S) - l - (2 - (4 ,10-Bis - [ ( (S) - l -phenyl -e thylcarbamoyl ) -
methyl]- l ,4 ,7 ,10-tetraaza-cyclododec- l -yl ) -acetyl-amino)-ethyl]-benzoic 
acid 2,5-dioxo-pyrrolidine 1-yl ester 
3+ 3CI 
Ph -< 
NH 
O 
H2Q 
H J N—v 
N N N o H 
N O 
HN 
O 
Ph 
E u ( I I I ) complex of 4-[(S)-l-(2-(4,10-Bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-
l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-ethyl]-benzoic acid (20 mg, 0.02 m-
mol), T B T U (8 mg, 0.025 mmol) and N E t 3 (0.006 ml, 0.043 mmol) in anhydrous 
D M F (0.5 ml) were stirred for 10 min followed by the addition of NHS (3 mg, 0.026 
mmol). The solution was stirred for 12 h under argon followed by removal of solvent 
under reduced pressure. The residue was taken up in anhydrous MeCN (0.5 ml) 
followed by precipitation of the crude desired product by the addition of anhydrous 
diethyl ether (5 ml ) . The solid was isolated by centrifugation then dried under 
reduced pressure; MS ( E S + ) m/z 497.4 [M + C H C 0 2 ] 2 + 90 %, 993.3 [M + C H C 0 2 
- H ] + 10 %; HRMS ( E S + ) m/z found 496.1719 [M + C H C 0 2 ] 2 + C 4 4 H 5 7 0 9 N 8 1 5 1 E u 
requires 496.1718. 
Acet ic ac id 2 ,5-dioxo-pyrrol idin- l -y l ester 
o XX) 
yV-Hydroxysuccinimide (1.33 g, 11.56 mmol) was transferred to stirring dry D C M 
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(10 ml) followed by the addition of dry N E t 3 (3.23 ml , 23.17 mmol) to form a ho-
mogenous solution. Acetyl chloride (1.07 ml , 15.05 mmol) was then added dropwise 
over 5 min to form a yellow tinged solution. The mixture was stirred for 2 h followed 
by washing of the reaction solution wi th H 2 0 ( 2 x 5 ml) . The organic phase was 
dried under reduced pressure to leave a yellow tinged solid. The solid was recrys-
tallised f rom ethyl acetate/hexane to yield the desired product as a white solid (1.02 
g, 6.49 mmol, 56 % ) ; m.p. 132-134°C ( L i t . 1 4 7 131-134°C); ^ - N M R ( C D 3 C N , 700 
MHz) 5 2.76 (s, 4H, NHS C H 2 ) , 2.30 (s, 3H, C H 3 ) ; 1 3 C - N M R ( C D 3 C N , 175 MHz, 
X H decoupled 700 MHz) 6 171.1 (2C, NHS C = 0 ) , 167.3 (1C, ester C = 0 ) , 26.4 (2C, 
NHS C H 2 ) , 17.7 (1C, C H 3 ) ; MS (EI) m/z 42.9 [CH 3 CO]+ 100%, 156.9 [M]+ 5 %. 
Solid phase supported E u ( I I I ) complex of 4 - [ (S) - l - (2 - (4 ,10-Bis - [ ( (S) -
l -phenyl-ethylcarbamoyl) -methyl] -1 ,4 ,7 ,10-tetraaza-cyclododec- l -y l ) -
acetylamino)-ethyl]-benzoic acid 
3+ 3Cr 
A f f l - G e l ® 102 bound complex 
Aff i -Gel® 102 (5 ml) was poured into an eppendorf followed by H 2 0 removal from 
the sample by centrifugation. The remaining gel was thrice washed wi th H 2 0 (5 ml) 
followed by centrifugation and solvent removal. H 2 0 (10 ml) was added to the re-
maining solid and the suspension was thoroughly vortex mixed, E u ( I I I ) complex of 4-
[(S)-l-(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclod-
odec-l-yl)-acetylamino)-ethyl]-benzoic acid (56 mg, 0.056 mmol) was added to the 
resultant gel followed by immediate pH adjustment to 4.8 wi th dilute K O H ( a q ) solu-
tion. E D C H C 1 (24 mg, 0.125 mmol) was added to the gel followed by vortex mixing, 
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the p H was immediately adjusted to 5 w i t h dilute HCl(aq) solution. The gel was left 
mixing end over end for 12 h. The reaction solvent was removed by centrifugation 
and dried under reduced pressure, analysis showed unreacted complex was present. 
The dried solvent layer was redissolved in H2O (10 ml) and added to the remaining 
solid followed by vortex mixing. EDC.HC1 (50 mg, 0.261 mmol) was added to the 
gel followed by immediate pH adjustment to 4.8, the reaction was left stirring end 
over end. Af te r 12 h the solvent was removed by centrifugation, the remaining solid 
was washed thrice wi th H 2 0 (10 ml) that was also removed by centrifugation. The 
remaining solid was dried under reduced pressure to leave the desired product as 
white granules. The resin was resuspended in D M F (1.5 ml) followed by the addition 
of acetic acid 2,5-dioxo-pyrrolidin-l-yl ester (24 mg, 0.153 mmol) . The mixture was 
stirred end over end for 12 h. Solvent was removed and the resin was washed and 
dried as described above to leave the desired N H 2 capped resin as white granules. 
Elemental analysis determined Eu( I I I ) content to be 0.22 %, 0.014 mmol g - 1 . 
T e n t a G e l ™ S - N H 2 bound complex 
T B T U (22 mg, 0.069 mmol) and H O B t . x H 2 0 (5 mg, 0.037 mmol) were added to a 
solution of E u ( I I I ) complex of 4-[(S)-l-(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-
methyl]-l,4,7,10-tetraaza-cyclododec-l-yl)-acetylamino)-ethyl]-benzoic acid (65 mg, 
0.065 mmol) in D M F (1 ml) and stirred for 20 min. The yellow tinged solution 
was then added to T e n t a G e l ™ S - N H 2 (530 mg) pre-soaked in D M F (2 ml) , under 
argon. The mixture was stirred end over end for 24 h. Solvent was removed by 
centrifugation. The remaining resin was washed w i t h D M F ( 2 x 5 ml) then H 2 0 
( 2 x 5 ml) w i t h the resin being separated by centrifugation. The washed resin was 
dried under reduced pressure. The resin was resuspended in D M F (1.5 ml) followed 
by the addition of acetic acid 2,5-dioxo-pyrrolidin-l-yl ester (90 mg, 0.573 mmol). 
The mixture was stirred end over end for 12 h. Solvent was removed and the resin 
was washed and dried as described above to leave the desired N H 2 capped resin 
as yellow granules. Elemental analysis determined Eu( I I I ) content to be 0.31 % or 
0.020 mmol g - 1 , this corresponds to 4.4 % derivatization as the resin N H 2 content 
is stated as ~0.45 mmol g _ 1 . 
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A separate experiment followed the above procedure and used the following amounts 
of material; T e n t a G e l ™ S-NH 2 (269 mg), T B T U (11 mg, 0.034 mmol) , H O B t . x H 2 0 
(1 mg, 0.007 mmol) and complex (33 mg, 0.033 mmol) . The resin was capped 
wi th acetic acid 2,5-dioxo-pyrrolidin-l-yl ester (38 mg, 0.242 mmol) . This yielded 
resin w i t h a E u ( I I I ) content of 1.01 % or 0.066 mmol g - 1 , corresponding to 14.7 % 
derivatization. ^ - N M R ( C D 3 O D , 500 MHz, MAS, partial data) Broadened peaks 
attr ibuted to paramagnetically shifted resonances of the E u ( I I I ) complex were ob-
served at 5 34.5, 30.8, 20.8, 22.2, 18.4, 17.5, -7.5, -10.2, -11.2, -13.0, -16.5, -19.9, 
-28.6. 
S i M A G - A m i n o bound complex 
Solvent was removed f rom an aqueous suspension of S iMAG-Amino particles (50 mg 
in 1 ml) by centrifugation. The remaining particles were washed w i t h an aqueous so-
lut ion of MES (0.1 M , pH 6, 2 x 1 ml) . EDC.HC1 (10 mg, 0.005 mmol) was dissolved 
in fresh MES solution (0.25 ml) followed by addition of the E u ( I I I ) complex of 4-[(S)-
l-(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cycIododec-
l-yl)-acetylamino)-ethyl]-benzoic acid (10 mg, 0.01 m M ) . The resulting solution was 
added to the S iMAG-Amino particles followed by addition of MES solution (0.5 ml) . 
The suspension was stirred end over end for 24 h, followed by isolation of the solid 
by centrifugation. The isolated particles were further washed by H 2 0 ( 2 x 1 ml) 
and MeOH (1 ml) , isolated by centrifugation each time followed by drying. The 
dried particles were suspended in anhydrous D M F (0.5 ml) followed by addition of 
acetic acid 2,5-dioxo-pyrrolidin-l-yl ester (5.5 mg, 0.035 mmol). The suspension 
was stirred end over end for 24 h followed by removal of solvent by centrifugation. 
The solid was washed as described previously to yield the desired capped orange-
brown particles. Elemental analysis determined Eu( I I I ) content to be 0.04 % or 
0.0028 mmol g _ 1 , this corresponds to 0.8 % derivatization as the resin N H 2 content 
is stated as ~0.35 mmol g - 1 . 
A n alternative procedure was also followed. A solution of Eu ( I I I ) complex of 4-[(S)-l-
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(2-(4,10-bis-[((S)-l-phenyl-ethylcarbamoyl)-methyl]-l,4,7,10-tetraaza-cyclododec-l-
yl)-acetylamino)-ethyl]-benzoic acid (12 mg, 0.012 mmol) and EDC.HC1 (3 mg, 0.016 
mmol) in D M F (1 ml) was shaken for 10 min then added to dried SiMAG-Amino par-
ticles (66 mg). The resulting suspension was stirred end over end. Af te r 24 h acetic 
acid 2,5-dioxo-pyrrolidin-l-yl ester (8 mg, 0.05 mmol) was added to the suspension 
and stirring continued for 3 h. The particles were then isolated by centrifugation, 
washed w i t h H 2 0 (2 x 1 ml) and MeOH ( 2 x 1 ml) , then dried under reduced 
pressure to leave the desired capped orange-brown particles. Elemental analysis de-
termined E u ( I I I ) content to be 0.02 % or 0.013 mmol g _ 1 , this corresponds to 3.8 
% derivatization as the resin N H 2 content is stated as ~0.35 mmol g - 1 . 
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Appendix A 
H P L C conditions and 
representative traces 
Solvent system A 
T i m e A B Gradient 
0 - 5 min 100 % 0 % N / A 
5 - 20 min 100 % ^ 0 % 0 % - » 1 0 0 % Linear 
20.1 - 25 min 0 % ^ 1 0 0 % 100 % - » 0 % Linear 
Table A . l - Flow rate: 1 ml m i n " 1 ; Solvent A: H 2 0 + 0.1 % HCOOH; Solvent B: 
MeCN + 0.1 % HCOOH. 
Solvent system B 
T i m e A B Gradient 
0 - 5 min 100 % 0 % N / A 
5 - 20 min 1 0 0 % - * 0 % 0 % -> 100 % Linear 
20.1 - 25 min 0 % - » 1 0 0 % 100 % - » 0 % Linear 
Table A.2 - Flow rate: 1 ml m i n - 1 ; Solvent A: H 2 0 + 0.1 % CF 3 COOH; Solvent 
B: MeCN + 0.1 % C F 3 C O O H . 
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Figure A . l - HPLC traces from analysis of [ E u L 4 4 a ] 3 + . Left: absorbance (335 nm); 
Right: emission (612 nm, A e x c = 335 nm); Solvent system B; 4.6 x 150 mm 4 u.m 
Phenomenex Synergi Fusion RP 80A analytical column. 
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Figure A.2 - HPLC traces from analysis of [ E u L 4 9 ] 2 + . Left: absorbance (332 nm); 
Right: emission (612 nm, A e x c = 332 nm); Solvent system A; 4.6 x 150 mm 4 |im 
Phenomenex Synergi Fusion RP 80A analytical column. 
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Figure A.3 - HPLC traces from analysis of [ E u L 5 0 ] 3 + . Left: absorbance (335 nm); 
Right: emission (612 nm, A e x c = 335 nm); Solvent system A; 4.6 x 150 mm 4 |j.m 
Phenomenex Synergi Polar-RP 80A analytical column. 
[GdL 4 4 b] 4 4 l 3 + 
350 
300 
250 
200 
S ' 5 0 
ra 100 
1 50 
<rt 
3 " 
•50 
-100 
•150 
200 
« 6 0 0 
0 1 2 3 4 5 6 7 6 9 10 11 12 13 14 15 16 17 IB 19 20 21 22 23 24 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
Time (min) 
Figure A.4 - HPLC traces from analysis of [ G d L 4 4 b ] 3 + . Left: absorbance (254 nm); 
Right: absorbance (380 nm); Solvent system A; 4.6 x 150 mm 4 |j.m Phenomenex 
Synergi Polar-RP 80A analytical column. 
A3 
[ E u L 5 1 b ] 3 + 
700 j 
6O0 i 
5O0 -. 
400 '-
O 
U 
C 300 •: 
a j 
| zoo J 
§ 100 : 
- loo. ; 
•200 | 
60 
« 
c 
30 
20 
J 
0 t 2 3 a 5 8 7 a 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 0 1 2 3 4 5 6 7 9 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
Time (mln) 
Figure A.5 - HPLC traces from analysis of [ E u L 5 1 b ] 3 + . Left: absorbance (370 nm); 
Right: emission (612 nm, A e x c = 370 nm); Solvent system A; 4.6 x 150 mm 4 u.m 
Phenomenex Synergi Fusion RP 80A analytical column. 
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Figure A.6 - HPLC traces from analysis of [ E u L 6 1 ] 3 + . Left: absorbance (255 nm); 
Right: emission (612 nm, AeXc = 255 nm); Solvent system B; 4.6 x 150 mm 4 u.m 
Phenomenex Synergi Fusion RP 80A analytical column. 
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Appendix B 
Ligand ^ - N M R spectra 
Full X H-NMR spectra of all ligands are shown below. 
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Figure B.5 - CD3CN, 700 MHz, 295 K, 3 mM. 
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Figure B.8 - CD 3CN, 700 MHz, 295 K, 5 mM. 
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Appendix C 
Crystal data 
Data for 2-phthalimidomethyl-7-methoxycarbonyl-l-azathioxanthone 
empirical formula C23H 1 4 N 2 O 5 S.0.5(C 6 H 6 ) 
formula weight 469.48 
r ( K ) 120 (2) 
crystal system triclinic 
space group P 
a (A) 13.2703 (17) 
6 ( A ) 13.8540 (18) 
c ( A ) 13.9589 (18) 
a (deg) 67.47 (1) 
P (deg) 66.06 (1) 
7 (deg) 73.64 (1) 
V ( A 3 ) 2142.2 (5) 
Z 4 
u. ( m m - 1 ) 0.20 
crystal dimensions (mm) 0.27 x 0.15 x 0.03 
A9 
Appendix D 
Notable structures 
Notable structures discussed in this thesis, included for reference use. 
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